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Abstract
This thesis argues that variable structure control theory finds application in immunology.
The immune system maintains a healthy state by using feedback to switch on and off
immune responses. Experimental and mathematical work has analysed the dynamics of
the immune response of T cells, relatively little attention has been paid to examine the
underlying control paradigm. Besides, in modelling and simulation studies, it is necessary
to evaluate the impact of uncertainty and perturbations on immunological dynamics. This
is important to deliver robust predictions and insights. These facts motivate considering
variable structure control techniques to investigate the control strategy and robustness of
the immune system in the context of immunity to infection and tolerance. The results
indicate that the dynamic response of T cells following foreign or self-antigen stimulation
behaves as a naturally occurring switched control law. Further, the reachability analysis
from sliding mode control highlights dynamical conditions to assess the performance and
robustness of the T cell response dynamics. Additionally, this approach delivers dynamical
conditions for the containment of Human Immunodeficiency Virus (HIV) infection by the
HIV-specific CD8+ T cell response and antiretroviral therapy by enforcing a sliding mode
on a manifold associated with the infection-free steady-state. This condition for immunity
reveals particular patterns for early diagnosis of eventual success, marginal and failure
cases of antiretroviral therapy. Together, the findings in this thesis evidence that variable
structure control theory presents a useful framework to study health and disease dynamics
as well as to monitor the performance of treatment regimes.
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This thesis presents an interdisciplinary research between control engineering and mathe-
matical immunology. In this thesis, the variable structure control paradigm is applied to
study the dynamics of the specific T cell response as well as to formulate dynamical condi-
tions for the maintenance of desirable immunological outcomes. The main objective is to
improve the understanding of health and disease dynamics by using a control approach in
order to contribute to modelling and simulation in immunology.
Control theory is a mature discipline in the analysis of dynamical systems with uncer-
tainty. Mathematical models of engineering or phenomenological processes are constructed
to capture the essential dynamics of the system in order to produce realistic input-output
behaviour. As an abstraction of reality, there are discrepancies between a model and the
real system. Furthermore, different factors such as ageing of the real system, disturbances,
neglected dynamics and variations in parameter values contribute to disparities between
every model and the real system. It is common practice to begin analysing the stability
and dynamical behaviour of the mathematical model at nominal conditions before consid-
ering potential uncertainties. In fact, it is important to design a control strategy which
exhibits robustness properties in order to enforce the desired stability and performance
despite uncertainty. Consequently, several analytical techniques have been developed to
study uncertain dynamical systems and to formulate robust control strategies.
1
Introduction 2
A fixed structure control approach consists in designing and imposing a single structure
control strategy such as a proportional feedback for the given system to meet the design
objectives and required robustness [3–5]. In contrast, a variable structure control approach
allows the control structure to change so that in high frequency the system dynamics can
achieve the desired dynamical behaviour and robustness properties [6–8]. This approach of-
fers several benefits and has been applied successfully to mechanical, electrical and chemical
systems [9–13]. Switching between different dynamics is advantageous because the desirable
properties of several subsystems can be combined so that the overall system possesses new
and enhanced dynamical behaviours, including properties that are not present in any of the
individual subsystems alone. Moreover, implementing a variable structure control strategy
has been demonstrated to yield strong robustness properties in the presence of parameter
uncertainties [7, 10, 14–16].
Sliding mode control is a special type of variable structure control [7, 10, 17]. In sliding
mode control, a switching function is chosen to ensure the system yields the desired stability
and performances when the states of the system lie on this manifold. Using Lyapanov
stability analysis [14–16, 18], a reachability condition, which represents a condition for the
sliding manifold to be attractive to the states of the system is, formulated. Next, a variable
structure control is designed to satisfy this reachability condition so that the system states
lie in the vicinity of the chosen switching function. Typically, a discontinuous or sigmoidal
control function is implemented [19–23]. The sliding mode control approach provides two
fundamental benefits: reduced order dynamics and total invariance to a certain class of
uncertainty implicit in the input channels [7, 10, 13, 24]. Furthermore, using the concept of
equivalent control, which represents the theoretical injection to maintain the sliding motion,
the dynamics of unknown input signals or disturbances can be reconstructed and estimated
[25–28]. Hence, the variable structure control theory provides a suitable framework for the
analysis of the systems with switching mechanisms, in addition to the impact of uncertainty
and disturbances.
In immunology, there is a need to understand the dynamics of the immune system in var-
ious contexts, such as acute infection, chronic infection and autoimmunity [29–31]. This
knowledge is important because it provides information on health and disease dynamics in
vivo and contributes to the improvement of treatment and prevention strategies. In recent
decades, mathematical studies have been conducted to investigate the dynamics of the im-
mune system [30, 32, 33]. Typically, a system of Ordinary Differential Equations (ODEs)
Introduction 3
inspired by Predator-Prey dynamics in ecology is constructed to model the immunological
phenomenon of interest. In addition to experimental studies, the mathematical modelling
of immune cells and virus dynamics in vivo has delivered relevant insights, including infor-
mation on HIV dynamics in vivo [34–36]
In order to formulate useful and robust predictions from a given model, it is important to
understand the impact of parameter and modelling uncertainty, as well as the discrepan-
cies between the observed dynamics and the dynamics produced by the model. In fact,
uncertainties in the model are associated with a number of different factors such as lack of
biological data for parameter estimation, unmeasurable state variables, ageing or patient-
to-patient variability. This motivates the use of tools from variable structure control in
immunological modelling and simulation because they enable the assessment of the effects
of uncertainty on the dynamics and predictions of the models.
Current findings in immunology present the immune system as a dynamical system with
feedback to maintain a robust healthy state in the body [2, 31, 37]. In fact, the immune sys-
tem can be regarded as a set of cellular and molecular feedback mechanisms which regulate
and control the immune response in order to preserve a healthy immunological homeostasis
[31, 38–40]. In [41], it was hypothesised that the population of immune cells and antibodies
either increases or decreases depending upon the antigen stimulation. The development
of experimental facilities has validated this hypothesis. Additionally, experimental studies
have provided kinetic data showing sharp changes in the population dynamics of T cells
following acute infection to achieve immunity and prevent tissue damage [1, 42, 43].
Following vigorous infection, the population of responding antigen-specific T cells increases
exponentially from a small number to a large number of cells at the peak of the response.
After this peak, which occurs a few days post-infection, a large number of T cells die and few
cells survive [44, 45]. This dynamical behaviour is known as the immune response program.
This immunological program dictates the expansion, contraction and memory phase of the
T cell response. From an immunological perspective, this dynamic control of the population
size of T cells occurs to contain the infection, as well as to prevent autoimmunity. Hence,
the population dynamics of the specific T cell response exhibit an inherent switching law
which underpins the observed cellular dynamics.
The cellular and molecular mechanisms driving the population dynamics of the specific T
cell response remain the subject of active research. Consequently, different mathematical
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approaches have been proposed to model the dynamics of the antigen-specific T cell response
[29, 38, 46, 47]. In previous analyses of the population dynamics of the specific T cell
response, experimental results on Lymphocytic Choriomeningitis Virus (LCMV) infection
in mice have often been considered. Experimental studies on LCMV infection in [1, 2,
48] have provided information on the kinetic variation of the number of CD8+ T cells
in the spleen over time after acute and chronic infection. These kinetic data have been
useful in the parameterisations of ODE models of the specific CD8+ T cell response. The
focus of previous modelling approaches was on formulating different biological hypotheses
for the immune response paradigm in order to explain the observed cellular dynamics
[1, 29, 39]. Nonetheless, the control features that these dynamics yield have not been
investigated. Further, previous mathematical studies neglected to analyse the robustness
of the expansion/contraction dynamics of the CD8+ T cell response following acute and
chronic infection.
A reason to consider that a switched control paradigm is at play is due to the fact that
despite the differences in mathematical expression and related biological assumptions, sen-
sible models of the T cell response provide a switching mechanism to engender the required
changes in T cell population dynamics to capture the expansion, contraction and memory
phase of the immune response. Additionally, a number of approaches have used saturation
functions to prescribe the required changes in T cell population [29, 46]. Interestingly, the
work in [38] referred to the immune response program as a switching process which governs
the dynamic response of T cells post-infection. Further, the authors in [38] investigated
the characteristics of candidate immune response functions. From the viewpoint of con-
trol engineering, the use of saturation functions to model the immune response program
engenders a dynamic change in feedback regimes. This motivates the investigation of the
synergies between the variable structure control paradigm and the T cell immune response
dynamics. These investigations are important to improve understanding of the dynamics
and robustness properties of the antigen-specific T cell response.
Besides, the dynamic response of the total T cell population plays a major role in the
maintenance of self-tolerance [31, 49, 50]. In mathematical studies, candidate immune
response functions have been proposed to describe the dynamic response of self-reacting
T cells in order to study the mechanism of self-tolerance and the onset of autoimmunity
[40, 51, 52]. It is important to analyse means by which candidate immune response functions
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establish a robust state of tolerance. This is useful to understand how self-tolerance is
maintained in vivo as well as to inform for candidate treatment for autoimmunity.
In the study of Human immunodeficiency Virus infection dynamics in vivo, the impact
of the HIV-specific CD8+ T cell response in the containment of the infection is a critical
research topic because it yields the potential for developing immunotherapies which will
relieve patients from the lifelong uptake of antiretroviral drugs [30, 36, 53]. It remains
unclear how the killing mechanisms of CD8+ T cells enforces an asymptomatic state in
HIV-infected patients. In the last three decades, different mathematical expressions have
been proposed to model the impact of HIV-specific CD8+ T cell response [30, 54, 55]. The
control of HIV infection is often evaluated by computing the reproductive ratio [34, 35, 56].
In effect, the reproductive ratio sets a static threshold condition to determine whether the
infection will spread or not.
Although it was mentioned that the HIV-specific CD8+ T cell response might control HIV
infection [56–58], no formal control analysis was conducted on this immunological control
mechanism. This motivates the analysis of the containment of HIV infection in vivo using a
control engineering approach. The objective is to improve the understanding of the control
performance of the HIV-specific CD8+ T cell response and antiretroviral therapy during
the progression of the infection.
1.2 Thesis organisation
The thesis is organized as follows:
Chapter 2 provides a background on the VSC paradigm. The purpose of this chapter is to
introduce analytical tools from VSC theory. The phase portrait analysis of the trajectories
of an oscillator system with different control strategies is used to illustrate the basic prin-
ciples and benefits of the variable structure control approach. Subsequently, a pendulum
system is used to present the framework of sliding mode control. The design procedure for
a sliding mode along with the reachability condition and the concept of the equivalent con-
trol are discussed. Moreover, a particular attention is given to show the robustness of the
closed-loop dynamics of the system, when a discontinuous or a sigmoidal control function
is applied.
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Chapter 3 begins with a background on immunology. Next, a VSC approach is used to
analyse the dynamics of the antigen-specific T cell response following vigorous infection.
Rather than formulating another candidate model, a variable structure control approach is
used to investigate the control features and robustness of the T cell response dynamics. It
is assumed that a dynamic control is at play because the immune system highly regulates
the cellular dynamics of T cells post-infection [2, 44, 45]. This regulation operates in
such a way that appropriate immunological feedback can be enforced in order to maintain
health. In essence, various feedback mechanisms are triggered following antigen stimulation,
and the outcome of the combined effects of these immunological feedback mechanisms
which promote or inhibit the immune response yield the observed kinetics of the T cell
population post-infection. Interestingly, the core of VSC consists of switching between
different feedback regimes according to a predefined switching logic that allows the system to
achieve the desired performance. A phase portrait analysis is conducted to assess the control
strategy of the immune system to elicit desirable immune response dynamics. Moreover, a
sliding mode control analysis is used to investigate the robustness of the immune response
dynamics.
Chapter 4 focuses on the mechanism of self-tolerance. A background on the biology of the
self-tolerance mechanism is provided at the beginning of this chapter. Afterwards, a simple
mathematical model of self-tolerance/autoimmunity is considered. Next, the characteristics
of a set of candidate immune response functions and their impact on the achievement of self-
tolerance are investigated. Candidate immune response functions are examined as candidate
control strategies. Thus, the stability and the dynamical behaviour of the resulting closed-
loop systems is analysed to understand the maintenance of or loss of self-tolerance. Finally,
a reachability analysis is performed to design an adaptive sliding mode controller which
models the inhibition of self-reacting effector T cells to achieve a robust self-tolerance
steady-state.
A VSC approach is used in Chapter 5 to study the containment of HIV infection by the
HIV-specific CD8+ T cell response. The model of HIV infection dynamics formulated in
[56] is chosen for analysis. The cytolytic killing mechanism of CD8+ T cells is treated as a
control input which aims to enforce a stable infection free steady-state. Further, a manifold
associated with the infection free steady-state is identified. A reachability analysis is used to
investigate conditions for this manifold to be attractive to the states of the chosen system.
This is used to examine the control of HIV infection in vivo.
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A case study is conducted in Chapter 6 to study the dynamics of HIV following initiation
of antiretroviral therapy. The basic model of HIV dynamics used in [35, 59, 60] is chosen.
A manifold associated with the infection free steady-state is identified and a dynamical
condition for the containment of HIV infection by antiretroviral therapy is formulated using
the reachability paradigm from variable structure control. Next, measurement of CD4+ T
cell count and HIV load in the peripheral blood are used to estimate all the parameters
of the model for a set of HIV infected patients. Data points collected in the first month
following initiation of antiretroviral drugs are used for the estimation. The reproductive
ratio as well as the reachability condition are computed for each patient to monitor and
predict the progression of HIV infection following initiation of antiretroviral therapy. The
reported clinical outcomes are used to assess the correctness of the predictions.
The final chapter is divided in two parts. First, the conclusions of the thesis are presented.
Then, future work to build on the main findings of the thesis are suggested.
1.3 Contributions
The contributions of this thesis lie within the realm of modelling and simulation in im-
munology. An overview is given in Fig. 1.1.. The novelty of the approach resides in the fact
Figure 1.1: The approach and contributions
that variable structure control theory is utilised to investigate health and disease dynamics.
The specific contributions are as follows:
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• The work in Chapter 3 demonstrates the synergies between the observed cellular
dynamics of the specific T cell response following vigorous infection and the variable
structure control paradigm. The dynamic response of antigen-specific T cell following
vigorous infection fits the variable structure control paradigm because changes in T
cell population kinetics are underpinned by switching between different immunological
feedback regimes in order to achieve immunity. In addition, the findings from the
sliding mode analysis reinforce the notion that T cell response dynamics represent a
closed-loop system, including a robust VSC law. Moreover, the reachability analysis
is shown to be a suitable means to assess the impact of uncertainty and perturbations
on the T cell response dynamics following acute and chronic infection.
• In Chapter 4, the VSC approach delivers further understanding of the impact of
candidate immune response functions for the maintenance of self-tolerance. Candidate
immune response functions reflect potential feedback regimes of the immune system
to ensure self-tolerance. The transient dynamics and stability of the self-tolerance
equilibrium are significantly dependent on the shape and characteristics of the immune
response function. The framework of sliding mode control is used to demonstrate
that a robust state of tolerance is achievable using an adaptive sliding mode control
mechanism modelling an active suppression of self-reacting effector T cells.
• In chapter 5 the framework of sliding mode control is seen to deliver a dynamical
condition for the containment of HIV infection by the HIV-specific CD8+ T cell
response. The cytolytic killing mechanism modelled with a double saturation function
is shown to operate as a boundary layer control strategy from the immune system
to contain the infection in vivo. The time evolution of this dynamical condition
for immunity indicates that the immunological requirements to contain HIV in vivo
changes during the course of the infection.
• The case study conducted in Chapter 6 presents the reachability paradigm as a tool
which delivers a time varying condition for the containment of HIV infection fol-
lowing initiation of antiretroviral therapy. Furthermore, the analysis of HIV patient
data using the reachability condition reveals a dynamical signature associated with
the outcomes of antiretroviral therapy. Together, the results show that the reacha-
bility paradigm is adequate to monitor and predict the progression of HIV infection
following initiation of antiretroviral therapy.
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The work in this thesis has produced the following articles:
1. Anelone, Anet J.N., Spurgeon, Sarah K., Modelling and simulation of the dynamics
of the antigenspecific T cell response using variable structure control theory, 2016,
PLOS ONE 11(11): e0166163. doi: 10.1371/journal.pone.0166163
2. Anelone, Anet J.N., Spurgeon, Sarah K., Prediction of the Containment of HIV Infec-
tion by Antiretroviral Therapy - a Variable Structure Control Approach, IET Systems
Biology, 2016, DOI: 10.1049/iet-syb.2016.0028
3. Anelone, Anet J.N., Orlov, Yury, Spurgeon, Sarah K., Synergies between the dynam-
ics of the immune response of T cells and the variable structure control paradigm,
Recent Advances in Sliding Modes (RASM), 2015 International Workshop on , vol.,
no., pp.1,6, 9-11 April 2015
4. Anelone, Anet J.N., Oza, Harsal B., Spurgeon, Sarah K., The immune system: A
variable structure control perspective, Proceedings of the 19th IFAC World Congress,
24-29 August 2014, Cape Town, South Africa.
5. Anelone, Anet J.N., Orlov, Yury, Spurgeon, Sarah K., Modelling the self-tolerance
mechanisms of T cells: An adaptive sliding mode control approach, Control (CON-
TROL), 2014 UKACC International Conference on, vol., no., pp.573,578, 9-11 July
2014 doi: 10.1109/CONTROL.2014.6915203
In short, this introductory chapter has presented the central avenues of the thesis. The





The adaptive immune response is a set of cellular and molecular mechanisms which aim to
destroy foreign pathogen and infected tissues as well as to prevent self damage within the
host [37, 40]. Experimental studies have demonstrated that the specific response of T cells
following infection with virus or bacteria engenders a number of changes in the metabolism,
physiology, population and behaviour of the responding cells to clear the infection [2, 43,
61]. Interestingly, mathematical studies in [1, 29, 38] have shown that a sigmoidal or a
discontinuous activation function can be used to prescribe realistic changes in the T cell
population dynamics following vigorous infection. In effect, various immunological feedback
mechanisms interact to activate or inhibit the T cell response to recover a healthy state.
Thus, the immune system is intrinsically a dynamical system consisting of feedbacks and
inherent immunological decision rules. Further, the dynamics of the specific T cell response
has been shown to exhibit some robustness with respect to changes in various factors such
as the initial number of responding cells or virus strains [29, 44, 45]. However, the presence
of pathogen might impair the dynamics of the specific T response and induce undesirable
outcomes [2, 37]. Consequently, it is important to quantify and analyse T cell and virus
dynamics to understand how immunity is achieved in vivo and to inform the design of
treatment [29, 30, 32].
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The field of control engineering is a mature discipline involved with the study of uncertain
dynamical systems. In fact, a set of tools have been developed to investigate how to main-
tain desired stability and performance in the presence of parameter and model uncertainty
and disturbances. In the early 1960s in the Soviet union, the seminal work of Emelyanov
and Barbashin introduced the concept of Variable Structure Control Systems (VSCS). The
publication of a book by Itkis (1976) and a survey paper by Utkin (1977) in English allowed
the VSC paradigm to be known outside of Russia. A VSCS is in essence a dynamical system
with a set of feedback structures and a decision rule based on the states of the system [7].
The designed decision rule allows the system to switch between different feedback dynamics
during its operation to achieve the desired performance. Besides, sliding mode control, a
special type of VSC, has been developed to satisfy stability and performance requirements
by designing a switched control law which confines the trajectories of the system to a chosen
manifold of the state space. Importantly, systems with a VSC law have been demonstrated
to possess some inherent robustness to uncertainty and disturbances [7, 13–16]. Further,
techniques derived from VSC theory have been shown to deliver sensible insights on the
impact of uncertainty and disturbances on the dynamical behaviour of systems [8, 62].
The design of a sliding mode control starts by defining a switching function which defines
associated manifold to prescribe a stable dynamical behaviour which meets all the prede-
fined constraints and requirements [7, 15, 22, 63]. Next, the existence condition for a sliding
mode also known as the reachability condition is formulated. Afterwards, candidate control
strategies are investigated to render the chosen manifold attractive to the trajectories of
the system. It is common to have a discontinuous control such as the unit vector control
[10, 14, 15, 22]. Fundamentally, the choice of the switching function and its parameters
determine the dynamical behaviour of the system whilst the control gain ensures that the
dynamics of the system reach and remain on the sliding manifold. The resulting closed-
loop dynamics consist of a reaching phase in which the switching function moves towards
the manifold of interest and a sliding phase in which the switching function is confined
to the sliding manifold. During the reaching phase, the dynamics of the system are not
robust to uncertainty and perturbations. However, when sliding motion starts the system
exhibits reduced order dynamics and complete invariance to ”matched uncertainty” i.e a
class of uncertainty and perturbations present in the input channels. These advantages
have motivated the development of sliding mode control strategies in various application
such as furnace control, automotive engine control, control of electric motors and control
Chapter 2. Variable Structure Control Paradigm 12
of chemical processes [8, 10]. in addition, the sliding mode control paradigm has been used
to design robust regulators, state observers, model-reference control, adaptive schemes and
fault detection techniques [62, 64–66].
Sliding mode control techniques have evolved to preserve the core benefits of reduced order
dynamics and robustness to matched uncertainty whilst addressing new challenges brought
by specific application requirements and constraints. In effect, it is often not possible to
have measurements of all state variables. As a result, a framework has been developed to
design sliding mode control in which the switching function has only a subset of state mea-
surements as inputs [13, 16, 24, 67]. This subset of state measurements is usually called the
system outputs. Additionally, a discontinuous control injection to enforce a sliding mode
is undesirable in some practical implementations because the discontinuous control action
generates chattering i.e high frequency switching around the sliding manifold [23]. From
the literature on sliding mode control, several adaptation methodologies have been designed
[23, 64]. An appropriate adaptation scheme needs to ensure the reachability condition holds
with the minimum required amplitude of control gain. The adaptation method developed
in [64] stops when ideal sliding motion occurs. In contrast, the method in [23] continues the
adaptation process using an estimate of the equivalent control i.e the ”average” action of
the applied discontinuous control when ideal sliding mode occurs. Recently, an adaptation
algorithm which provides the minimum possible magnitude of the discontinuous control
under parameter uncertainty as well as reduction of chattering in first order sliding mode
control has been introduced in [25].
Apart from adaptation strategies, the smoothing approach which consists of using a contin-
uous approximation of the discontinuous control function eliminates chattering but does not
allow the switching function to remain on the sliding manifold [15, 21, 22, 63]. Therefore,
the resulting closed-loop dynamics lose some robustness. Next, an integral sliding mode
control has been proposed in [17] to remove the non-robust reaching phase. Moreover,
higher order sliding mode controllers in which the discontinuous control is found in higher
order derivatives of the switching function have been developed to suppress chattering and
achieve high performance [20, 25, 68].
This chapter reviews theory of VSC with a particular interest on some key notions which
will be used later in this thesis to investigate T cell and virus dynamics in vivo.
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The chapter is organized as follows: the basic philosophy of the VSC paradigm is presented
in the first section. The next section, sliding mode control theory, a special class of VSC
is reviewed. Next, the robustness properties of VSC are demonstrated in the third section.
Finally, the last section summarizes the main features of VSC theory.
2.2 Basic principles of switched control system
The VSC paradigm consists of changing the control structures during the operation of the
system according to a switching logic to force the system to exhibit desired stability and
performance requirements. The following examples from [7, 10] are used to show cases
in which switching between different control structure is beneficial to achieve the desired




which represents a double integrator system, a mass-spring damper with zero damping. The
initial conditions are y(0) = 1 and dy(0)
dt
= 0. The control objective is the establishment of
a stable motion of the dynamics of the system towards the origin using the control input
u(t).
The outcome of a single structure control strategy is investigated using the candidate linear
state feedback from [7]
u(t) = −ky(t) (2.2)
where the parameter k is a strictly positive scalar, equivalent to the spring constant. The
phase portrait of the dynamics of the closed-loop system generated by the negative feedback
(2.2) for two different values of k i.e k1 = 0.5 and k2 = 1.5 shows that the trajectories do
not move towards the origin, see Fig. 2.1. Therefore, this fixed structure control approach
does not achieve the required stability and performance. A Lyapanov analysis is conducted
to investigate the stability of the closed-loop system formed by the negative feedback (2.2).
In simple terms, Lyapanov stability theory states that if a positive definite function V can
be constructed using an algebraic combination of the state variables of the system, the
equilibrium of interest is asymptotically stable if the corresponding derivative is a negative
definite function of the state variables of the system [18]. From [10], a Lyapanov function
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Figure 2.1: Phase portrait of the double integrator system (2.1) with a fixed structure
control strategy (2.2).










Therefore, V (y(t), y(t)
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negative definite, when y(t)dy(t)
dt
< 0, k must be less
than unity but when y(t)dy(t)
dt
> 0, k must be greater than unity. Thus, the expression
(2.4) demonstrates that the magnitude of the gain k must change to allow the temporal
derivative of the Lyapanov function V (y(t), dy(t)
dt
) to be negative definite at all times so that
the resulting dynamics are asymptotically stable.
This is a motivation for the use of a switched control approach to achieve the desired
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control objective. In effect, the VSCS is characterized by a decision rule which purposefully
switches between different feedback dynamics during the process to achieve desired stability




















The phase portrait of the closed-loop dynamics resulting from this VSC law, see Fig. 2.2,
shows that the trajectories of this VSCS exhibits an asymptotically stable motion towards
the origin. In fact, this VSC law forces the trajectories to move closer to the origin in
each quadrant. Thus, the desired stability and performance requirements are achieved
by switching between two different feedback gain according to the evolution of the state
variables. Hence, in this example, the VSC approach is shown to generate a dynamical
behaviour which cannot be realized using a single control structure approach. Besides,
Figure 2.2: Phase portrait of the double integrator system (2.1) with a variable structure
control (2.5).
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+ u(t)y = 0 (2.6)
where ξ is a constant and u(t) is the control input. In the simulations, the parameter
ξ = 0.7 and the initial conditions are y(0) = 1 and dy(0)
dt
= 1. Here, a fixed structure
control where u(t) = 0.6 is shown to generate stable dynamics and to satisfy the desired
control objective, see the phase portrait in Fig. 2.3. Alternatively, the control objective can
Figure 2.3: Phase portrait of the oscillator system (2.6) with a stable fixed structure
control u(t) = 0.6 with poles at (−0.35 + 0.69i)
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with











where m is a positive scalar designed using the stable poles of the system (2.6).
Importantly, the phase portrait of the closed-loop dynamics imposed by the VSC law (2.7)
with m = 1, see Fig. 2.4, shows that after a short transient the trajectories of the oscillator
system move in a straight line i.e ”slide” towards the origin whilst being confined to a man-
ifold i.e s(y(t), dy(t)
dt
) = 0 of the state-space. This specific dynamical motion, conventionally
called a sliding mode [7, 10, 13, 16, 22], will be discussed in the next section. In comparison,
Figure 2.4: Oscillator system (2.6) with a variable structure control law. α = 0.6 and
m = 1.1 from (2.9) (2.7).
the time evolution of the output y(t) in Fig. 2.5 shows that the VSCS with (2.7) produces
a faster motion to reach and remain at the origin as compared to the ones produced by the
stable fixed structure control strategy. In fact, the VSC (2.7) has been designed to exploit
the fact that the unstable subsystem with u = −0.6 possesses some rapid transient towards
the origin, see Fig. 2.6.
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Figure 2.5: Comparison of the output response y(t) of the oscillator system (2.7) gener-
ated by the stable fixed structure control in Fig. 2.3 versus the switched control in Fig. 2.4.
The output response of the oscillator system shows that the designed switched control law
yields a faster settling time than the stable feedback alone.
Together these findings evidence the ability of the VSC approach to generate new dynamical
properties and behaviour which are not inherent in any of the sub-systems. Changing the
dynamic structure of a system during its operation using an appropriate decision rule is
seen to be beneficial to achieve desired stability and performance requirements.
2.3 Sliding mode control design and properties
The pendulum system is selected to present the basic design principles and properties of
sliding mode control, a special class of VSC. In fact, the pendulum system is relatively
simple and has been used in the literature to review the theory and benefits of SMC
[10, 13, 14, 16]. Although, a single input single output system has been used to demonstrate
the basic principles of sliding mode control, these results hold for multiple input multiple
output systems. The dynamical equations modelling a pendulum system can be written as
d2y(t)
dt2
= −a1sin(y(t)) + u(t) (2.10)
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Figure 2.6: Phase portrait of the unstable sub-system of (2.7) with the fixed control
structure u(t) = −0.6 with poles at 0.5 and −1.2
where a1 is a positive scalar. The state variable y(t) is the variation over time of the angular
displacement of the attached object from the vertical. The chosen control input is u(t), the
force applied at the point of suspension. Consider that the states variables y(t) and dy(t)
dt
are measurable and the initial conditions are y(0) = 0 and dy(0)
dt
= 0. The control objective
remains to force the trajectories of the system to attain and stay at the origin.
The design process starts by analyzing a linear approximation of the pendulum system
(2.10). In effect, in the study of dynamical systems, it is sensible to study the dynamics
of a system without its nonlinearities to have an initial understanding of its dynamical be-
haviour [10, 14, 51, 69]. By neglecting the nonlinear term sin(y(t)) in (2.10), the dynamical
equations collapses to form a second order dynamical system corresponding to the double
integrator system in (2.1).
A sliding mode control strategy for the system (2.1) is designed using the switching function




) s˙ = ds
dt
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As a result, the dynamics of the system (2.1) exhibit a first-order decay towards the origin.
Therefore, the choice of the switching function (2.8) together with the switching line s = 0
is appropriate to generate the desired dynamical behaviour. Importantly, this motion is
independent of any applied control signal. It is worth noting that the double integrator
system (2.1) exhibits reduced order dynamics (2.11) during sliding motion.
Knowing that desirable dynamics are achieved when the trajectories of the system (2.1)
exhibit a sliding mode, the next step consists in defining sufficient conditions to force the
switching function to reach and to remain in the chosen sliding manifold. In the literature
of sliding mode control, this process is known as defining the reachability condition for a
sliding mode [7, 10, 13, 14, 16, 70]. In essence, to render the manifold s = 0 attractive,
lim
s→0+
s˙ < 0 and lim
s→0−
s˙ > 0 (2.12)
Conventionally, this expression is written as
ss˙ < 0 (2.13)
Both expressions (2.12) and (2.13) are termed reachability conditions [7, 13, 14, 16]. To
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Fundamentally, this inequality reveals a dynamical condition to confine the trajectories of
the system to lie on the desired manifold and to enforce the desired stability and perfor-
mance requirements. Alternatively, a stronger condition called the η-reachability condition
given as
ss˙ ≤ −η|s| (2.16)
where η is a small positive constant which is called reachability constant to guarantee that
a sliding mode will be reached in finite time [7, 13, 14, 16]
The η−reachability condition (2.16) becomes
ss˙ = −ρ|s| < −η|s| (2.17)
since s sign(s) = |s|. Consequently , for 0 < η < ρ the candidate control (2.14) satisfies
the reachability condition (2.17) and ensures that the states reach the manifold s = 0 in
finite time and remains on it.
2.4 Robustness properties
Forcing the dynamics of the system (2.1) to lie on the switching manifold (2.8) is seen in
this case to prescribe a linear, first order dynamics (2.11) to the system where the choice of
the dynamical behaviour is entirely specified by the selection of the parameter m. In terms
of VSC, robust performance is synonymous with attainment of the dynamics prescribed by
the choice of switching surface despite the presence of model and parameter uncertainty [15,
21, 22, 63, 67]. Dynamical equations constructed to model phenomenological or mechanical
systems are intrinsically abstractions of real system. Besides, systems can change due to
ageing, accumulated damage, or perturbations. Further, the constructed model might be
simplified or linearized to facilitate the use of existing mathematical tools to analyse its
dynamics.
Let ω(t)be an unknown function of a time varying disturbance and M > ‖ω(t)‖. The
dynamical equation of the system (2.1) with this disturbance is given as
d2y(t)
dt2
= ω(t) + u(t) (2.18)






+ ω(t) + u(t)
)
ss˙ < − (ρ−M) |s| < −η|s| (2.19)
and the η-reachability condition is satisfied for ρ > M and 0 < η < ρ−M .
The nonlinear component of the pendulum system (2.10) has been ignored in the design
of the sliding mode control (2.14) to achieve stability and performance requirements. For
the pendulum system, ω(t) = −a1sin(y(t)). The robustness of the control (2.14) applied





− a1sin(y(t)) + u(t)
)
= s (−a1sin(y(t))− ρsign(s)) < 0 (2.20)
This suggests that the feedback gain ρ must have sufficient magnitude to satisfy the reach-
ability condition (2.20) to enforce a sliding mode for the pendulum system (2.10), see
Fig. 2.7. Consequently for these settings, the dynamics (2.11) enforced by the switching
function are rendered insensitive to the effects of the unknown disturbances during the
sliding motion. In effect, when (2.20) holds, s = 0 after some fine time ts1 then s˙ = 0 for
all t > ts1. Interestingly, the expression of the dynamics of the pendulum system in the
sliding mode becomes (2.11). Thus, the dynamical behaviour of the pendulum system is
identical to the one of the double integrator system after sliding motion takes pace (see
the phase portrait in Fig. 2.8). This evidence that sliding mode system exhibits total in-
variance to a particular class of uncertainty, the so-called matched uncertainty, which acts
in channels where the control feedback acts directly [7, 10, 13–16, 63]. Fundamentally, to
achieve robustness, the magnitude of the applied control signal must be sufficiently large
to guarantee that the reachability condition holds in the presence of matched parameter
and uncertainty. Knowledge of the likely bound of the uncertainty rather than its exact
dynamical behaviour is sufficient to design a robust sliding mode control law.
To demonstrate the inherent robustness of VSCS, the notion of the equivalent control
introduced in [7] is presented. By definition [10, 16, 25], the equivalent control, usually
denoted ueq is the unique solution to the algebraic equation formed by equating the temporal
derivative of the switching function to zero. In essence, the equivalent control action is the
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Figure 2.7: Time evolution of the switching function (2.8) for the pendulum system
(2.10) with a1 = 0.5 under the switched control (2.14) with m = 1 and ρ = 1
Figure 2.8: Phase portrait of the double integrator system (2.1) and the pendulum
system (2.10) with a sliding mode
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theoretical control action needed to maintain sliding motion. It should be noted that the
equivalent control is only valid after the time at which sliding motion takes place. It is
not the actual discontinuous control signal applied to the system. The equivalent control
action can be regarded as the average injection produced by the applied control signal. The
inherent robustness of the closed-loop dynamics resulting from the VSC law is proven by








+ ω(t) + ueq(t) (2.21)
= 0
Hence, the effects of the uncertainty is effectively cancelled as long as sliding motion holds
because the reachability condition (2.19) is satisfied.
. Besides, the concept of the equivalent control has been shown to be useful to investigate
the dynamics of the unknown input signals [10, 13, 14, 16].
In applications where the effects of a discontinuous control signal are undesirable, a contin-
uous approximation of the discontinuity is employed [15, 21, 22, 63]. A typical smoothing




where δ > 0 is a designed parameter which determines the steepness of this saturation








Using this smooth control signal with δ = 0.01, ideal sliding motion does not occur but the
switching function (2.8) is confined in a vicinity of the switching manifold where |s| < δ,
see Fig. 2.9. This motion of the system trajectories within this boundary layer is called a
pseudo-sliding mode [10]. In some applications, desirable performances can still be achieved
whilst remaining within a certain neighborhood of the sliding manifold [21]. Therefore,
maintaining the switching function within a certain boundary layer of the desired manifold
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using a smooth control signal has been shown to be good enough to achieve desired system
performance [10, 21].
Figure 2.9: Pendulum system (2.10) produced by a smooth control (2.23).
Since the continuous control (2.23) does not achieve ideal sliding motion, the effects of
matched uncertainty and disturbances cannot be completely rejected. Nevertheless, the
closed-loop dynamics still exhibit some level of robustness to parameter and model uncer-
tainty because the smooth control action behaves like a high gain control feedback during
pseudo-sliding mode [10, 21].
Of note, the choice of the parameter δ determines both the magnitude of the boundary layer
around the sliding manifold s = 0 as well as the steepness of the saturation function (2.22).
To achieve better performance and robustness, various approaches have been developed
to have δ as a function of time or state variables to produce a dynamic boundary layer
[15, 22, 63].
Interestingly, (2.22) is similar to saturation functions used to represent T cell activation
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where 0 ≤ S is the substrate concentration, Vmax > 0 the maximum rate produced at
maximal substrate concentration and Km > 0, the Michaelis-Menten constant. As a result,
the Michaelis-Menten function (2.24) shares identical properties with (2.23) when 0 ≤
s. Further, the Michaelis-Menten constant defines the steepness of the curvature of the
saturation function (2.24). The effects of the Michaelis-Menten function as an candidate
control function will be investigated in the next chapters.
2.5 Conclusion
In this chapter, the phase portrait analysis of engineering systems under a variable structure
control law was used to present the dynamical behaviour and benefits of variable structure
control systems. Similarly, in the following chapter, a phase portrait analysis will be con-
ducted to demonstrate the synergies between the dynamics of the specific T cell response
and the ones of engineering systems with a VSC law. Next, the dynamics of the specific T
cell response following vigorous infection will be studied from a variable structure control
perspective. The framework of sliding mode control presented in this chapter is used to
understand the switching mechanism of the specific T cell response. Moreover, this chap-
ter has shown that the reachability condition for a sliding mode defines a dynamical and
sufficient condition for any candidate control strategy to enforce desired stability and per-
formance requirements. In the following chapters, the reachability paradigm will be used
along with a model of dynamics of the Human immunodeficiency Virus (HIV) infection in
vivo to formulate a dynamical condition for immunity. Hence, the purpose of this chapter
was to provide the necessary background to understand the subsequent investigation of
T cells and virus dynamics using tools from variable structure control and sliding mode
control paradigm.
Chapter 3
Synergies Between the Dynamics
of the Immune Response of T Cells
and the Variable Structure Control
Paradigm
3.1 Introduction
In the previous chapter, it has been demonstrated that for a closed-loop system with a vari-
able structure control law, switching between different feedback regimes using information
from the states of the system is an approach to satisfy some constraints and performance
requirements. Interestingly, experimental studies in immunology reveal that the popula-
tion dynamics of the specific CD4+ and CD8+ T cell response following vigorous infection
are governed by an inherent ”immune response program” which changes the population
size and dynamic of the response to achieve immunity [32, 38, 39, 43, 44]. Furthermore,
experimental observations have shown that the T cell population dynamic resulting from
this immune response program exhibits some robustness to variations in some virological,
cellular and host factors [2, 39, 44, 45, 74].
Developing mathematical models and techniques to study T cell kinetics is important to
investigate the quantitative characteristics and dynamical features of T cell mediated im-
mune responses. In fact, it is crucial to understand the factors determining success or failure
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of the specific T cell response in various contexts such as transplantation, autoimmunity,
chronic infection and drug treatment [2, 29, 30, 42, 55]. The mathematical models of the
dynamics of the immune system can be constructed using a system of Ordinary Differential
Equations (ODEs) analogous to the Predator-Prey models from ecology [73]. These mod-
els describe the dynamics of some cellular and molecular phenomenon in an immunological
scenario of interest. Importantly, mathematical modelling and investigations have provided
several insights in immunology [29, 30, 32, 55].
Experimental studies have extensively investigated the kinetics of some antigen-specific
CD8+ T cell responses because this immune response has been shown to play a major
role in the control of infection [2, 38, 57, 75]. As a result, quantitative data have been
published and used to perform model-fitting and parameter estimation [1, 76]. Modelling
the specific T cell response involves defining a sensible mathematical relationship between
the antigen stimulation and the subsequent antigen-specific T cell population dynamics.
Mathematical modelling of the T cell population dynamics has shown that the immune
response program of CD8+ T cells can be appropriately modelled using a sigmoidal or a
discontinuous function [29, 38, 39]. In effect, candidate immune response functions dictate
the dynamical behaviour of the antigen-specific T cells. Importantly, the immune response
function influences both transient dynamics and the steady-states of T cell population
[43, 51, 55, 74, 76].
Consequently, the specific T cell response to pathogens can be regarded as a closed-loop sys-
tem because it consists of intrinsic biological feedback mechanisms which allow the immune
response to be activated and inhibited to remove the pathogen and maintain a healthy
state. Thus, tools from control theory can be used to analyse the performance of these
naturally occurring feedback mechanisms to understand dynamical factors underpinning
health or disease. The work in [77] has looked at the specific T cell response as a decen-
tralized control system in which the local interaction of different types of cells engenders
a population dynamic response. Interestingly, this dynamic response has been shown to
contain, a differential sensor, an on/off switch and an integral feedback.
The variable structure control paradigm introduced earlier is utilized in this chapter to
demonstrate the synergies between the dynamics of the specific T cell response and the
dynamics of engineering systems with a variable structure control law. Though the cellular
and molecular feedback mechanisms which take part in the immune response are still the
subject of active research, current findings in immunology provide compelling evidence that
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the dynamic response of the population of antigen-specific CD4+ and CD8+ T cells, as
shown in [1, 39, 44, 45] behaves as a variable structure control system.
As a VSC law, the immune response program is shown to enforce T cell expansion or
contraction dynamics for a given period of time according to some inherent immunological
law to achieve the control of acute infection. Moreover, this switching mechanism correlates
with changes in the metabolic energy regime of the responding T cells [32, 61, 78, 79].
The chapter is structured as follows: firstly, the biology of specific immune response of T
cells is reviewed. Secondly, the similarities between the VSC paradigm and the immune
response program are highlighted and discussed. Finally, a robustness analysis is conducted
to show that the specific T cell response exhibits some inherent robustness properties.
3.2 Review of the specific T cell response
The immune system consists of various cell populations which interact to achieve immunity
and maintain health [31]. The population of T cells or T lymphocytes is a type of white
blood cells which are produced by the bone marrow and matured in the thymus, a lymphoid
organ. The population of T cells consists of billions of clones having a unique T cell receptor
(TCR) which characterizes the specificity of the response. The TCR determines the binding
affinity of the clone to antigen i.e a complex of peptides bound to molecules of the major
histocompatibility complex (MHC). The T cell response is antigen specific because each T
cell clone is activated by a particular combination of peptides bound to MHC. A self-antigen
is formed by peptides derived from protein within the body whilst a foreign antigen is not.
The differentiation between self and foreign antigen by T cells is crucial because improper
activation of T cells by self antigen, known as autoimmunity, induces damage to self tissues
[31, 80]. Therefore, the dynamic response of T cells following antigen stimulation play an
important role in the control of infection and the maintenance of good health [2, 31, 42, 53].
Also T cell can further be classified based on their cell surface molecules or physiology. For
instance, CD4+ T cells are regarded as helper T cells because they contribute to the activity
of other immune cells. Whilst CD8+ T cells also known as killer T cells aim at destroying
foreign and infected tissues. Moreover, the population of T cells can be divided into different
subtypes based on their phenotypes [29, 37].
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Naive T cells are identified as conventional T cells whose unique antigen specific receptors
have never been stimulated by the matching self or foreign epitopes (antigen). The recog-
nition of the threat by the immune system involves identifying the presence of pathogen
destroying healthy cells. The presence of the threat usually leads to an increase in the
population of damaged cells and the production of antigen specific to the pathogen. In the
presence of signals from the innate immune response, immature Antigen Presenting Cells
(APCs) residing in the tissues absorb peptides at the site of the infection or inflammation.
As a result, APCs undergo maturation and become professional antigen presenting cells
which are the only type of cell capable of providing the required signals to activate naive
T cells. Naive T cells move towards APCs such as Dendritic cells (DCs) and macrophages,
scan them by brief contacts while they are constantly recirculating through the blood
stream and through the peripheral lymphoid[29, 40]. Two types of signals are needed from
professional APCs so as to activate naive T cells. Those signals are from the recognition of
naive T cell cognate antigen presented by professional APCs and from the interaction with
the co-stimulatory molecules on the same APCs [40, 81].
The activation of naive T cell stops their recirculation and activated T cells remain in
the peripheral lymphoid tissue. The immune response is produced by the maturation
of naive T cells, with proliferation and differentiation mostly into effector cells [40, 77].
Cytokine interleukin (IL)-2, produced by activated T cells and by other sources, drives
the reproduction of mature T cells [9, 37, 77, 82]. After differentiation of mature T cells,
effector T cells are released into the blood stream through the lyphagion and are directed
to the site of the infection. Subsequently, T cell-mediated immune response is performed
and supported by complementary immune system mechanisms such as B cells action.
From experimental studies on LCMV infection in mice [1, 2], measurements of virus titers
and LCMV-specific CD8+ T cells in the spleen at various days post acute infection produce
the trajectories displayed in Fig 3.1.
The initial number of activated T cell clones specific to the pathogen increases to a large
number to contain the infection. Following the eradication of the pathogen after an acute
infection, the population of activated T cells undergo a contraction phase in which activated
T cells die. Antigen-specific T cells are cleared from the infection site via apoptosis or
due to the effects of regulatory T cells [37, 39, 43, 50, 83]. Although the existence and
action of regulatory T cells has been proved and supported by different experimental and
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Figure 3.1: Time evolution of the population dynamics of specific CD8+ T cells after
acute infection from experimental data in [1, 2]
mathematical works, the mechanism by which regulatory T cells exert suppression remains
unclear [40, 84–89]. A proven and recognized apoptotic process is Cytokine Deprivation
Induced Death (CDID). CDID consists in causing T cell death by the depletion of cytokine.
This greatly reduces the growth factor of T cells [37, 90]. Independently of the mechanisms,
the contraction phase is needed so that responding T cells do not cause damage to the
surviving or surrounding healthy cells as well as to prevent autoimmunity. After the immune
response, a small number of activated cells survive the contraction phase and differentiate
into memory T cells. Immunological memory is formed from those remaining T cells.
Importantly, the response of memory T cells to the same antigen in case of acute infection
is better than the ones of naive T cell [2, 29, 74].
From this review of the immunology of the specific T cell response, it can be deduced
that suitable regulation of the activation, expansion and reduction of the population size
of specific T cell clones is required to satisfy immunological requirements. Similarly, in
engineering systems with a variable structure control law, appropriate switching between
different feedback structures is necessary to realise the desired outcome [7, 15, 16, 21, 22].
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Hence, it can be argued that the switching mechanism of the T cell response is an important
feature which underpins the achievement of immunity and the maintenance of good health.
3.3 Synergies between the dynamics of the immune response
of T cells and the variable structure control paradigm
In this section, VSC techniques are used to interpret recent experimental and mathematical
work related to the dynamics of the antigen-specific T cell response. In [29], the following




= σ + rN − aNF(t)N − dNN (3.1)
dA
dt
= F(t) (aNN + aMM + ρA)− (1−F(t))(mA)− dAA (3.2)
dM
dt
= (1−F(t))mA+ rMM − aMF(t)M − dMM (3.3)
The state variables N,A and M represent the time evolution of the population of naive,
activated and memory CD8+ T cells responding to a specific antigen following infection.
The parameters σ, rN and dN denote the production, replication and death rate of naive T
cells respectively. Activated T cells proliferate at a rate ρ, die at a rate dA and differentiate
into memory T cells at a rate m. The generated memory T cells replicate at a rate rM , get
activated at a rate aM and die at a rate dM . A brief description of the terms of the model
eq (3.1)-(3.3) is provided in Table 3.1 and Table 3.2. The likely range of the parameters
given in Table 3.2 are obtained from the work in [1, 29, 91].
Table 3.1: List of the state variables of the general model of the antigen-specific T cell
response eq (3.1)-(3.3)
State variable Symbol
Number of naive T cells N
Number of activated effector T cells A
Number of memory T cells M
The scenario of a primary specific CD8+T cell response to an acute infection [2, 43–45]
is considered. The model (3.1)-(3.3) has been chosen because the studies in [1, 29] have
demonstrated that it describes well the immunological phenomenon of interest. The state
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Table 3.2: List of parameters for the general model of the antigen-specific T cell response
eq (3.1)-(3.3)
Description Symbol Unit Nominal Value Likely Range
Production rate of σ day−1 0 0 ≤ σ
naive T cells
Replication rate of rN day
−1 0 0 ≤ rN
naive T cells
Activation rate of aN day
−1 1 0 < aN
naive T cells
Death rate of dN day
−1 0.001 0.027 ≤ dN ≤ 0.007
naive T cells
Proliferation rate of ρ day−1 1.93 1.4 ≤≤ 3.0
activated T cells
Death rate of dA day
−1 1 0.19 ≤ dA ≤ 1
activated T cells
Production rate of m day−1 0.05 0.008 ≤ m ≤ 0.05
memory T cells
Replication rate of rM day
−1 0 0 ≤ rM
memory T cells
Activation rate of aM day
−1 1 0 < aM
memory T cells
Death rate of dM day
−1 0.01 0 ≤ dM
memory T cells
Immune response F(t)) 0 ≤ F(t)) ≤ 1
function
variables, parameters and the complexity of mathematical representation have been de-
signed to capture the impact of various cellular or molecular mechanisms involved in the
specific T cell response to foreign pathogen.
The default initial conditions are: N(0) = 100;A(0) =M(0) = 0 is chosen to be the default
initial conditions as in [1, 29]. The default parameter values, taken from [29], are as follows:
σ = rN = 0 day
−1; dN = 0.001 day
−1; aN = 1 day
−1; ρ = 1.93 day−1; dA = 1 day
−1;
m = 0.05 day−1; rM = 0 day
−1; aM = 1day
−1; dM = 0.01 day
−1. These initial conditions
and biological rates are analogous to the ones used in some previous studies [1, 29].
The immune response program of CD8+ T cells is defined by the function 0 ≤ F(t) ≤ 1.
Here, the impact of F(t) on the population dynamic of responding CD8+ T cells is examined
from a control engineering perspective to demonstrate that the immune response program
[38] fits the variable structure control paradigm [7, 15, 21, 22, 63].
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Now, the dynamical behaviour produced by a fixed structure immune response function
with F(t) = 0 and F(t) = 1 is investigated using a phase portrait analysis as in Chapter
2. The phase portrait of the closed-loop dynamics with F(t) = 1 shows that this structure
leads to a motion away from the unique equilibrium located at the origin, see Fig 3.2.
This motion corresponds to an exponential increase in the population size of activated T
cells. As a result, this fixed structure engenders the clonal expansion phase only. The
stability analysis of the system reveals that this clonal expansion phase is underpinned
by an unstable dynamic because the equilibrium has an unstable pole. This unstable
dynamic leading to a rapid increase in the number of activated T cells is desirable to achieve
protective immunity quickly [2, 91]. However, a prolonged expansion phase of activated T
cells can lead to detrimental effects such as autoimmunity [37, 42, 92]. In contrast, stable
dynamics and a reduction of the population of activated T cells are enforced by the fixed
structure with F(t) = 0. The phase portrait, see Fig 3.2, shows that the dynamics of the
system move towards the origin. Imposing this structure right after the initiation of an
infection is undesirable because it prevents clonal expansion to take place. Nevertheless,
this structure is useful after the clearance of the infection to enforce the contraction and
memory phase of the specific T cell response. From these closed-loop dynamics with a fixed
structure immune response program, it is clear that an immune response function with a
single structure is not able to provide the required and observed dynamical changes in the
population of antigen-specific T cells following infection. In fact, F(t) must be designed to
describe a realistic relationship between the antigen stimulation and the dynamic response
of T cells following infection [1, 29, 38, 39].
Interestingly, experimental and mathematical studies [1, 29, 39] have demonstrated that the
following discontinuous immune response program can be used to reproduce the dynamics
of the specific T cell response
F(t) = 1 if ton ≤ t ≤ toff
F(t) = 0 otherwise (3.4)
where experimental records have provided
• ton: the time (in days) at which the number of activated T cells starts to increase to
combat the infection
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Figure 3.2: Phase portrait analysis of the T cell population dynamics of (3.1)-(3.3) with
an activation function having a fixed structure. Top: the trajectory of the T cell response
generated by F(t)) = 1 is shown. This induces unstable dynamics and a motion away from
the origin. The trajectory depicts an exponential and unbounded expansion of activated
T cells. Bottom: the trajectory of the T cell response generated by F(t)) = 0 is seen. The
trajectory exhibits a stable motion towards the origin. This motion depicts the contraction
of the population of activated T cells and the formation of memory T cells.
• toff : the time (in days) at which the decay of the population of activated T cells is
enforced after the infection
It is worth to mention that ton and toff are not external inputs. In vivo, these parameters
are indeed influenced by the states of the system.. For more details, please refer to [1, 29,
38, 93].
The output dynamics and phase portrait generated by (3.4) are shown in Fig. 3.3. During
the expansion phase i.e F(t) = 1, this induces an unstable positive feedback with motion
of the trajectories away from the origin. This motion ensures rapid increase in the number
of activated T cells as required to respond to infection [2, 43, 48, 94]. Next, when F(t) = 0
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is enforced, the immunological control structure switch to a stable negative feedback which
forces the decay of the activated T cells and the production of memory T cells is imposed
on the system. Individually, each feedback structure is inappropriate to reproduce the T
cell response observed post-infection. Therefore, without a suitable switching mechanism
between these different immunological feedback structures, the population dynamic of the
T cell response is not consistent with experimental data. Hence, the model (3.1)-(3.3) of the
T cell response dynamics without switching behaviour is unable to replicate the dynamic
behaviour observed in practice [29, 38, 51, 77].
The time-based on/off activation function (3.4) defines a switched control law and enables
the system to exhibit appropriate immunological feedback control. T cell population dy-
namic from the expansion phase to the contraction phase is underpinned by a sharp switch-
ing from a positive to a negative feedback. The VSC viewpoint on modelling the dynamics
of the immune response of T cells implies that there exists an inherent immunological
switching logic associated with F(t) which governs the response of the T cells. Although
early work has argued that changes in the population dynamics of T cells post-infection are
orchestrated by an intrinsic time-based autonomous program [1, 29, 38], recent experimen-
tal and mathematical publications in immunology suggest that changes in the population
dynamics of T cells after infection are the result of interactions between different immuno-
logical feedback mechanisms which increase or decrease the population size of responding
T cells [2, 38, 93, 94]. The immunological dynamics involved in this inherent switching rule
are still the topic of active research [2, 94]. Hence, this suggests that the VSC paradigm is
a suitable means to explain the observed antigen-specific T cell response following vigorous
infection.
In [1, 29], a candidate Michaelis-Menten function has been utilized to provide a smooth
switching process between the activation and the inhibition of the specific T cell response
based on the time evolution of the antigen concentration following viral infection. This
saturation function is expressed as




Where B is the antigen concentration and h > 0 is the antigen concentration at which
F(B) is half maximal. Consider the pathogen dynamics given as
dB
dt
= rB − kBA (3.6)
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Figure 3.3: Population dynamics of the specific T cell response of the model (3.1)-(3.3)
with a discontinuous immune response function (3.4).
where r is the replication rate of the pathogen and k is the killing rate by activated CD8+
T cells [91]. Let a closed-loop system formed by (3.1)-(3.3),(3.6) with the immune response
function (3.5). let B(0) = 1000, r = 5 day−1 and k = 310−8 day−1 from [29, 91]. The
time evolution of the total antigen-specific T cell population, see Fig 3.5 is consistent with
the ones observed in experimental studies [1, 2, 43]. Furthermore, the corresponding phase
portrait, see Fig 3.5 depicts a stable dynamics towards the origin after a transient period.
Though, the subsystems with F1(t) = 1 and F1(t) = 0 independently exhibit unstable and
stable dynamics, yet the switching strategy with (3.5) ensures the overall motion is stable
and desirable in terms of speed of response. This dynamical behaviour is typical of VSCS
[13, 14, 16, 22]. From the viewpoint of variable structure control [7, 13, 14], (3.5) defines a
switching logic to enforce the clonal expansion phase and then contraction phase according
to the antigen density. In effect, this saturation function induces appropriate variation with
time of the population size of antigen-specific T cell in response to infection [1]. Hence,
the phase portrait analysis of the specific T cell response presents a strong case for the
synergies between the dynamics of the specific T cell response and the ones of engineering
systems with a variable structure control law. Indeed, realistic models of the specific T cell
response [29, 32, 38, 39] are shown to support the reasoning that the function modelling
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Figure 3.4: Simulation of the scenario of CD8+ T cell population dynamics following
acute infection. Top: Time evolution of the population dynamics of the antigen-specific T
cell response, closed-loop system formed by (3.1)-(3.3),(3.6). Bottom: the time evolution
of the antigen-dependent activation function eq (3.5). Following infection, the magnitude
of the activation function is at a maximum. This induces the reduction of the state N
and an increase of the state A. The state variable N decreases because naive T cells
become activated T cells. The state variable A increases due to the expansion of the
population of activated T cells. When the magnitude of the immune response function
falls to zero, the expansion phase is interrupted. There is production of memory T cells,
the state M increases whilst the activated T cells undergo contraction i.e the state A
decreases. Consequently, the activation function prescribes the variation over time of the
total population of the antigen -specific T cells (N +A+M) following infection.
the immune response program of T cells can be considered as a VSC feedback control.
This suggests that the response of the population of antigen-specific T cells observed in
experiments [2, 94, 95] is the result of switching between different immunological dynamics.
Different mathematical functions, motivated by different biological assumptions, have been
proposed to describe T cell response dynamics following antigen stimulation. The differ-
ences in the expression of the immune response function reflect various views on the charac-
teristics of the immune response program. From predator-prey dynamics in the domain of
ecology, a mass action kinetic has been assumed and utilized in different studies [54, 55, 96].
Besides, various saturation functions have been formulated from a Michaelis-Menten anal-
ysis of the process of T cells binding to APCs [1, 46]. These saturation functions output
the maximal T cell proliferation when the antigen stimulation or concentration is high.
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Figure 3.5: Phase portrait of the trajectories of the specific T cell response. Closed-
loop system formed by (3.1)-(3.3),(3.6) with the sigmoidal antigen-dependent activation
function (3.5)
Fundamentally, using sigmoidal or discontinuous candidate immune response program, sim-
ilar results can be obtained. For instance, the following candidate saturation function has
been proposed in [46]:




where K is a Michaelis-Menten like constant reflecting the ability of activated T cells
to proliferate. This function incorporates a double saturation mechanism based on the
antigen concentration and the population of activated T cells. Interestingly, this candidate
function has been shown to generate a net expansion of T cell population when the antigen
concentration exceeds a certain threshold.
Apart from these antigen dependent immune response functions, experimental studies on
the CD4+ and CD8+ T cell response dynamics following vigorous infection have observed
that the clonal expansion continues for few days after the clearance of the infection [2, 39,
97]. Additionally, experimental studies have successfully determined the precise timings
and magnitude of the expansion and contraction of the population of specific CD8+ T cells
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for different viral or bacterial infection [29, 44, 45, 74]. These findings have motivated the
development of antigen-independent immune response program which provide a continuous
or a discontinuous switch between the extremum of F1(t) post infection [29, 38, 98]. Using
these timings provided by experimental data, some models of the antigen-independent
response are constructed using a time based switching logic [29, 76, 99].
Nevertheless, the recent experimental studies such as [2, 93, 94, 97, 100] suggest that the
type of pathogen strains, the initial infection dose or early curtailment of the infection and
antigen presentation induce changes in the duration and magnitude of the clonal expansion.
Therefore, it can be argued that the timings and magnitude of the expansion and the
contraction phase are produced by cellular and molecular feedback mechanisms [32, 38,
93]. Consequently, current thoughts consider that the immune response program of T
cells consists of an antigen-dependent phase followed by an antigen independent phase
[38, 47, 93, 97].
From this review of the immune response program, it is proposed that the population dy-
namic of the specific T cell response following infection incorporates a switching mechanism
based on some inherent dynamics to enforce the expansion and the contraction phase at
appropriate timings to achieve immunity. Therefore, it can be argued that the dynamical
behaviour of the specific T cell response is prescribed by an inherent switched control feed-
back which aims to combat infection and maintain health. Hence, this work suggests that
immunological objectives could be achieved via a VSC mechanism.
3.4 Robustness analysis
In immunology, there is a need to understand the factor sustaining or impairing the specific
T cell response [2, 31, 32, 42]. In the context of designing a control strategy for an engineer-
ing system, a robustness analysis is conducted to investigate how modelling and parameter
uncertainty affect the stability and the performance enforced by the designed control action
[10, 67, 101]. Formulating the immune response function as a VSC law is useful to provide
a constructive framework to investigate the effects of uncertainty and perturbations on the
T cell population dynamics.
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Uncertainty associated with the model of the specific T cell response (3.1)-(3.3) can be
related to changes in biological rates, neglected immunological dynamics such as the dy-
namics of APCs and perturbations caused by pathogen. In the following, the term du is
introduced to represent some biological perturbations in the dynamics of the activated T
cells. It is worth to mention that instead of this additive perturbation, parameter and
modelling uncertainty can also be considered. The dynamical equation for the population
of activated T cells becomes
dA
dt
= F(t) (aNN + aMM + ρA+mA)− (m+ dA)A+ du (3.8)
This is motivated by the fact that the dynamic of the population of activated T cells can
be impaired by the effects of pathogen following infection [2, 42, 48, 52, 57, 102]. In this
section, a particular type of VSC, the so-called sliding mode control [13–16] is used to
analyse the dynamics of the specific T cell response observed experimentally [2, 45, 103].
In Chapter 2, sliding mode control principles have been reviewed using the classical example
of the pendulum system [7, 10]. A switched control strategy was formulated to drive and
then constrain the states of the pendulum system to lie within a close neighbourhood of a
predefined switching function. Furthermore, the choice of the switching function has been
shown to dictate the dynamic behaviour of the system. Additionally, the switching function
provides a measure of the desired performance of the system. Here, the sliding mode control
framework and analytical tools are not used to design and implement a controller but to
study the immune response function as a VSC immanent in the dynamics of the specific T
cell response.
The following switching function,
s1 = A (3.9)
is chosen because the manifold s1 = A = 0 is associated with the absence of an ongoing
immune response and a healthy state. Furthermore, s1 = 0 enforces a stable immunological






A (F(t) (aNN + aMM + ρA+mA)− (m+ dA)A+ du) < 0 (3.10)
Chapter 3. Synergies Between the Dynamics of the Immune Response of T Cells and the
Variable Structure Control Paradigm 42
Note that s1 is always non-negative because this switching function represents a number
of cells. The expression of the reachability condition (3.10) reinforces that the immune
response function F(t) plays a major role in the determination of the dynamical behaviour
of the specific T cell response. Considering the values of biological rates estimated in various
studies, see Table 3.2 and [1, 29, 91], (3.10) shows that the immune response program is
robust to variations in the values of these biological rates due to changes in virus strains and
epitopes. In essence, despite the occurrence of biological perturbations following infection,
the immune response function must satisfy s1
ds1
dt
> 0 to induce the clonal expansion phase
for a certain period of time to clear the infection as well as switch to s1
ds1
dt
< 0 to enforce the
contraction and memory phase of the specific T cell response. Consider the time evolution
of the reachability condition in Fig 3.6 from the simulation of the specific T cell response
in Fig 3.4. Initially, s1 moves away from the chosen sliding manifold s1 = 0. However,
this transient dynamic is necessary from an immunological standpoint because it enforces
the rapid proliferation of activated T cells to contain the infection to achieve protective
immunity [1, 2]. After the transient phase of the clonal expansion, the manifold s1 = 0 is
rendered attractive by the immune response function. As a result, the trajectory of s1 is
driven towards the origin and the contraction and memory phase of the T cell response is
induced. Hence, the reachability analysis used here, delivers analytical conditions for the
immune response program to prescribe desirable T cell population dynamics.
The simulation of the model for an extended time period shows that the switching function
(3.9) exhibits a sequence of oscillations rather than lying on the manifold s1 = 0. These
oscillations are caused by frequent rebound of the pathogen. In fact, the considered dy-
namical equation (3.6) for the pathogen growth dynamic does not produce a steady-state
behaviour matching that of acute viral/bacterial infection [2, 44]. However, the transient
dynamics generated by the resulting closed-loop system is consistent with the ones of the
primary antigen-specific CD8+ T cell response up to day 28 [29].
Thus, the dynamics of the model after day 28, do not allow the reachability condition to
remain satisfied. Hence, the reachability analysis is shown to capture the discrepancies
between the dynamical behaviour of the model and experimental observations in [1, 2, 29].
The limitation of this model is due to the mathematical relationship between the pathogen
dynamic (3.6) and the candidate antigen-dependent immune response function (3.6). On
the one hand, the mathematical expression of eq (3.6) has an unstable pole i.e r > 0 at the
healthy state where B = 0. This feature allows the model to reproduce the rapid growth of
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Figure 3.6: Time evolution of the sliding surface and reachability condition for the
dynamics of the specific T cell response described by the closed-loop system formed by
(3.1),(3.3),(3.6) and (3.10) with the antigen-dependent activation function (3.5)
the pathogen in the early days post infection but also prevents the model exhibiting realistic
kinetics of pathogen decay and clearance observed after acute infection [2]. On the other
hand, the candidate antigen-dependent immune response function (3.6) solely relies on
the pathogen dynamics to provide the required switch in the feedback regime governing the
population dynamics of T cells. Although this simple expression delivers reasonable results,
it is clear that the connection between the antigen stimulation and T cell response dynamics
is more sophisticated. Consequently, in other studies it is important to determine the
boundaries within the model match experimental observation and to investigate a sensible
relationship between the kinetics of the pathogen concentrations and the kinetics of T cell
populations.
From this point onwards, the work focuses on the time window from day 0 to day 28
post-infection because these dynamics match the ones observed in experimental studies
[2, 29].
The analysis of the simulation of the model eq (3.6)-(3.3) with eq (3.5) reveals that the
model appropriately captures the dynamics of the T cell response to acute infection for a
given period of time.
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After considering the nominal case with du = 0 in Fig 3.4 and Fig 3.6, the impact of
perturbation signals on the population dynamic of the specific T cell response is examined
by analysing the dynamics of the system in the sliding mode. Assume that after a time ts,
the sliding mode occurs and s1(t) =
ds1
dt
= 0 for all t > ts1 . It follows that s˙1 = A = 0 and






By substituting (3.11) in (3.8), it is seen that the action of the immune response cancels
the effects of the disturbance in the sliding mode. This demonstrates that the immune
response program effectively possesses some robustness properties.
Furthermore, consider a candidate Lyapanov function for the reduced order dynamics given
by V (N,M) where
V (N,M) = N +M (3.12)
dV (N,M)
dt
= −(anN + amM)F(t)eq − dNN − dMM (3.13)
This Lyapanov function is positive definite as required [104] because the state variables
N ≥ 0 and M ≥ 0. From (3.11), it can be deduced that when the perturbation signal
is a function of A, the dynamics in the sliding mode are not affected and remain stable.
Nevertheless, this type of perturbation can drastically influence the transient dynamics of




see (3.10). In practical implementation of sliding mode control, it is well known that
though some disturbances are cancelled when sliding mode is reached, they might impair
the reaching phase and transient dynamics of the system [10, 13, 16, 17, 22]. In the VSCS
example presented in Chapter 2, it has been seen that the designed discontinuous control
action provides complete invariance to parameter and modelling uncertainty when sliding
mode occurs.
In experimental and mathematical studies of the kinetics of the virus-specific memory CD8+
T cell response following chronic infection, it has been shown that the clonal expansion
phase is impaired [2, 48]. In effect, activated memory CD8+ T cells undergo a block in
their proliferation and the clonal expansion phase does not last long enough to clear the
infection [2]. The simulation experiment conducted in Fig 3.7 shows a perturbation signal
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Figure 3.7: Time evolution of the reachability condition and total population of antigen-
specific T cells in the presence of a strong biological perturbation. du = −2A for t > 8 and
du = 0 otherwise. Model of the specific T cell response described by the closed-loop system
formed by (3.1),(3.3),(3.6) and (3.10) with the antigen-dependent activation function (3.5)
du = −2A which occurs during clonal expansion. The resultant population dynamic of the
T cell response is consistent with the ones observed in experiments. From the reachability




cell proliferation is no more satisfied. This causes an early and undesirable reduction of
the population size of activated T cells. From a VSC standpoint, the magnitude of the
proliferation of activated memory CD8+ T cells must be boosted to keep s1
ds1
dt
> 0 as long
as required to achieve protective immunity despite chronic infection.
Though the disturbance signal du = −2A alters the transient dynamics of the T cell re-
sponse, (3.11) shows that this is effectively a zero perturbation in the sliding mode because
s1 = A = 0. The Lyapanov stability analysis from (3.12)-(3.13) confirms that the dynamics
in the sliding mode remain stable when du = −2A. Besides, a disturbance signal which is
a time-invariant function or a function independent of the population of activated T cells
or a function of the virus dynamic does not vanish in the sliding mode, see (3.11). Of
note, this type of perturbations are completely rejected when the immune response func-
tion establishes a sliding mode. In Chapter 2, it was demonstrated that when the designed
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control action enforces sliding mode, the control action totaly rejects the effects of matched
uncertainty such as non-vanishing perturbation signals acting in the input channel.
Although the population dynamic of CD8+ T cells exhibits some inherent robustness prop-
erties, some biological phenomena such as unwanted T cell activation have the potential to
disturb feedbacks regulating the appropriate dynamic and population size of CD8+ T cells
[37, 40, 42, 45]. In fact, inappropriate activation or inhibition of the immune response of T
cells can lead to inflammation-induced tissue damaged, persistent infections or autoimmu-
nity [2, 31, 42, 105]. In a VSCS under the effects of disturbance, failure of the reachability
condition is synonymous with the inability of the designed control action to enforce a slid-
ing motion in the presence of these disturbances [10]. In other words, the magnitude of
the control action is insufficient to cancel the effects of the disturbance. In such cases, a
different equilibrium (stable or unstable) is exhibited by the system.
The scenario of an inappropriate CD8+ T cell activation caused by non-specific prolifer-
ation signals or bystander effects [9, 37, 40, 52] is simulated in Fig 3.8. This simulation
demonstrates that when a potent disturbance signal occurs (in this case an inappropriate
activation), the immune response program fails to overcome the effects of the disturbance.
Consequently, the reachability condition is no longer satisfied and the sliding motion is lost.
Hence, failure of the dynamical conditions provided by the reachability analysis in presence
of disturbance is congruent with inappropriate T cell response dynamics.
3.5 Conclusion
In this chapter, experimental and mathematical studies on the specific T cell response
dynamics following infection [2, 29, 38, 39, 76] have been revisited from a control engi-
neering standpoint. The immune response program, the function describing the dynamical
behaviour of antigen-specific T cells in response to the infection, has been shown to pos-
sess characteristics similar to the ones of a variable structure control law. In essence, this
function switches between different feedback regimes to enforce the clonal expansion phase
followed by the contraction and memory phase of the T cell response to achieve immunolog-
ical requirements. Furthermore, the robustness properties of the dynamics of the specific
T cell response observed in experimental studies have been formally assessed using tools
from sliding mode control theory.
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Figure 3.8: Time evolution of the reachability condition and total population of antigen-
specific T cells following infection with an undesirable proliferation signal du at day 23.
Model of the specific T cell response described by the closed-loop system formed by
(3.1),(3.3),(3.6) and (3.10) with the antigen-dependent activation function (3.5)
Collectively, the results of this chapter motivate the analysis of the immune system as a
closed-loop feedback system in which the immune response function changes T cell popu-
lation dynamics to respond to threat and to maintain health. Importantly, analytical tools
from variable structure control are shown to provide sensible means to study the dynamics
of proper and improper T cell responses.
Consequently, control engineering techniques are used to examine the dynamics of tolerance
and autoimmunity in the next chapter. Furthermore, the dynamics of Human Immunodefi-
ciency Virus infection in vivo are considered and the reachability analysis is used to provide
dynamical conditions to enforce the containment of the infection by the HIV-specific CD8+
T cell response and by antiretroviral drugs.
Chapter 4
Self-Tolerance Mechanism of T
Cells, a natural VSC
4.1 Introduction
In this chapter, the characteristics of the control mechanism governing the self-tolerance
dynamics of T cells are studied using tools from control theory. The novelty of this ap-
proach resides in the use of VSC techniques to study tolerance mechanism of the immune
system. Candidate immune response functions are analysed as different control strategy
to achieve tolerance. Motivated by the synergies between the immune system and VSCS
shown in Chapter 3, the sliding mode control paradigm introduced in Chapter 2 is used
to design an adaptive sliding mode control modelling immunological feedbacks which sup-
presses autoimmune responses and achieve a robust tolerance steady-state.
The maintenance of a healthy state by the immune system is underpinned by an appropriate
regulation of immune responses to clear infection as well as to prevent damage of self tissues
[31, 32]. The notion of self-tolerance of the immune system refers to the ability of the
immune system to both prevent and suppress autoimmune responses i.e immune responses
targeting self tissues. In effect, the immune system incorporates feedback mechanisms
to regulate the dynamics of self-reacting T cells to establish a healthy tolerance state.
Consequently, the healthy state enforced by the immune system is maintained despite the
presence of self-antigen and self-reacting T cells.
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The relation between the density of self-antigen and the inducement of tolerance or autoim-
munity influences the dynamics of immune cells and determines the maintenance or loss of
a healthy state. Different immune response functions have been proposed in [40, 51, 52] to
investigate different ways in which the density of self antigen induces the activation/prolif-
eration of self-reacting T cells. Fundamentally, these candidate immune response functions
establish a positive feedback between the density of self antigen and the population dynam-
ics of self-reacting T cells.
When a linear or a Michaelis-Menten immune response function is used, the work in [40,
51] have shown that the concept of the reproductive ratio can be used to determine the
maintenance of the tolerance steady-state. In effect, the reproductive ratio in this context
highlights a steady-state condition for the stability of the tolerance steady-state. This
approach infers that the break down of tolerance state imposed by the immune response
function is sensitive to changes in the values of the biological rates of the model. In contrast,
when a sigmoidal immune response function is considered, the reproductive ratio cannot
be defined and the attainment of the tolerance steady-state depends on the density of self
antigen. Hence, the framework of the reproductive ratio is not robust to changes in the
mathematical formulation of the immune response function.
The framework of control engineering is considered because the work in Chapter 3 has
demonstrated that the specific T cell response to acute infection is effectively a closed-loop
dynamical system. Furthermore, the control analysis performed in Chapter 3 has proved
that the immune response program, which dictates T cell population dynamics following
infection, fits the variable structure control paradigm presented in Chapter 2. In fact, the
immune response program operates as a variable structure control law which changes in T
cell population dynamics to clear the infection and restore a healthy state. Moreover, it
was shown that analytical tools from sliding mode control provide means to examine the
conditions for the robustness of the closed-loop dynamics imposed by the immune response
function. Motivated by these results, the framework of sliding mode is utilized to formulate
a dynamical condition for the immune response function to enforce a robust tolerance
steady-state.
Current findings in immunology indicate that self-tolerance is not only due to a weak
positive feedback between the density of self antigen and the responding CD4+ or CD8+ T
cells [31, 50, 80, 83]. In fact, the population dynamic of regulatory T cells has been shown
to be crucial for the maintenance of a robust tolerance state. The action of regulatory T
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cells operates a negative feedback suppressing ongoing autoimmune responses [31, 86, 106].
In the mathematical studies in [9, 40, 87, 107] where the population of regulatory T cells
is modelled explicitly, the gain of the feedback engendered by regulatory T cells must have
a sufficient magnitude to enforce the tolerance steady-state. The similitude between the
robustness properties of high gain linear state feedback systems and discontinuous systems
have been proven by control theory [10, 21]. Further, it is demonstrated that a discontinuous
feedback inhibiting autoimmunity can indeed establish a robust tolerance steady-state.
The organisation of the chapter is as follows. First, the tolerance mechanisms of the immune
system are reviewed. Next, a model of the immune system is considered and the impact
of some candidate immune response functions on the maintenance of tolerance is analysed.
Finally, a sliding mode control analysis is performed to model a robust tolerance mechanism.
4.2 Review of tolerance mechanisms
The seminal paper of Medawar [108] introduced the notion of immune tolerance to self
tissues in 1953. This early work shows that there is a central mechanism of tolerance exerted
by the thymus. It was first thought that tolerance was established by the elimination of all T
cells in the thymus. Subsequent experimental studies [106] clarified that many autoreactive
T cells undergo clonal deletion in the thymus due to negative selection. Unexpectedly, it
was found that some T cells with a high affinity to self antigen are preferentially selected and
survive to form the population of natural regulatory T cells (nTregs). Nonetheless, there
are autoreactive T cells which are able to exit the thymus and circulate in the lymphoid
and peripheral blood stream.
Furthermore, there exist peripheral tolerance mechanisms which prevent or shut down
immunogenic responses against self tissues [31]. The activation and clonal expansion of T
cells requires three signals: antigen presentation signal, costimulatory signal and cytokine
IL-2 signal. Inappropriate T cell activation signals at the cell surface engender clonal
deletion and/or anergy. Interestingly, each of these signals is associated with a certain
tolerogenic process [31]. In addition, the combination of these signals at the cell surface
obeys a particular decision-making rule to induce antigen-specific T cell responses [37].
In fact, the avidity of the T-cell-receptor (TCR) interaction with cognate antigen must
exceeds a certain threshold to activate the T cell [109, 110]. This activation threshold is
determined by a certain costimulatory molecule [111] and the avidity is influenced by both
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the affinity of the antigen with the TCR and the quantity of available antigen [110]. Hence,
different molecular feedback mechanisms allow the immune system to tolerate the presence
of mature autoreactive T cells in the peripheral blood and tissues [31, 106].
Besides, recent experimental studies have demonstrated the existence of regulatory T cells
and their dominant role in the control of immune responses elicited by self and foreign
antigen as well as the maintenance of immunological homeostasis [31, 42, 50, 86, 88, 106].
In addition, to the existing population of natural regulatory T cells, adaptive regulatory T
cells are generated from naive CD4+ T cells during inflammation [31, 106]. The activities
of both natural and adaptive regulatory T cells provides an active mechanisms to generate
robust tolerogenic responses and maintain a robust tolerance steady-state [31, 50, 86]. In
the case of autoimmunity, an insufficient number of regulatory T cells or defective regulatory
T cells are found at the site of the inflammation or damage [50, 92, 106]. Thus, the state
of autoimmunity results from an improper balance between immunigenic and tolerogenic
mechanisms. Interestingly, therapeutic strategies have shown that the healthy balance can
be restored using cytokine IL-2 to increase the number and/or to enhance the efficiency of
regulatory T cells [31, 92].
Collectively, current experimental findings reinforce the notion of tolerance as active mech-
anisms which dynamically regulate and control immune responses [31, 92]. Fundamentally,
the induction and maintenance of tolerance is achieved by the interactions between different
types of cells and molecular pathways. Appropriate switching between feedback regimes
that trigger or suppress the immune response is accomplished by the immune system to
provide required immunological actions to sustain good health [2, 31, 42, 80]. Consequently,
there exists strong synergies between the dynamics of the immune system and the dynamics
of engineering systems with a switched control law shown in Chapter 2. Inherent immuno-
logical switching rules in combination with cellar and molecular feedback mechanisms allow
the immune system to change its dynamics (expansion or reduction of some cell population)
to achieve immunity and tolerance. It can be argued that experimental results and insights
on the mechanisms of tolerance [31, 106] constitute compelling evidence for the notion of
the immune system as a robust variable structure control system.
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4.3 Analysis of dynamics of self-tolerance
A simple mathematical model as been presented in [51] to study the mechanisms under-
pinning the dynamics of tolerance and autoimmunity. The dynamical equations are given
as:
T˙ = λ− µT − βTC
D˙ = βTC − αD (4.1)
C˙ = u− γC
The state variables are T , the population of healthy target cells (cells/ml), D the population
of damaged target cells (cells/ml) and C, the population of self-reacting T cells (cells/ml)
destroying target cells. Note that in the model (4.1), the effects of other molecular or
cellular dynamics such as cytokine Il-2, dentritic cells or regulatory T cells are implicit.
Various mathematical models have been proposed to study the dynamics of self-tolerance
[9, 40, 51, 82, 107, 112]. The differences in the dynamical equations are due to differences
in modelling assumptions and focus of the investigations. A block diagram of the model
(4.1) is given in Fig. 4.1.
Figure 4.1: Model (4.1) of self-tolerance/autoimmunity where the immune response func-
tion describes the dynamic response of self-reacting T cells after self-antigen stimulation
The model (4.1) has been chosen due to its simplicity and especially due to the fact that
it describes the dynamical interactions between self reactive T cells and the targeted self
tissues. This simplicity facilitates the mathematical analysis to study the impact of the
immune response function in the context of self-tolerance. Additionally, it was shown in
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[51] that this model produces reasonable qualitative behaviour despite the fact that various
cell populations such as antigen presenting cells, regulatory T cells and some molecular
dynamics are not explicitly represented in the dynamical equations.
Here, the model (4.1) describes the scenario of an autoimmune response of C, a population
of self-reacting T cells (CD4+ or CD8+ T cells) towards a target tissue T after simulation
by self antigen from damaged target cells D. Consequently, the default initial conditions
are chosen to be T (0) = λ
µ
;D(0) = 1;C(0) = 0 as in [51].
Target cells are produced at a constant rate λ and die at a constant rate µ. Thus, the
population growth of healthy cells (T ) is assumed to be affine in this model. The parameter
β describes the efficacy of the damage process induced by autoreactive T cells. From [51],
β also refers the rate at which immune cells find target cells and the rate at which the
target cells are successfully attacked by immune cells. The parameters α and γ denotes the
death/clearance rate of damaged cells and autoreactive effector T cells respectively. It is
assumed that there are constant death rates for each type of cell. Of note, these biological
parameters and state variables are non-negative due to their biological meanings.
The default parameter values are taken from [51] and given as: λ = 10; µ = 0.1; β = 0.5;
α = 1.1; γ = 0.1.
Consider u, an immune response function influencing the dynamic response of the popu-
lation of self-reacting T cells following self antigen stimulation. A candidate closed-loop
dynamics formed by
u = FPI(D) (4.2)
The personal immune response function approach in [51, 52] effectively assumes that dif-
ferent people have different immune response characteristics. The function u is studied
here as an inherent immunological control feedback for the closed-loop model (4.1). The
impact of candidate mathematical functions for u to model the establishment of tolerance
or autoimmunity will be investigated from a control standpoint.
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From (4.3), it is clear that the immune response function u determines both the expression
and magnitude of the steady-state of the cell population. In experimental studies [31, 80,
113, 114], the population size of target cells and self-reacting effector T cells are sensible
indicators to monitor and diagnose autoimmunity. It can be deduced from (4.3) that the





; D0 = C0 = 0 (4.5)
where u = 0, corresponds to a tolerance steady-state because the population of target cells
is not affected by autoreactive T cells. From a control perspective, a means to achieve
robust tolerance is to ensure that the population dynamics of the system (4.1) attain and
remain at this healthy equilibrium irrespective of initial conditions, parameter and model
uncertainty. The characteristic equation obtained from the computation of the Jacobian
matrix (6.9) at this trivial equilibrium is given as:
(ss + µ)(ss + α)(ss + γ) = 0 (4.6)
Consequently, the tolerance steady-state (4.5) is stable because the characteristic equation
(4.6) has three real and negative poles which are −µ,−α and −γ [51, 69]. Recall that these
biological decay rates are positive.
Next, consider the stability and performance of the open-loop system where u is not a
function of the states of the system. This open-loop system has only one equilibrium, see
(4.3). From the characteristic equation of the open loop system, a root-locus analysis is
performed. Changes in the values of u in Fig. 4.2 demonstrate that the immunological
steady-state is imposed by the considered open-loop system. Although changes in the
magnitude of u affects the amplitudes of the poles, they remain in the left hand side of the
complex plane. Nevertheless, different values of u lead to different clinical interpretations of
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the exhibited immunological steady-state due to the associated changes in the population
size of target cells and self-reacting effector T cells.
Figure 4.2: Variation of the poles with respect to an increase in the value of the open-loop
control 0 ≤ u ≤ 2 for the system (4.1)
The simulations in Fig. 4.3 and Fig. 4.4 produced using different constant values of u
depict a tolerance and an autoimmune disease steady-state respectively. As the value of
u increases from zero, the population of self-reacting effector T cells C increases and this
leads to the reduction of the population of healthy target cells. Consequently, the dynamics
of the system move away from the tolerance steady-state and attains a stable non-trivial
autoimmune disease steady-state.
Now, consider the closed-loop dynamics formed by (4.2), an antigen dependent immune
response function is considered. The function FPI(D) is effectively an immune response
program [1, 32, 38, 80] which defines how the density of self antigen influences the ac-
tivation/proliferation of self-reacting effector T cells. From a control standpoint, (4.2)
represents a state feedback which closes the loop for the system (4.1). Consequently, can-
didate immune response functions proposed in the literature [46, 51, 52] are examined as
candidate feedback regime which determine the dynamics of the immunological response
upon antigen stimulation.
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Figure 4.3: Simulation of the open-loop system u = 0 in system (4.1).
Figure 4.4: Autoimmune disease scenario when the open-loop u = 0.7 in system (4.1)
A basic approach is to suppose that the proliferation of autoreactive T cells is proportional
to the antigen density. This leads to the linear immune response function given as
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FPI1(D) = kD (4.7)
where k > 0 is the average magnitude of activation/production of T cells responding to
antigen stimulation [51]. This formulation of the immune response function has been used
in various studies [40, 51, 54]. The use of (4.7) reduces the complexity of the mathematical
model. The closed-loop system with (4.7) has two steady-states: the tolerance steady-











corresponding to an autoimmune disease state. The relation λβk − µγγ = 0 obtained
from the characteristic equation at the tolerance equilibrium determines the sign of the
poles at the equilibrium. Therefore, the stability of the equilibria is dictated by parameter
values. This relation obtained at the steady-state underpins the reults produced by the




From a biological perspective, (4.7) implies that self-tolerance is accomplished when the
magnitude of the activation rate k is small enough to keep the tolerance equilibrium (4.5)
stable despite the density of self antigen. The state of tolerance is lost and an autoimmune
disease steady-state is reached when the value of k is large or due to variations in the
values of the biological rates. From a control perspective, (4.7) represents a linear state
feedback, as such, the dynamics prescribed by (4.7) are sensitive to parameter variations
and modelling uncertainty, see simulation results in [51]. Changes in the value of any
single parameter or multiple parameters can trigger autoimmunity. Consequently, the use
of (4.7) generates some unrealistic insights on the robustness of the tolerance steady-state.
For instance, changes in the value of λ, the production rate of target cell can induce
autoimmunity and this is not realistic [31, 80].
Alternatively, a number of investigators have assumed a Michaelis-Menten kinetics to for-





where m is the maximum proliferation rate of self-reacting T cells and Km is the antigen
concentration at which the proliferation rate is half maximal [1, 29, 40, 51, 71, 98]. The
function (4.8) is a hyperbolic function which is well established in enzyme kinetics within
chemistry. Additionally, it has been applied in a diverse range of systems including ecology,
the immune response and analysis of epidemics, functional response [71–73]. At low antigen
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concentration, when D ≪ Km, FPI(D) =
m
Km
D so that the rate is directly proportional to
the antigen concentration. At high antigen concentration, FPI(D) = m so that the rate is
maximal and independent of antigen concentration. When D = KM , then FPI(Km) =
m
2
and KM is equal to the antigen concentration at which the reaction rate is half its maxi-
mal value [71–73]. Thus, the Michaelis-Menten function (4.8) is effectively an asymptotic
switching curve. The stability and performance characteristics of the closed-loop system
with are sensitive to parameter variations [51].
Using the linear approximation (4.7) or the Michaelis-Menten function (4.8), the system
(4.1) has a tolerance steady-state (4.7) and a nontrivial equilibrium associated with an
autoimmune disease state. When one equilibrium is stable, the other one is unstable.
The parameter values of the system determine which one of these equilibria is stable.
Importantly, these functions yields poor robustness properties and do not allow a dynamic
switch of the immune system between tolerance state and a state of autoimmunity upon
self antigen stimulation as observed in experimental studies [31, 80, 113].






where m is the maximum proliferation rate of immune cells and h is the antigen concentra-
tion at which the proliferation rate is half maximal. This function can also be referred to as
a sigmoidal Hill function. The nonlinearity is achieved by increasing the effect of the stateD
and the variable KM of the Michaelis-Menten candidate (4.8). (4.9) suggests that the pro-
liferation of rate of activated T cells saturates at high antigen density. The resulting closed-
loop system has three equilibria which exist if and only if λ2β2m2−4µγα2h2(µγ+βm) > 0,
see analysis in [51]. There is the tolerance steady-state (4.5), an unstable transient equilib-
rium E− and a autoimmune disease steady-state E+ . The poles of the tolerance equilibrium
are : −µ;−α;−γ. These poles are negative because these parameters are positive biological
constants. Therefore, the tolerance steady-state is always stable. It has been proven that
whenever E+ exists it is always stable if µ >> γ. E− is a saddle equilibrium having a
two-dimensional stable manifold and a one dimensional unstable manifold. It was shown in
Fig. 8 in [51] that E− depicts a boundary surface between the absorbing domain of E0 and
E+. When the antigen population is small the stable trivial equilibrium is reached, whereas
the stable autoimmune disease equilibrium is experienced when the antigen concentration
is large. As a result, the closed-loop system with (4.9) is a bistable system. The initial
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conditions influence the dynamic response produced by the sigmoidal immune response
function (4.9). Hence, the nonlinear state feedback generated by (4.9) generates a new dy-
namical behaviour and changes the mathematical structures of the equilibria, leading to a
bistable immune system with some robustness properties. It can be deduced that (4.9) acts
as a smooth variable structure control for the system (4.1) because it changes the dynamic
response and structure of the system based on the antigen density.
In chapter 3, it has been demonstrated that the dynamics of the specific T cell response
behaves as a variable structure control system in which the control law is defined by the
immune response function. Further, the dynamical behaviour and robustness properties
generated by the immune response function were shown to be similar to the ones of engi-
neering systems with a discontinuous control feedback.
Considering the immune response function as a control switch, it can be deduced that there
are strong similarities between the dynamics of VSCS shown in Chapter 2 and the closed-
loop dynamics produced by biologically-inspired saturation functions [29, 46, 51, 52] for
the immune responses. As seen in Chapter 2, the choice of the feedback strategy and its
magnitude determines the robustness properties. This contributes to new understanding
the nature of feedback mechanisms underlying biological phenomena.
Motivated by the observed activation threshold of the immune response [31, 82, 109, 115]
and knowledge of variable structure control, a discontinuous function which models this
switching mechanism and yields an improvement in the robustness of the immunological




m (S + 1) (4.10)
S = sign(D − h) =
D − h
‖D − h‖
where h is an antigen threshold, has been developed from a control engineering perspective.
This function reflects an activation/proliferation of antigen-specific T cells which depends on
a threshold based on the antigen stimulation (density) as observed in experimental studies
[31, 80, 109–111]. An on/off immunological switch is constructed using a sign function
based on D. To yield a non-negative output, the sign function is shifted in the positive
quadrant. The amplitude of the response m, is the saturation (maximum) proliferation
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rate of the attacking autoreactive T cells. It has a step-like behaviour made up of a brutal
(sharp) change in its output, the proliferation of autoreactive T cells. The discontinuous
behaviour also yields antigen tolerance but implies an instantaneous change of behaviour
(activation/inhibition). The behaviour of the discontinuous personal immune response
function is the switching logic which changes the mathematical structure of the immune
system whilst moving between the healthy and the autoimmune disease state.
The closed-loop system with (4.10) has three equilibrium points: the tolerance equilib-
rium (4.5) a transient equilibrium and an autoimmune disease equilibrium. The output of
(4.10) determines which equilibrium is enforced. Considering the case where S = −1 =>
FPI(D) = 0 which means that the population of antigen is less than the threshold, the
tolerance equilibrium point is obtained.. The Jacobian is evaluated at (4.5). The roots of
the characteristic equation are : −µ;−α;−γ. Since death rates are always positive, the
poles are always negative. Therefore, the tolerance steady-state is always stable.
When the concentration of antigen is equal to the antigen threshold that is S = 0 <=>
FPI = m/2. the immune response is in a transient phase so it produces half the maximum










The Jacobian at this equilibrium point is evaluated. The characteristic equation is a third
order polynomial having positive coefficients for all powers of sS . The Routh-Hurwitz
stability criteria are applied and the transient equilibrium (4.11) is unstable. Now, the
immunological scenario where D > h <=> S = 1 <=> FPI(D) = m. This indicates that
the antigen threshold is surpassed and the personal immune response function delivers the











This non-trivial equilibrium (4.12) is associated with an active autoimmune response and
the reduction of the population of target cells. The Jacobian at this equilibrium (4.12)
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is evaluated and its eigenvalues are: −α;−γ;−(µ + mβ
γ
). Since biological parameters are
always positive, the eigenvalues are all negative. Therefore, this autoimmune disease steady-
state is also stable. Hence, when the concentration of antigen is above the threshold, the
immune response is activated and a stable chronic autoimmune disease state is exhibited.
The function (4.10) thus provides a discontinuous switch between a stable tolerance steady-
state and a stable autoimmune disease steady-state. It should be noted that the stability
of these equilibria is insensitive to parameter variations. Importantly, the closed-loop dy-
namics generated by this discontinuous immune response function exhibit bistability and
robustness to parameter uncertainty.
In summary, the nature of the immune response function significantly impacts the stability
and robustness properties of the system (4.1) as seen in Table 4.1. The behaviour of the
reviewed immune response switching curves upon antigen stimulation is shown in Fig 4.5.
In simulations, using the analytical expression of the equilibria, each candidate function can
be parameterized to have identical numerical coordinates for a stable non-trivial equilibrium
to reach a common autoimmune disease steady-state. The purpose of Fig 4.6 is to highlight
that each candidate immune response function engenders a particular transient dynamics.
Thus, the nature of FPI(D) influences the stability, performance and robustness of the
observed immunological states as well as their corresponding mathematical structures. It
can be concluded that the immune response function of the form FPI(D) which models a
positive feedback for the proliferation of self-reacting T cells by self antigen must change
its structure dynamically to allow the immune system to switch between the tolerance and
the autoimmune disease state.
Collectively, the analysis of the impact of the immune response function on the maintenance
of self-tolerance [40, 51, 52] reinforces the argument that the immune response function is
an immanent VSC feedback which governs the dynamic response of T antigen-specific T
cells as well as the establishment of tolerance and autoimmune disease steady-state.
In Chapter 2, it has been seen that analytical tools from sliding mode control theory
delivers means to investigate the stability, performance and robustness of VSCS. Further,
the work in Chapter 3 proves that the framework of sliding mode control provides sensible
insights on the dynamical behaviour and robustness of the specific T cell response following
acute infection. Consequently, if the state of tolerance can be associated with an attractive
manifold of the state-space, a reachability analysis can be performed to investigate the
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Figure 4.5: Different personal immune response curves (4.7)-(4.10): - linear, + Michaelis-
Menten, o sigmoidal and x discontinuous.
performance of the immune response function, as an inherent control to achieve robust
tolerance.
4.4 Sliding mode control framework
The framework of sliding mode control is considered to investigate the dynamics of tol-
erance due to the fact that the immune system as demonstrated in the previous sections
Table 4.1: Comparison of the mathematical structures and robustness of the immune
system due to changes in the personal immune response function.
Personal immune Qualitative
response function behaviour
Proportional to Stability and
antigen performance of
concentration as in the two equilibria are
equation (4.7), [116] sensitive to parameter values
Michaelis Menten Similar to
as in (4.8), [51] above
Sigmoidal Bistability
(Holling type III) Saddle equilibrium
equation (4.9), [51] Robust performance
Discontinuous switch Bistability
based on antigen population Unstable equilibrium
equation (4.10) Robust performance
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Figure 4.6: 3D plot of the dynamical behaviour of the immune system (4.1). Compari-
son of the transient dynamics resulting from the implementation of the candidate immune
response functions (4.7)-(4.10). H.S.: Healthy tolerance steady-state (4.5), A.S.: Autoim-
mune disease steady-state. T : Target cells, D: damaged cells and C: self-reacting effector
T cells.
incorporates an intrinsic VSC feedback, the immune response function which determines
immunological responses and outcomes. Further, the reachability paradigm is used as a
tool to assess dynamical conditions for the maintenance of tolerance. This adds to the
state-of-the-art because when the reproductive ratio can be defined, it only provides a
time invariant steady-state condition for the maintenance of tolerance [40, 51]. Further-
more, analytical tools from sliding mode control are utilized to assess the robustness of
the immunological dynamics prescribed by the immune response function in the context of
tolerance/autoimmunity as performed in chapter 3 in the scenario of infection.
A switching function given as:
s = D + C (4.13)
has been designed using self antigen and autoreactive T cell dynamics because these dy-
namics are strongly involved with the dynamic response of the immune system to enforce
tolerance homeostasis [31, 80, 109, 113, 117]. Importantly, the manifold s = 0 is associated
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with the tolerance steady-state (4.5). Consequently, the tolerance state will be exhibited
when the states of (4.1) lie on this manifold.
The reachability condition, introduced in Chapter 2, is expressed as:
ss˙ < 0
From (4.1) and (4.13),
ss˙ < s(βTC − αD + u− γC) (4.14)
This inequality represents a dynamical condition for the immune response function u to
allow the states of the system (4.1) to attain and remain on the manifold s = 0 associated
with the tolerance steady-state (4.5). Consequently, the reachability condition (4.14) is a
means to determine in the maintenance or loss of the tolerance state.
As seen in the previous section, the antigen-dependent immune response functions (4.7)-
(4.10) describe a positive feedback mechanism in which the increase of the density of self
antigen leads to an activation/proliferation of self-reacting T cells which causes the re-
duction of the population size of self tissues. Consequently, the output of the candidate
immune response functions (4.7)-(4.10) where u = FPI(D) must vanish after self antigen
stimulation to allow their respective closed-loop dynamics satisfy (4.14). In effect, when
the output FPI(D)→ 0 and vanishes because this leads to C → 0 and an exponential decay
of the states of the system towards the manifold s = 0.
When the reachability condition (4.14) is satisfied, it follows that s = s˙ = 0. The dynamics
of the system under sliding mode are reduced to
T˙ = λ− µT (4.15)
since C− > 0. This dynamical equation for the target cell population has a unique equilib-
rium λ
µ
and a stable pole at −µ. It can be deduced that when immune response function
render s = 0 attractive and achieves tolerance, the effects of self-reacting T cells on the
population dynamic of target cells are cancelled.
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In essence, the candidate immune response function (4.7)-(4.10) describe the positive feed-
back of self antigen stimulation on the activation/proliferation of self-reacting effector T
cells. Autoimmunity sets off when the magnitude of this positive feedback is sufficient to
fail the reachability condition (4.14) and induces proliferation of autoreactive effector T
cells. In immunology, it is well know that the presence of self antigen also triggers cellular
and molecular mechanisms such as regulatory T cells and co-stimulatory molecules to sup-
press autoimmune responses [31, 50, 84, 86, 106, 111]. The action of these mechanisms can
be regarded by biologists as regulatory loops that the immune system possesses to main-
tain robust tolerance homeostasis. Further, in mathematical studies where the dynamics
of regulatory T cells explicitly represented [40, 87, 107], they produce a negative feedback
to slow down or stop the proliferation of self-reacting T cells.
Current findings in immunology show that the immune system possesses regulatory mech-
anisms to suppress unwanted immune responses [31, 50, 86]. Physiologically, self-tolerance
or autoimmune response inhibition is driven by immunological mechanisms which induce
the death of activated autoimmune effector T cells [31, 86, 88]. Based on self antigen stim-
ulation, the dynamics of regulatory T cells and other molecular signals produce a negative
feedback to suppress autoimmunity and maintain a robust tolerance equilibrium.
The work in Chapter 2 has shown that when reachability condition for a sliding mode is
satisfied, the states of the system are driven to chosen sliding manifold and remain on it. As
a result, the closed-loop dynamics prescribed by the chosen sliding manifold are exhibited.
In effect, the reachability analysis is used to design a VSC strategy to render the sliding
manifold attractive to the states of the system. Motivated by the synergies between the
control mechanisms of the immune system and the VSC paradigm shown in the previous
sections, sliding mode control techniques are used to design a negative feedback modelling
the effects of regulatory loops which inhibit autoimmunity. Since the manifold (4.13) is
associated with the tolerance steady-state, a VSC strategy is designed to achieve a sliding
monde on this manifold to produce a robust feedback to inhibit autoimmunity. Consider
the following discontinuous function which yields autoimmune response inhibition when D
and C are present:
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The reachability condition (4.14) becomes:
ss˙ ≤ s(βTC − αD − ρsgn(s)− γC)
ss˙ ≤ |s|(βTC − αD − γC − ρ) < 0 (4.17)
Since s > 0, the sign of (4.21) depends only on s˙. The reachability condition thus reduces
to:
βTC − αD − γC − ρ < 0
βTC − αD − γC < ρ (4.18)
The amplitude of the controller for which the reachability condition is satisfied is sought.
Failure of the reachability condition is a condition for failure of self-tolerance. For a range of
initial conditions, a static value of ρ can be chosen to guarantee that the condition (4.18) is
met and the sliding surface is reached. From (4.18), it can be noticed that the reachability
condition is a function of the state variables and parameter values. The amplitude of ρ
required to satisfy this condition will vary during the motion. The adaptation algorithm in
[25] has been designed assuming a sliding mode condition which is a time-varying parameter
bounded above and below. (4.18) does not directly yield an implementable controller in
the case where parameters are uncertain.
It is an open problem to design a dynamic adaptive gain controller which produces the
minimum magnitude of the discontinuity under uncertainty before and after ideal sliding
motion.
An adaptation scheme is considered to reflect the fact that the regulatory loops of the
immune system produces a dynamic response to suppress autoimmunity [31, 80, 86, 88].
The adaptation method considered here is a control gain proportional to the state variables.
This tuning of the magnitude of the discontinuity has the benefit of reducing high control
activity [10, 15]. Let ρ be a function of the state variables.
ρ = ρo + βoTC (4.19)
where ρo is a small constant. This produces the following adaptive sliding mode control
Chapter 4. Self-Tolerance Mechanism of T Cells, a natural VSC 67
u1 = −(ρo + βTC)sign(s) (4.20)
A block diagram of this self-tolerance mechanism is given in Fig. 4.7.
Figure 4.7: Model (4.1) of self-tolerance/autoimmunity where the immune response func-
tion u (4.20) is an adaptive sliding mode control feedback which imposes a robust state of
self-tolerance via inhibition of self-reacting T cells
The ability of this function to enforce the tolerance steady-state and to render the manifold
s = 0 is proven by substituting (4.20) in the expression of the reachability condition (4.14).
This yields
ss˙ < s(βTC − αD − (ρo + βoTC)sgn(s)− γC) < 0
−βδTC − αD − γC − ρo < 0 (4.21)
since |s| = sign(s) and s > 0 and βδ = βo− β > 0. As a result, u1 satisfies the reachability
condition. The desired negative feedback control action u1 ensures that the trajectories of
(4.1) reach the manifold s = 0 in finite time and remain on it. Consequently, he stable
healthy tolerance steady-state (4.5) is enforced.
Consider the nominal values of the parameter of system (4.1) taken from [51]: λ = 10;
µ = 0.1; β = 0.5; α = 1.1; γ = 0.1;βo = 1; ρo = 0.0.
The purpose of the simulation in Fig. 4.8 is to demonstrate that function (4.20) as a
regulatory feedback is capable of forcing the system trajectories to move and remain at the
self-tolerance equilibrium (4.5). The negative feedback (4.20) engenders a rapid inducement
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of inhibition of autoreactive T cells due to a step-like function. Fig. 4.10 shows that the
reachability condition is satisfied during the whole simulation. Therefore, the manifold s is
attractive and the states D and C attain s = 0 after a fine time and stay on it, see Fig. 4.10.
Thus, the dynamical behaviour of the immune system induced by the discontinuous self-
tolerance feedback is shown to exhibit a sliding mode which enforce the tolerance state.
Figure 4.8: Immunological dynamics driven to the tolerance steady-state (4.5). Closed-
loop system (4.1) with the negative tolerance feedback (4.20) .
When an ideal sliding mode takes place after a time ts, s = s˙(t) = 0 for all t >= ts.
The concept of the equivalent control introduced in Chapter 2 is considered. Here, the
equivalent control represents the theoretical injection required to maintain sliding motion
on (4.13) to exhibit tolerance. From s˙(t) = 0, the expression of the equivalent control is
given as:
ueq = αD + γC − βTC (t >= ts) (4.22)
The time evolution of the equivalent control action, see Fig. 4.11 illustrates the variation
over time of the magnitude of the suppression signal acting on the population dynamic
of autoreactive T cells C due to the intrinsic self-tolerance control feedback (4.20). This
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Figure 4.9: Time course of the switching function (4.13). Closed-loop system (4.1) with
the negative tolerance feedback (4.20).
exemplifies the notion that self-tolerance as an active immunological VSC action to maintain
desirable homeostasis and a healthy state [31, 40, 50, 83]. The amplitude of the equivalent
control is proportional to the state variables. Considering the trivial equilibrium values
of the state variables, it is clear that in the absence of disturbance, the equivalent control
action vanishes when the tolerance equilibrium (4.5) is attained. This can occur in sliding
mode control and may be expected at nominal conditions [23].
The dynamical behaviour of the immune system with respect to changes in one or more
parameter values is analysed. The parameter values used in the mathematical studies
of self-tolerance dynamics in [51, 52] are chosen to test the stability and performance of
the design control outside of nominal conditions. Changes in parameter values represent
changes in the rate of biological processes such as production rates and death rates. The
following uncertain parameters are considered: λ = 2, µ = 0.1, β = 0.45, α = 0.145,
γ = 0.01.
Unfortunately, it has not been possible to obtain experimental data for the model (4.1).
As discussed in [82], mathematical models to study self-tolerance dynamics have not yet
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Figure 4.10: Time course of the reachability condition (4.21). Closed-loop system (4.1)
with the negative tolerance feedback (4.20).
Figure 4.11: Time course of ueq, the equivalent control signal (4.22) t > ts = 5days.
Closed-loop system (4.1) with the negative tolerance feedback (4.20)
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been enriched by kinetics data from mouse or human experiments. In contrast, mathemat-
ical investigations have benefited from experimental studies on HIV infection dynamics to
deliver sensible immunological insights [30, 35]. This motivates the study of HIV infection
dynamics in the next Chapters.
Simulations are conducted in Fig. 4.12 to compare the robust stability and robust perfor-
mance of (4.20) with the ones generated by a linear feedback u2 = kD. In [51], u2 has been
shown to achieve nominal stability and performance of the tolerance state.
Looking at Fig. 4.12, the immunological rates are different from the ones which have been
discussed in the nominal case. Parameter variations in λ and µ affect the steady-state pop-
ulation size of target cells. Although the population of healthy cells has greatly decreased,
the dynamical behaviour induced by (4.20) satisfy the reachability condition (4.14) and
exhibits a tolerance state. In effect, the concentration of self antigen and autoreactive T
cells are driven to zero and the trajectories reach and remain on the sliding manifold (4.13).
Unlike u1, the control u2 cannot reject the perturbation in parameter values. In fact, u2
does not satisfy the reachability condition (4.14). This comparison of the immunological
behaviours is evidence that (4.20) achieves robust stability and robust performance of the
healthy immune system.
The effect of modelling uncertainty in (4.1) is investigated. Changes in the assumed growth
function of target cells are considered to reflect different tissue growth dynamics. The linear
growth process of target cells in (4.1) is substituted by a logistic and density dependent
process as in [51]. The dynamical equation related to the target cells becomes:
T˙ = λ+ (pT )(1−
T
L
)− µT − βTC (4.23)
Here, target cells can be created both by a constant production rate λ and by the prolif-
eration of existing target cells with p as the maximum proliferation rate. Also, the target
cell population saturates at a predefined carrying capacity L.
The expression of the reachability condition in (4.21) prove that the adaptive scheme in-
cluded in the control (4.20) allows this control feedback to keep the inequality (4.21) true
despite the variation of the population size of target cells. As a result, the manifold s = 0
remains attractive to the states of the system and self-tolerance is achieved despite changes
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Figure 4.12: Comparison of the performance of control laws u1 in (4.20) and u2 = kD
with parameter disturbance: λ = 2, µ = 0.1, β = 0.45, α = 0.145, γ = 0.01 and k = 0.002
in the dynamics of target cells. The dynamical behaviour of the system trajectories is sim-
ilar to that observed in Fig. 4.8. During ideal sliding motion s = D + C = 0. Since D > 0
and C > 0, D = C = 0 when sliding mode occurs. Therefore, the term βTC vanishes
in (4.23). This means that when the control (4.20) enforces a sliding mode and achieve
tolerance, the dynamics of target cells are not impaired by the effects of self-reacting T
cells. Hence, the self-tolerance dynamics generated by the control law (4.20) are robust
to changes in the dynamics of target cells. This matches with the immunological reality
because the tolerance state is exhibited in vivo for various tissues [31, 92].
Together, the results of the conducted robustness analysis demonstrate the synergies be-
tween sophisticated immunological control mechanisms and robust engineering control strate-
gies.
4.5 Conclusion
In this chapter, tolerance mechanism have been examined from a control engineering per-
spective. Analytical and numerical analysis highlight that the characteristics of the immune
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response function determine the establishment and maintenance of a robust tolerance state.
Furthermore, feedback mechanisms to establish a robust tolerance steady-state are inves-
tigated using the framework of sliding mode control introduced in Chapter 2. A manifold
associated with the tolerance steady-state has been identified and the conditions for en-
forcing sliding motion on this manifold are determined. Conditions for the establishment
of self-tolerance by the immune response function are found to be consistent with condi-
tions for a sliding mode. Importantly, the reachability condition delivers a nonlinear tool
to assess and monitor immunological dynamics. The study of self-tolerance mechanisms of
the immune system strengthens the argument that the immune system is naturally a VSCS
because the establishment of tolerance is achieved by inherent immunological switching
logic and feedback loops.
The advantage of the sliding mode control approach is based on the fact that it binds
immunological requirements with the reachability conditions. As seen in this chapter,
this provides a means to understand how a given immunological control feedback realise
the desired immunological outcome. In the context of HIV infection, it is important to
understand how the HIV-specific CD8+ T cell response achieves immunity. Consequently,
analytical tools from sliding mode control will be used in the next chapter to investigate
the containment of HIV infection in vivo by the HIV-specific T cells response. Finally, in
Chapter 6, the availability of patient data from HIV clinical trials motivates a case study
in which the reachability paradigm is used to monitor the containment of HIV infection by
antiretroviral drugs.
Chapter 5
Evaluation of the Conditions for
the containment of HIV infection
by the HIV-specific CD8+ T Cell
response, a Variable Structure
Control Perspective
5.1 Introduction
In this chapter, it is demonstrated that the reachability paradigm introduced in Chapter 2
can be utilized to formulate a dynamical condition for the control of HIV infection by the
HIV-specific CD8+ T cell response.
HIV is a persistent infection which mainly targets CD4+ T cells and in most cases leads
to Acquired Immune Deficiency Syndrome (AIDS) [30, 37, 118]. Experimental studies
have demonstrated that the HIV-specific CD8+ T cell response is a major immunological
dynamic opposing the spread of infection in the host [30, 55, 57, 58]. It is of current
interest to understand how the HIV-specific CD8+ T cell response contains HIV infection
[30, 57, 119]. It is not clear whether immunity is achieved by the cytolytic or the non-
cytolytic killing mechanism of HIV-specific CD8+ T cells [55, 56, 75]. This motivates the
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use of control theory to formally investigate the control action of the killing mechanism of
the HIV-specific CD8+ T cell response.
Mathematical modelling of HIV dynamics in vivo has significantly contributed to the un-
derstanding of the HIV pathogenesis along with the design of treatment regimes to boost
the immune response and/or to reduce the severity of the infection [30, 53, 60]. Early math-
ematical models of HIV dynamics in vivo can be found in the seminal papers [60, 120]. A
third order model can encompass the observed biological characteristics of the acute phase
of HIV infection using the variation over time of the population of healthy CD4+ T cells,
the infected population of CD4+ T cells which produce new virion along with the concen-
tration of the HIV-1 free virus [35, 60]. Although this model describes experimental data
well, it does not include the dynamics of the HIV-specific CD8+ T cell response explicitly
[55, 60].
HIV-specific CD8+ T cells combat HIV by killing HIV infected cells [57, 118, 119]. Early
thoughts assumed that HIV-specific CD8+ T cells kill HIV-infected cells whilst they are
producing new virion [56, 58, 60, 102] but recent studies proved that HIV-specific CD8+ T
cells have a minor impact on the death rate of virus-producing HIV-infected cells [30, 58, 75].
Current findings suggest that HIV-specific CD8+ T cells kill HIV-infected cells via a cy-
tolytic mechanism during the eclipse phase of the infection, before infected cells start pro-
ducing new virion. Furthermore, the non-cytolytic mechanism of HIV-specific CD8+ T
cells has been demonstrated to have an important role on the containment of the infection
by preventing the infection of new cells [35, 56, 75]. Consequently, these features have been
explicitly incorporated in recent models to improve the realism of the model as well as the
understanding of the impact of the HIV-specify CD8+ response on the containment of the
infection [56, 58].
The outcome of a viral infection in a host is classically evaluated using the reproductive
ratio R0 which measures the number of new cells that a single infected cell produce at the
start of infection when there is no target cell limitation [34, 35]. The reproductive ratio is
an algebraic combination of some biological rates which can be retrieved using the constant
term of the characteristic equation of the nonlinear dynamical equations of an HIV dynamic
model linearized at the infection-free steady-state [35, 56]. Typically, when R0 < 1, the
infection-free steady-state is stable and the infection will not spread. Since the parameters
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associated with the killing efficacy the HIV-specific CD8+ T cell response are included in
the expression of the reproductive ratio, the condition for the containment of the infection
depends on the HIV-specific CD8+ T cell killing mechanism to enforce the reproductive
ratio to be below unity [35, 56, 121]. Thus, the framework of the reproductive ratio provides
a static condition which infers that the condition for the containment of the infection solely
depends on the values of some biological rates rather than population dynamics.
However, recent studies argue that the immunological requirements for the containment of
the infection rather than being static changes during the course of the infection [34, 102,
119]; the immunological requirements might be weaker before the peak of the virus load
due to the small number of viral particles at the site of the infection [34]. The work in
[122] suggested that the failure of the HIV-specific CD8+ T cell response to eradicate the
infection is explained by a low ratio between the number of effector HIV-specific CD8+ T
cells and the population size of the infected cells (target) at the early stage of the infection
before the peak of the virus load. The effector/target ratio increases after the peak of
the virus load and a greater immunological pressure is exerted on the infection dynamics.
Furthermore, experiments have demonstrated that the depletion of virus-specific CD8+ T
cells post infection leads to an increase of the virus load [56]. Hence, the framework of
the reproductive ratio does not encompass the emerging notion that the condition for the
containment of the infection changes during the course of the infection according to changes
in biological rates and population dynamics [30, 34, 102, 119].
The dynamic of HIV in vivo is inherently a closed-loop system because natural control
strategies such as the non-cytolytic and the cytolytic mechanism of the HIV-specific CD8+
T cell response are intrinsically applied by the immune system to eradicate HIV infection
[30, 56, 58]. Therefore, models of HIV dynamics in vivo can be analysed using the tools of
control theory to evaluate the performance of the HIV-specific CD8+ T cell response and
to develop additional feedback strategies, which in this context amounts to hypothesizing
treatment regimes.
Exploring immunological mechanisms from the perspective of control engineering can be
found in several papers in the literature relating to both theoretical biology and control
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engineering. A significant set of publications focus on enhancing the action of the immune
response and antiretroviral drugs to contain the infection.
Optimal control strategies have been investigated to design treatments. In [123], the control
analysis has postulated the early start of treatment to improve success. The method pro-
posed in [124] offers some robustness with parameter perturbation. The control and therapy
strategy is to have a slow reduction of the drugs dosage during the course of the treatment.
This investigation was inspired from an optimal control strategy which developed a minimal
cost function for drugs therapy in HIV [125].
Model predictive control techniques have been considered due to problems with safety and
difficulty of implementation of the continuous treatment regime resulting from optimal
control strategies [126]. In [127], interrupted drug scheduling was investigated. Using this
approach, a new optimal control law is computed at each sampling period. This has the
benefit of boosting the immune response to provide stability of the immunological state
and to exhibit robustness to parameter and model uncertainty [126, 127].
Besides, nonlinear two loop feedback controls law is developed in [128]. An inner controller
aims to cancel the effects of the nonlinearity caused by the product of healthy CD4+ cell
and virus state variables. Using exact linearization methods and measurement of the virus
concentration, this inner controller is a function of time which changes by steps. This
control law infers that the HIV-1 dynamics progresses according to a series of switched
linear dynamic models. As a result, the control signal of the inner controller is not smooth.
The control action of the outer loop feedback is based on the availability of measurement of
both virus and CD4+ concentrations. In fact, the outer controller compensate the intrinsic
nonlinearity of the model using the product of the virus concentration and the sum of
uninfected and infected CD4+ concentrations.
The outer loop with a static gain feedback control law manipulates the inner lop and
achieves the tracking of the reference ( low level) HIV concentration. The smooth control
signal is obtained in the absence of noise in the outputs. As in [129, 130], a discrete time
version of the control action is implemented for satisfying practical constraints of measure-
ments. The stability and performance of the control strategy is deteriorated with increase
in the interval between blood samples. A trade-off between the design of sophisticated
control laws and selection of sampling times is suggested to be investigated.
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In [131], a control Lyapanov function approach has been used to design a treatment regime
for HIV. Using the basic HIV-1 model and parameter values from [132], the nominal design
is performed. The most efficient design is to apply the control strategy into the infected
cells dynamic. The performance is influenced by parameter uncertainty and noise in the
input channel. In presence of +or - 20% variation, the controller reduces dramatically
the virus load but the concentration of uninfected T cells fails to reach its desired healthy
equilibrium. It interesting to note that the decrease in the value of the natural decay rates
is improves the performance.
In [130], the model developed in [133] has been considered for designing a singularity free
nonlinear controller. From knowledge of the dynamics of HIV-1 infection, the model is
divided into two subsystems. In the finite region corresponding to the origin, a local non-
negativity and singularity free controller is designed using a decoupled Lyapanov function
over the origin. In the other region, complement to the origin, the properties of the system
are exploited using backstepping techniques and a global controller is constructed. Consid-
ering the periodical acquisition of blood samples, the control action trough HAART drugs
administration to the patient is fixed during the sampling interval to model medical prac-
tice as in [37, 134, 135]. The assumption is that the efficacy of the drugs is constant during
the sampling interval.
The antiretroviral therapy is adjusted according to measurement of the viral load obtained
from a blood sample at a particular instant. In other words, the control action is changed
according to the region in which the system is currently in. Furthermore, the blood sampling
period is adjusted with respect to the severity of the infection which is determined by the
measured virus concentration. For instance, an aggressive control action is applied in the
complement region with a high sampling period because the virus concentration is larger
than the predefined threshold. Unlike in [129], the control energy can be significantly
reduced when the viral load is close to zero due to the fact that an softer control action is
applied in this region. Hence, the nonlinear control law implemented in [130] is a variable
structure like control strategy [7].
A theoretical sliding mode controller has been investigated as a candidate treatment strat-
egy in [136]. The nominal design of the controller was performed on a basic HIV-1 model
such as the one in [60] with parameters values from [137]. The desired healthy equilibrium
is shifted to the origin to ease the construction of the sliding surface. The sliding surface
consists of both (uninfected and infected)T cells and virus concentration dynamics. The
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control action is bounded in the range [0; 1]. This is to reflect the effectiveness of the drugs.
For example, when U = 1, drugs have 100% efficacy. Right after the sliding surface is
reached, the discontinuous control action is deliberately replaced by the equivalent con-
troller. A Lyapanov analysis has been used to prove the stability of the desired virus free
equilibrium under the closed-loop control. The simulations have shown robust stability
and performance with respect to parameter uncertainty. Although the publication [136]
stands as one of the first attempt proposing a discontinuous control as a treatment strategy
for HIV-1, the controller design needs to be improved by including constraints related to
practical issues such as the availability of clinical data [138].
Evaluating the condition for the containment of the infection by the HIV-specific CD8+ T
cell response using a Variable Structure Control (VSC) approach can be motivated from
the following observations:
1. Experimental studies in [119] show that the dynamic response of an elite CD8+ t cell
response contains HIV infection and reduces HIV load below the limit of detection
50 RNA/ml. It has been shown in Chapter 2 that in a variable structure control
system, the control structure changes during the process according to a predefined
switching law to achieve desired performance [7, 10, 13, 16, 22]. Further, the work in
Chapter 3 has demonstrated that the immune response program of the specific CD8+
T cells [30, 55, 56, 139] is effectively an inherent VSC law which dictates the dynamic
of the response according to some immunological law. Besides, the recent study in
[139] has demonstrated using a double saturation function is appropriate to model
the cytolytic mechanism of CD8+ T cells. The findings of this study reveal that
the structure of the killing action changes during the course of a viral infection and
saturates according to the population size of target cells and CD8+ T cells. Hence,
the cytolytic mechanism of CD8+ T cells can be regarded as an inherent VSC to kill
infected cells and achieve immunity.
2. The immune system is a highly robust system, maintaining a steady-state corre-
sponding to health or disease in the presence of perturbations and disturbances. A
potent cytolytic CD8+ killing action is most simply represented with a large con-
stant killing rate [35, 56]. Alternatively, a Michaelis-Menten Function with a small
Michaelis constant and an appropriate saturation rate can be designed to produce
similar effects at steady-state [56]. These functions are effectively high gain negative
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feedback where the latter is very similar to the continuous approximations used in the
domain of engineering to implement discontinuous control strategies. Control theory
has demonstrated the similarities between the robustness properties of high gain lin-
ear state feedback systems and discontinuous systems [7, 10, 15, 16, 22]. Further,
implementation of discontinuous control strategies in the domain of engineering has
been routinely carried out using smooth approximations to the discontinuous func-
tion; one example is the so called unit vector control law [10]. Moreover, Chapter 4
shows that there are strong similarities between the two domains and the functions
used to provide practical robustness.
3. It has been demonstrated that the function describing the killing mechanism of the
HIV-specific CD8+ T cell response and the magnitude of this killing action influence
the immunological steady-state and the outcome of the infection [56]. In the domain
of sliding mode control, the dynamics will typically attain a desired steady state which
is defined by the chosen sliding surface when the so called reachability condition is
met [7, 15, 16, 22]. When the reachability condition fails to hold, the system will
exhibit different dynamics, usually exhibiting a different equilibrium. If appropriate
sliding manifolds can be designed to represent the biological phenomena, a reachability
analysis can be used to formally assess the condition for the containment of the
infection by the HIV-specific CD8+ T cell response.
Unlike the static condition provided by the reproductive ratio computed at the infection-free
steady-state, the novelty and the major contribution of the VSC approach resides in the fact
that the reachability analysis provides a dynamical condition for the HIV-specific CD8+
T cell response to reach and maintain the infection-free steady-state. Furthermore, this
condition encompasses the nonlinearities of the model and exhibits some robustness prop-
erties with respect to parameter and modelling uncertainty. Importantly, the dynamical
condition for immunity provided by the VSC analysis can be reproduced by experimental
studies such as the one in [34, 35] using estimation of the size of the different population
and the biological rates involved in the population of dynamic of infected cells in which the
HIV-specific CD8+ T cell response is acting.
This chapter is structured as follows: In section 1, a model of HIV dynamics in vivo in
which HIV-infected cells are killed in the eclipse phase is presented. In section 2, the
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dynamical condition for immunity using the VSC paradigm is formulated. Next, this con-
dition is tailored to candidate control function modelling the cytolytic killing action of the
HIV-specific CD8+ T cell response. Afterwards, the steady-state condition for immunity
using the reproductive ratio is computed and analysed in section 3. Finally, in section 4,
simulation experiments are conducted to support the analytical analysis and the notion
that the dynamical condition for immunity from the reachability analysis is an appropriate
tool to monitor the immunological requirements to eradicate the infection.
5.2 Model description
The model studied in [56] is considered for investigating the condition for the containment
of the infection by the HIV-specific CD8+ T cell response. The state variables are the
population of uninfected CD4+ T cells T , the population of HIV-infected CD4+ T cells
in the eclipse phase I, the population of HIV-infected CD4+ T cells which produces new
virion P , the dynamics of free virions V (virus load per ml) and the population dynamic
of HIV-specific CD8+ T cells E. The dynamical equations are given as:
dT
dt
= λ− δTT − βTV
dI
dt
= fβTV − γI − δT I + uC
dP
dt
= γI − δPP
dV
dt
= pP − δV V
dE
dt
= gE − δEE (5.1)
The immune response function for the proliferation of HIV specific CD8+ T cells follows a
Michaelis-Menten process and is expressed as:
g =
gmaxI
hg + I + E
(5.2)
where hg has been set to zero [55, 56].
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The non-cytolytic killing mechanism of the HIV-specific CD8+ T cells is modelled by the





where 0 ≤ ǫE, and ǫ represents the efficacy of CD8+ T cells exerting non-cytolytic killing
of HIV-infected cells in the eclipse phase.
The cytolytic mechanism of the HIV-specific CD8+ T cell response is encompassed in the
parameter uC where uC ≤ 0. A block diagram of this process is given in Fig. 5.1.
Figure 5.1: Model (5.1) of HIV infection dynamics in which infected cells in the eclipse
phase are killed by the cytolytic effect of CD8+ T cells
In this chapter, the cytolytic mechanism of HIV-specific CD8+ T cells is treated as an
intrinsic immunological control action because it is assumed that HIV-specific CD8+ T
cells control/contain HIV infection in vivo via cytolytic mechanism, i.e killing of HIV in-
fected cells in the eclipse phase [55, 56]. The non-cytolytic mechanism is not the focus but
constitutes a candidate immunological means to contain the infection in vivo [55, 58, 75].
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; Is0 = Ps0 = Vs0 = Es0 = 0 (5.4)
Throughout the chapter, the term condition for immunity is defined as the condition that
the killing mechanism of the CD8+ T cell response needs to satisfy for zeroing the state
variable I, the population of HIV-infected CD4+ T cells in the eclipse phase to reach and
maintain the infection-free steady-state. Thus, the control objective of uC is to satisfy the
condition for immunity.
5.3 Dynamical condition for immunity using the reachabil-
ity analysis
As in Chapter 3, the framework of sliding mode control is utilized to investigate the per-
formance of the specific T cell response. Here, a sliding manifold representing the immuno-
logical objective of the HIV-specific CD8+ T cell response is defined and a reachability
condition is formulated to ensure that immunity is achieved. The sliding surface is given
as:
sE(t) = I (5.5)
In this sliding mode control approach, the HIV-specific CD8+ T cell response in the ideal
case is thought to render the manifold sE = 0 attractive. In the sliding mode,




defines the dynamical behaviour of the system (5.1). In fact, the sliding surface sE is
selected so that ideal sliding motion yields a stable infection-free steady-state. It should
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be mentioned that the sign of sE(t) is non-negative at all times because it relates to the
number of HIV-infected CD4+ T cells in the eclipse phase I ≥ 0.






= fβTV − (γ + δT )I + uC (5.7)
Next, the concept of the equivalent control, introduced in Chapter 2 is considered. The
equivalent control uCeq, the effective control action required to maintain sliding motion on
sE = 0, is retrieved from
dsE
dt
= 0 as follows:
uCeq = −fβTV + γI + δT I (5.8)
Hence, the equivalent control is meaningful and represents quantities that can be measured
or estimated [35, 59, 141].





I (fβTV − (γ + δT )I + uC) < 0 (5.9)
(fβTV − (γ + δT )I + uC) < 0
since 0 ≤ I by definition. This inequality formulates a dynamical condition for the HIV-
specific CD8+ T cell response to zero the population dynamic of HIV-infected cells I in
the eclipse phase to ensure immunity. This dynamical condition for immunity is the main
contribution of this chapter.
This dynamical condition also infers that the negative feedback provided by the HIV-
specific CD8+ T cell response should overcome the positive feedback of HIV pathogenesis
encompassed by the product βTV . When immunological dynamics satisfy (5.9), sE = 0
is rendered attractive and the population dynamics of the system (5.1) move towards the
infection-free steady-state (5.4). Thus, the inequality (5.9) reflects the balance between the
progression of the infection and the immunity provided by the HIV-specific CD8+ T cell
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response [35, 57, 122]. In fact, the term fβTV is a dominant component which sustains HIV
pathogenesis. As a result, the condition for immunity is mainly influenced by the infection
rate β, the population size of uninfected cells and the virus load. This suggests that the
killing mechanism of the HIV-specific CD8+ T cell response might operate as an adaptive
control mechanism which aims to provide a sufficient magnitude to achieve and maintain
immunity despite fluctuation in the magnitude of the term βTV . This interpretation is
consistent with the study conducted in [122] in which the killing action of the HIV-specific
CD8+ T cells after vaccination has been demonstrated to be insufficient to prevent viral
growth due to a low effector to target cell ratio at the beginning of the infection.
In Chapter 2, it has been shown using the example of the pendulum system that when
the system exhibits a sliding mode, the closed-loop dynamics become robust to matched
uncertainty and perturbations. Typically, the magnitude of the control action is designed
to satisfy the reachability condition despite parameter and modelling uncertainty present
in the dynamic where the control action is applied. As a result, the dynamical behaviour
of the system prescribed by the choice of the sliding surface is enforced and the dynamics
exhibit some invariance properties.
Furthermore, the robustness of the killing mechanism of the virus-specific CD8+ T cell
response can be observed in experimental and mathematical studies on acute Lymphocytic
Choriomeningitis Virus (LCMV) infection [2, 29, 43, 91]. In these studies, the immunity
provided by the virus-specific CD8+ T cell response is robust to various biological factors
such as changes in the initial number of responding CD8+ T cells, changes in the rate of
clonal expansion, changes in virus strains and in the biological rates associated with the host
mice. Additionally, clinical studies have shown a great variety in the population of HIV-
infected individuals called elite HIV controllers which are able to maintain the virus load
in their body below the limit of detection without receiving any treatment [30, 37, 57, 58].
This suggests that an elite HIV-specific CD8+ T cell response is robust to changes in the bi-
ological rates and infection dynamics associated with the difference between patients along
with differences in virus strains.
The expression (5.9) provides a means to clarify the effects of uncertainty in the values
of biological rates and population dynamic of the system (5.1) on the containment of the
infection. In fact, the work in [55, 122, 140] on modelling HIV dynamics in vivo pointed
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out that some of the constant parameters in (5.1) represents biological rates which vary
according to time or to some population dynamics during the course of the infection. For
instance, the infection rate β is influenced by the antibody response to HIV [142]. Also,
HIV pathogenesis seems to create a positive feedback which activates uninfected CD4+ T
cells and increases their number as a function of the virus load [143]. From (5.9), it is
possible to argue that that the condition for immunity is insensitive to changes in the exact
mathematical representation of the population of uninfected CD4+ T cells T , the popula-
tion of infected CD4+ T cells which produces new virion P , the dynamics of free virion V
and the population dynamic of HIV-specific CD8+ T cells E. As a result, the condition
for immunity (5.9) exhibit some robustness with respect to modelling uncertainty in these
dynamics because these uncertainty do not appear in the expression of the reachability
condition (5.9). Nevertheless, parameter and modelling uncertainty in the dynamic where
the killing action of the HIV-specific CD8+ response is present influence the magnitude
of the dynamical threshold and they might cause (5.9) to fail. In essence, the dynamical
condition for immunity provided by the reachability analysis holds despite changes in the
initial condition of the system. This means that the condition can be used to investigate
different infection scenario and vaccination strategies [30, 35, 122].
It should be noted that this condition for immunity is irrespective of a particular candidate
control function. In [55, 122], the mathematical representation of the HIV-specific CD8+
T cell response has been shown to influence the immunological requirement to contain the
infection. This reachability analysis proves that the dynamical condition for immunity is
invariant to the explicit mathematical formulation of the cytolytic or non-cytolytic killing
mechanism of the HIV-specific CD8+ T cell response. The inequality (5.9) supports the
notion that both cytolytic or non-cytolytic killing mechanism of HIV-specific CD8+ T cells
are important to enforce immunity [58, 75, 140]. The expression of a candidate function
for the killing mechanism of the HIV-specific CD8+ T cell response rather than affecting
the condition for immunity changes the immunological insights retrieved when considering
a particular function [55, 56, 122].
Importantly, the dynamical condition for immunity can be examined in experimental stud-
ies by estimating the size of the different population and the biological rates involved in the
population of dynamic of infected cells in which the killing mechanism HIV-specific CD8
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T cells is acting. For instance, the dynamical threshold can be evaluated in the studies in
[35, 140] and [122] using the expression of the population dynamic of productively infected
cells because in these studies the cytolytic mechanism of the HIV-specific CD8+ T cells
acts on this dynamic. As a result, the time evolution of the condition for immunity can
be analysed for different combination of parameter values and initial condition. Thus, the
condition for immunity provided by the VSC analysis can be used to compare the evolution
of the immunological requirement to contain the infection using experimental data from
different patients [35, 140].
Hence, this reachability analysis supports the notion that the condition for immunity
changes during the course of the infection [30, 34, 122].
5.3.1 Candidate control function modelling the cytolytic killing mecha-
nism
A number of mathematical approach based on different biological assumptions have been
proposed to model the HIV-specific CD8+ T cell response [55, 122, 140]. Functional re-
sponses inspired from ecology or Michaelis-Menten functions from enzyme-substrate kinet-
ics are often used to model the expansion and cytolytic killing action of the HIV-specific
CD8+ T cell response [55, 56, 139]. The mathematical expression of the function describ-
ing the killing mechanism and the population dynamic of the HIV-specific CD8+ T cell
response are both sensible because they influence the transient dynamics as well as the
steady-states of the model along with the corresponding interpretation of the impact of the
HIV-specific CD8+ T cell response on the containment of the infection [35, 55, 56, 122, 140].
Typically, functions modelling the cytolytic killing mechanism of CD8+ T cells have the
following form:
uC = −KI (5.10)
where CD8+ T cells kill infected cells at a rate K which encompasses the cytolytic killing
process [35, 140]. This immunological control action is effectively an intrinsic negative state
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feedback which opposes the infection dynamics in vivo. The simplest approach is
K1 = k (5.11)
where k is a constant killing rate. A candidate linear state feedback is thus formulated as:
uC1 = −K1I (5.12)
The condition for immunity (5.9) associated with (5.12) can be written as:
fβTV − (γ + δT )I − kI < 0
fβTV
I
− (γ + δT ) < k (5.13)
This inequality shows that the killing rate k acting as the gain of the immunological control
feedback must be high enough to satisfy these inequalities to render the manifold sE = 0
attractive. This supports the notion that increasing the cytolytic killing rate to a sufficient
level is a mean to contain the infection [56, 58]. Thus, a strong cytolytic killing action by
HIV-specific CD8+ T cells is analogous to a high gain state feedback [10, 56]. Nevertheless,
modelling a potent cytolytic action with a large and fixed value of the killing rate makes
the system suffering from the lack of robustness (such as sensitivity to changes in biological
rates) of linear state feedback control [10, 21] and the resultant dynamics of the model
might not reflect the robustness of the immunity associated elite HIV-specific Cd8+ T cell
response [30, 57, 144]. this .
A more realistic assumption is to consider that the cytolytic killing rate of HIV-specific
T cells changes during the time course of the infection [122, 140]. Recently, a general
functional response of the cytolytic killing mechanism of CD8+ T cells has been formulated
[139]. A double-saturation (DS) function with two different saturation constants has been
demonstrated to encompass different cytolytic killing processes. Here, the killing rate is
dynamical and it is a function of the population of infected cells I and the population of
HIV-specific CD8+ T cells E as follows:
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K2 =
k′E
1 + E/hE + I/hI
(5.14)
where hE and hI are the saturation constant of the population of HIV-specific CD8+ T
cells E and the population of infected cells (target) in the eclipse phase I respectively. The
parameter k′ is a mass action killing rate. As a result, the candidate control action with
the DS function is given as:
uC2 = −K2I = −
k′EI
1 + E/hE + I/hI
(5.15)
Tailoring the reachability condition to (5.15), the candidate control action constructed using
the general functional response from [139] produces:
fβTV − (γ + δT )I −
k′EI
1 + E/hE + I/hI
< 0 (5.16)
This reveals that there exists a dynamical threshold above which the population size of
effector HIV-specific CD8+ T cells renders the manifold sE = 0 attractive and forces the
decay of the infection. This dynamical condition highlights that changes in the population
size of infected cells I and HIV-specific CD8+ T cells induce variation in the magnitude of
the killing action and this influences the satisfaction of the condition for immunity. This
contributes to the findings in [102] where it has been shown using a bifurcation analysis that
the apoptosis of HIV-infected cells and HIV-specific CD8+ T cells affect the immunological
steady-state and the severity of the infection.
Further, the value of the saturation constants hE and hI plays an important role on the sat-
isfaction of the condition for immunity because the value of these biological rates influences
the magnitude of the immunological control action. This result extends the findings in [139]
where thef efficacy of the cytolytic killing process has been associated with the value of the
saturation constants hE and hI of effector CD8+ T cells and target cells respectively.
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Hence, the reachability analysis supports the emerging notion that the population size of
target cells and virus-specific CD8+ T cells and their corresponding saturation constant
determine the ability of the cytolytic killing action of virus-specific CD8+ T cells to ”con-
trol” the infection and to achieve immunity [56, 91, 122, 139].
In Chapter 2, it has been seen that when a continuous approximation of the discontinuous
sign() function is implemented, ideal sliding motion can longer be achieved. Instead, the
applied continuous control action keeps the states of the system within a vicinity of the
sliding manifold. From the expression (5.15), it is clear that the candidate DS function is
not discontinuous. Consequently, it is argued that the cytolytic mechanism of the CD8+ T
cell response operates as a nonlinear negative state feedback which forces the population size
of infected cells to be confined in a neighbourhood of the ideal sliding manifold sE = I = 0.
Consequently, using the results of Chapter 2 on smoothed variable structure control sys-
tems, it can be concluded that the immunological control action of the cytolytic mechanism
of the HIV-specific response modelled with the DS function (5.15) rather than zeroing the
population of infected cells, forces the population size of infected cells to remain at small
steady-state level determined by the magnitude of the cytolytic killing action. Moreover,
the DS function, as a nonlinear control feedback, provides some robustness of the immuno-
logical dynamics to uncertainty during sliding motion [10, 21, 22, 63].
5.4 Steady-state condition for immunity provided by the
reproductive ratio
The reproductive ratio R0 represents the number of new infected cells that a single infected
cell produces in absence of target cell limitation [34, 35, 56]. Here, the concept of the
reproductive ratio is reviewed from a control engineering perspective. In the study of
virus dynamics, the reproductive ratio is a well-known tool used to evaluate the outcome
of infection [34]. The reproductive ratio represents the number of newly infected cells
produced by one infected cell during its lifetime, assuming there is no limitation of target
cells [34]. The expression of the reproductive ratio derived in [56] using the infection-free
steady-sate of model (5.1) is as follows:
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where the first factor is the population size of T at the infection-free steady-state see (5.4).
The second factor is the probability that an infected cell becomes a virus-producing cell
before it dies. The third factor is the lifetime of a virus-producing cell. The fourth factor
is the number of virus particles produced per infected cell, and the last parameter repre-
sents the infection rate for a single virus particle in presence of the non-cytolytic effects of
HIV-specific CD8+ T cells.
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The characteristic equation can be written as
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where the coefficients of the polynomial are as follows:
a4 = 1
a3 = (δT + (δV δT + δT δI + δT δP + δTγ)/δT )
a2 = (δV δT + δT δI + δT δP + δTγ + (δV δT δI
+δV δT δP + δT δIδP + δV δTγ + δT δPγ)/δT )
a1 = (δV δT δIδP − fβγλp+ δV δT δPγ) /δT
+δV δT δI + δV δT δP
+δT δIδP + δV δTγ + δT δPγ
a0 = −fβγλp+ δT δIδP δV + δTγδP δV (5.20)
The expression of the reproductive ratio can be computed using a0 = 0 as in [40, 51]. From
a0 = 0, the ratio can be formulated:
−fβγλp+ δT δIδP δV + δTγδP δV = 0
R0 =
fβγλp
δT (γ + δI)δP δV
(5.21)
Hence, the expression of the reproductive ratio is retrieved using the stability analysis of the
system (5.1) linearised at the infection-free steady-state (5.4). It is clear that the value of R0
above or below unity influences the sign of a0. When R0 < 1, a0 > 0 and the characteristic
polynomial of fourth order has no sign changes. Using Descartes rule of sign as in [40, 145],
it is possible to deduce that the infection-free steady-state is stable. Whilst R0 > 1 implies
a0 < 0 and the fourth order characteristic polynomial has a positive pole. As a result,
the infection-free steady state is unstable. Thus, the behaviour of R0 influences the sta-
bility of the infection free steady state of the system along with the outcome of the infection.
This well know feature of R0 [56, 60] has been revisited to evidence that the condition for
the stability of the infection-free steady-state i.e the outcome of the infection using the
reproductive ratio (??) is a steady-state argument. Indeed, the poles of the system (5.1)
change during the time evolution of the state variables i.e the time course of the infection.
As a result, the value of R0 is inappropriate to determine the outcome of the infection when
the system is not at steady-state. Hence, the reproductive ratio has limitations as a means
to monitor dynamically the containment of the infection by the HIV-specific CD8+ T cell
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response.
Experimental studies [34, 35] have observed that the value of R0 is influenced by the HIV-
specific CD8+ T cell response. Here, the cytolytic mechanism of the HIV-specific CD8+
T cells is encompassed in δI, the death rate of infected cells in the eclipse phase [56]. As a
result, δI = δT +K because it is assumed that the death rate of infected cells in the eclipse
phase is equal to the one of uninfected cells in absence of the cytolytic killing action of
HIV-specific CD8+ T cells [55, 56].
Thus, the expression of the reproductive ratio can be rewritten as:
R0 =
λγpfβ
δT δP δV (γ + (δT +K))
(5.22)
The expression of the reproductive ratio in (5.22) shows that both the non-cytolytic mecha-
nism and the cytolytic mechanism of the HIV-specific CD8+ T cell response affect the value
of R0 and the outcome of the infection [56]. As per experimental data, the reproductive
ratio decreases in the presence of the HIV-specific CD8+ T cell response [34, 35, 56].
Using the framework of the reproductive ratio, the cytolytic killing rate of HIV-specific
CD8+ T cells should force and maintain the reproductive ratio (5.22) below unity to erad-
icate the infection [34, 35, 56]. Mathematically, this is formulated as:
R0 < 1
K > fβλγp−δT γδP δV
δV δT δP
− δT (5.23)
The inequality (5.23) is effectively a steady-state condition for the infection-free steady-
state to have negative poles and to be stable. Therefore, the gain of the state feedback
control (5.10) should exceed a critical threshold value determined by the values of the
biological rates present in the right hand side of the inequality (5.23). In other words, a
sufficient cytolytic killing rate is needed to eradicate the infection. Further, (5.23) implies
that stability of the infection-free steady-sate i.e the eradication of the infection is sensitive
to changes in the values of the biological rates involved in the expression of the reproductive
ratio. This implies that the cytolytic mechanism of the HIV-specific CD8+ T cells is not
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robust to uncertainty and perturbations in these biological rates because changes in these
biological rates affect the required killing rate [35, 56, 140]. This implies a lack of robustness
of the HIV-specific CD8+ T cell response which might not be realistic [57, 144].
5.5 Simulation experiments
Immunological experiments are simulated to show that the dynamical condition for im-
munity (5.9) provided by the reachability analysis appropriately tracks the immunological
requirements for immunity during the course of the infection and is superior to the steady-
state condition (5.23) formulated using the reproductive ratio (5.22). In the simulations,
the initial condition depicts a scenario where the population of uninfected CD4+ T cells
is at steady-state T (0) = λ
d1
, the infection is assumed to be induced by a single virion
I(0) = P (0) = 0;V (0) = 1 and precursor HIV-specific CD8+ T cells E(0) = 1. The pa-
rameter values shown in Table 5.1 are taken from [56].
The population dynamics of the system (5.1) in the absence of a killing action from HIV
specific CD8+ T cell response i.e g = 0 and uC = 0 are displayed in Fig. 5.2. This
simulation models experimental studies in which CD8+ T cells are depleted in order to
assess their impact of HIV load in vivo [57, 146, 147]. From a control engineering standpoint,
this simulation experiment is regarded as an analysis of the open loop dynamics of the
system. The open-loop dynamics in Fig. 5.2 are consistent with the experimental findings
Chapter 5. Evaluation of the Conditions for the containment of HIV infection by the
HIV-specific CD8+ T Cell response, a Variable Structure Control Perspective 95
in [146, 147] because they show a large viral load steady-state along with the reduction of
the population of target CD4+ T cells when HIV-specific CD8+ T cells are absent.
Figure 5.2: Open-loop system (5.1). Simulation of HIV infection in the absence of a
killing action from the HIV-specific CD8+ T cell response. T (0) = 2.106; I(0) = P (0) = 0;
V (0) = E(0) = 1. f = 1;K = gmax = 0.
Using the biological rates given in Table 5.1, the reproductive ratio (5.22) is R0 = 5.45
and the numerical value of this steady-state condition for immunity using the reproductive
ratio is given as:
K > 4.9 (5.24)
This inequality is effectively a threshold that the cytolytic killing rate must exceed to
produce negative poles to render the infection-free steady-state stable, see characteristic
equation (5.19)-(5.20). Since uC = 0, K = 0 for the open-loop dynamics. As a result,
(5.24) is not satisfied and the dynamics will not reach the infection-free steady-state. As
in [56], the reproductive ratio indicates that the infection will spread.
The purpose of Fig. 5.3 is to show the time evolution of the dynamical condition for immu-
nity when there is no HIV-specific CD8+ T cell response. This is regarded as the condition
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for immunity of the open-loop dynamic where there is no control action. Although the
steady-state condition for immunity (5.24) using R0 has a static value, the reachability
analysis through Fig. 5.3 demonstrates that the condition for immunity changes during the
time evolution of the infection. Concurrently, the magnitude of the sliding surface changes
during the infection, see Fig. 5.4. Since the reachability condition is not met, the manifold
of interest sE = 0 is not reached and sE attains a non-trivial steady-state value associated
with the HIV infection steady-state.
Figure 5.3: Time evolution of the dynamical condition for immunity (5.9) in absence of
the HIV-specific CD8+ T cell response uC = 0.
From a VSC stand-point, the following dynamical insights can be formulated. Firstly, it is
worth to note that the positive peak of the condition for immunity, see Fig. 5.3 is associated
with the peak of the virus load, see Fig. 5.2. From Fig. 5.3 and Fig. 5.4 It can be noticed
that at the early days following infection (before the peak in viral load) the magnitude of
the immunological action required to achieve immunity is smaller. Thus, the VSC analysis
reinforces the notion that early therapeutic interventions are desirable [30, 34]. Secondly,
the transient negative phase of the dynamical condition for immunity, see Fig. 5.3 shows
that the saturation effects caused by the limitation of target cells whilst reducing the viral
load satisfy the condition for immunity.
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Figure 5.4: Time evolution of the sliding surface (5.5) with uC = 0.
It can be concluded that the analysis of the open-loop dynamics show that the framework
of sliding mode control is a superior tool to examine the infection dynamics as compared
to the reproductive ratio because the formulated condition for immunity determines the
outcome of the infection as well as highlights time varying immunological requirements to
achieve immunity. This is a contribution from the VSC analysis in this HIV study.
5.5.1 Constant cytolytic killing action
Consider the closed-loop system formed by candidate control function uC1 (5.12) with a
fixed killing rate k = 10day−1.
The value of R0 with this candidate control action is R0 = 0.5. Note that k has been
chosen to satisfy the steady-state condition (5.24) provided by the reproductive ratio. Con-
sequently, the infection-free steady-state (5.4) is stable and the infection does not spread.
This result is congruent with the numerical analysis in [56] where it was shown that increas-
ing the killing rate of CD8+ T cells above the value K = 5day−1 produces a reproductive
ratio below unity and leads to the eradication of the infection.
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Similarly, the time evolution of the dynamical threshold Fig. 5.5 is always negative and this
predicts the decay of the infection because the condition for immunity (5.9) is satisfied. In
effect, the population of infected cells in the eclipse phase I will keep on decreasing and
this leads to a continuous reduction of the virus load.
Figure 5.5: Time evolution of the dynamical condition for immunity (5.13) with the
cytolytic killing mechanism of the HIV-specific CD8+ T cell response uC1 = −10I .
The time evolution of the sliding surface Fig. 5.6 shows that the large killing rate of the
candidate cytolytic killing mechanism uC1 produces negative feedback, see Fig. 5.7, of
sufficient magnitude to force the switching function sE to decay exponentially towards
the desired manifold sE = 0. As a result, the immunological objective is met and the
trajectories of the system move towards the infection-free steady-state.
It is worth to mention that the fast transient observed in Fig. 5.5- 5.7 is due to the fact
that a large and constant magnitude of ( k = 10 day−1) of cytolytic killing action has been
utilized in the simulation. These figures represent a proof-of-concept to support the notion
that a potent killing action from HIV-specific CD8+ T cells is adequate to enforce a sliding
mode on sE = I = 0, to contain HIV infection, and maintain an infection-free steady-state.
However, this high and constant cytolytic killing action might not be realized by CD8+ T
cells in vivo.
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Figure 5.6: Time evolution of the sliding manifold (5.5) with uC1 = −10I
Figure 5.7: Time evolution of the control action (5.12) with uC1 = −10I
It can be deduced that the framework of sliding mode control applied to HIV dynamics in
vivo delivers suitable tools to evaluate the outcome of the infection.
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5.5.2 Dynamical cytolytic killing action
Consider the closed-loop system where (5.15) is the control. The general functional response
from [139] is selected to investigate the containment of the infection because it is a sensible
model of the cytolytic killing mechanism. In [56], the specific case of a monogamous killing
process derived from (5.15) was considered to study the impact of the cytolytic killing
of HIV-infected cells in the eclipse phase. This monogamous killing process describes a
cytolytic mechanism where a single effector CD8+ T cell kills target cells. Mathematically,





with k′ = kmax
hk
and hk = hE = hI . The maximum killing rate is kmax and the parameter
hk which is effectively a Michaelis-Menten constant defines the immune responsiveness
[56, 139]. The resultant monogamous killing mechanism (5.25) uC3 with the maximum
killing rate kmax = 50 day
−1 and the saturation constant hk = 1 as in [56].
The expression (5.25) is chosen to conduct the following analysis to build on the findings
in [56]. Using numerical analysis, it has been shown in [56] that (5.25) influences the
steady-state level of the virus load. It was found that reducing hk increases the efficacy
of the killing process and leads to a reduction in the steady-state value of virus load.
Consequently, the findings in [56] motivates a control engineering approach to provide
an analytical framework to formally assess (5.25) as a control mechanism to eradicate HIV
infection in vivo. Moreover, (5.25) was selected to demonstrate the benefits of the dynamical
condition for immunity over the reproductive ratio.









Here, the value of R0 changes over time due to changes in the killing rate of uC3 during
the course of the infection.
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The purpose of Fig. 5.8 is to display the time evolution of the biological population dynamics
of the closed-loop system (5.1) with the considered monogamous cytolytic killing action.
The transient dynamic and the steady-state of the dynamic of free-virion is reduced by the
cytolytic killing of HIV-infected cells I by the HIV-specific CD8+ response.
Figure 5.8: Closed-loop dynamics (5.1). Simulation of HIV infection with a potent HIV-
specific CD8+ response with uC1. T (0) = 2.10
6; I(0) = P (0) = 0; V (0) = E(0) = 1.
f = 1; hk = 1
From Fig. 5.9 which illustrates the control effort of the monogamous killing cytolytic killing
action during the time evolution of the infection, it can be seen that the control effort is in
the neighbourhood of the critical threshold (5.24) computed using the reproductive ratio.
Fig. 5.10 reveals that the value of reproductive ratio changes during the time course of
the infection. As per the numerical analysis in [56], R0 approaches unity at steady-state
when the control action (5.25) is applied. Importantly, the value of the reproductive ratio
during the transient dynamics of the system is misleading to assess the outcome of the
infection because the value of R0 fluctuates above and below unity during the transient
phase. R0 < 1 wrongly suggests the eradication of the infection from day 0 to day 10 and
from day 18 to day 22, see Fig. 5.10. This is due to the fact that the poles of the system
(5.1) vary during the infection before the population dynamics reach a steady-state. This
shows the limitation of the reproductive ratio to reflect appropriately the condition for
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Figure 5.9: Time evolution of the control action (5.25) with uC3 hk = 1
Figure 5.10: Time evolution of the reproductive ratio using uC3 (5.25) with hl = 1.
immunity when the system is not at steady-state.
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The time evolution of the reachability condition displayed in Fig. 5.11 reveals that the
condition for immunity is not met at the beginning of the infection in contrast with the
prediction of the reproductive ratio. Although, the considered control action uC3 reduces
significantly the dynamical threshold for immunity but it does satisfy the dynamical con-
dition for immunity (5.16) the manifold of interest sE = 0 is not reached (see Fig. 5.12).
Nevertheless, it should be noted that the candidate monogamous cytolytic killing action
uC3 contains the infection to a low level steady-state close to the infection-free steady-state
by keeping the sliding surface close to the desired manifold after a transient period (see
Fig. 5.12). Therefore, VSC analysis allows the monitoring of the condition for immunity
and the impact of the killing action of the HIV-specific CD8+ T cells during the infection.
Figure 5.11: Time evolution of the dynamical condition for immunity (5.16) with the
cytolytic killing mechanism of the HIV-specific CD8+ T cell response uC3 (5.25)
In [56], it has been shown using a numerical analysis that the value of hk affects the
steady-state population size of infected cells I and the steady-state level of the virus load.
Using the sliding mode framework, changes in the saturation constant hk influence the
magnitude of the control effort (killing action) uC3 as well as distance between the manifold
of interest sE = 0 and the value of sE generated by uC3 with a particular value of hk. The
reachability condition is not satisfied when hk is large. This reinforces the notion that the
saturation constant plays an important role to achieve immunity [56, 139]. Thus, failure
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Figure 5.12: Time evolution of the sliding surface (5.5) with uC3 (5.25).
of the reachability condition explains why this cytolytic killing mechanism fails to zero the
population dynamic of infected cells I and to eradicate the infection.
Although the manifold of interest sE = 0 is not attained using the cytolytic killing function
uC3, this candidate control action keeps the sliding surface in the neighborhood of the
desired sliding manifold and contains the infection within a region close to the infection-
free steady-state (see Fig. 5.12 and Fig. 5.8). In effect, the virus load is below the limit of
detection which is 50 RNA copies per ml from [56, 148] and the population of uninfected
CD4+ T cells is near its infection-free equilibrium. Therefore, from a clinical perspective,
this candidate cytolytic killing mechanism produces a desirable outcome.
Thus, the cytolytic control functions which maintain the sliding surface in the vicinity of
the sliding manifold sE = 0 can be classified as elite HIV-specific CD8+ response when the
control action forces the virus load to remain below the limit of detection [30, 36, 56, 58].
Consequently, the condition for immunity can be relaxed to force the infection dynamics to
remain within a boundary region associated with the virus limit of detection and other clin-
ical requirements. Mathematically, this means that the condition for immunity is reduced
to sE < δ where δ is an upper bound associated with desirable clinical outcome.
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These results supports the notion that immunological requirements for the eradication of
HIV infection changes during the time course of the infection and the ability of the HIV-
specific cytolytic mechanism to induce immunity is influenced by the population size of
infected cells and effector Cd8+ cells and their corresponding saturation constant.
Importantly, these findings cannot be retrieved using the reproductive ratio because R0
suggests just that the infection will decay but does not articulate the decay of the infection
in finite time neither a decay to zero.
5.6 Conclusion
In this chapter, tools from VSC theory have been used to articulate a dynamical condition
for the cytolytic killing mechanism of the HIV-specific CD8+ T cell response to zero the
population of infected cells I. This dynamical condition has been demonstrated to monitor
the immunological requirements for immunity during the time evolution of the infection ap-
propriately. Failure of the candidate HIV-specific CD8+ response to satisfy the dynamical
condition for immunity is consistent with failure of the CD8+ T cell response to reach and
maintain the infection free steady-state. Additionally, the dynamical condition for immu-
nity as compared to the steady-state conation provided by the reproductive ratio describes
the immunological requirements for immunity during the course of the infection well.
In the next chapter, the approach developed in this chapter will be applied to investigate the
effects of antiretroviral drugs to achieve the containment of HIV infection in vivo. In effect,
it has been proven in this chapter that HIV infection dynamics in vivo are effectively a
closed-loop system with the HIV-specific immune response as an intrinsic control feedback.
As a result, the uptake of antiretroviral drugs represents an outer control feedback to
contribute to the containment of the infection.
Chapter 6
Case Study: Prediction of the
Containment of HIV Infection by
Antiretroviral Therapy - a Variable
Structure Control Approach
6.1 Introduction
A case study is conducted in this chapter to demonstrate that the reachability paradigm
from Variable Structure Control (VSC) theory presented in Chapter 2 is a suitable frame-
work to monitor and predict the progression of the HIV infection following initiation of
antiretroviral therapy.
In the previous chapter, it has been demonstrated that HIV infection dynamics in vivo
represent a closed-loop system in which the effects of the HIV-specific CD8+ T cell response
operates as a VSC feedback to contain the infection. In the majority of patients infected
with HIV this inherent control mechanism fails to clear the infection and recover a healthy
state [30, 37, 149].
Antiretroviral therapy (ART) seeks to perturb the pathogenesis of the virus to allow infected
individuals to stop exhibiting HIV related symptoms and to recover a certain level of
immunity so that the quality of their lives can be improved [149]. Thus, ART can be viewed
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as an outer-loop control strategy applied to enforce recovery. Using current experimental
facilities, the standard clinical data for diagnosis and monitoring HIV infection in patients
are the total number of CD4+ T cells measured by flow cytometry and HIV viral load
measured by Polymerase Chain Reaction (PCR) [148–151]. ART attempts to reduce HIV
load and this usually leads to recovery to a suitable level of CD4+ T cell count (> 200
cell/mm3) in the peripheral blood [30, 150, 152]. However, this desirable outcome is not
always achieved and the design of appropriate ART, the prediction of outcomes using
clinical data and the assessment of virologic failure are the subject of active experimental
and mathematical research [59, 153].
To allow mathematical models of HIV dynamics to be used as a tool for personalized clinical
diagnosis and ART, it is crucial to estimate all the biological rates of the chosen model for
each patients [59, 152, 154]. This can be a challenging problem using standard clinical data
[59, 138, 154]. Further, current experimental facilities do not allow direct measurement of
some pertinent state variables, such as the population dynamic of HIV-specific CD8+ T
cells or infected CD4+ T cells in the eclipse phase [30, 55, 148]. Due to these practical
limitations, the HIV model utilized in Chapter 5 is not selected to conduct the following
investigations.
A third order Ordinary Differential Equation (ODE) model has been shown to encompass
the observed biological characteristics of the acute phase of HIV infection using the variation
over time of the population of healthy CD4+ T cells, the infected population of CD4+
T cells which produce new virions along with the concentration of the HIV-1 free virus
[60]. Using techniques from engineering, the authors in [137, 141] have proved that the
parameters of this model can be estimated from standard clinical data. This method
is based on the computation of higher-order derivatives of the output measurements to
formulate a set of identification equations and the solution of this system of equations
allows the computation of the biological rates of the HIV model. Subsequently, a multiple
time point (MTP) estimation algorithm using values at different time instants to reduce the
need for higher-order derivatives of the output measurements has been used to formulate
the identification equations [59].
Statistical estimation methods such as the simplex method [35], the differential evolution
method [59] and the Monte-Carlo approach [148, 155] have been implemented to estimate
HIV parameters in patients following the initiation of antiretroviral treatment. More recent
contributions in this area can be found in [154, 156]. Together, this literature demonstrates
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that the third order model of HIV infection correlates well with clinical data obtained
from patients undergoing antiretroviral treatment [59, 148, 154] and that HIV dynamic
parameters estimated a few weeks after initiation of ART can be used to investigate the
impact of ART on the progression of HIV infection for individual patients [152, 153, 155].
In the literature [59, 60, 153], the impact of antiretroviral drugs on the progression of HIV
infection has been investigated using the concept of the reproductive ratio R0 presented
in Chapter 5. In fact, using the values of the parameter estimated for the basic HIV
model, the reproductive ratio is calculated to determine the progression of the infection
[35, 59, 60]. For the basic third order ODE HIV model, the expression for R0 is a function
of the model parameters and not the states and thus a time-invariant condition for the
containment of the infection is formulated. The work in Chapter 5 along with other studies
[30, 34, 57, 102] argue that the condition for the containment of the infection rather than
being static changes during the course of the infection. Furthermore, the work in [153] has
shown that the value of the reproductive ratio estimated at different weeks after the start
of ART can switch from R0 < 1 to R0 > 1 in the later weeks due to the appearance of drug
resistance.
The purpose of this case study is to utilize the analytical tools from sliding mode control
as alternative means to investigate the dynamics of HIV infection following antiretroviral
therapy.
From the classical example of a pendulum system with a sliding mode, shown in Chapter 2,
it is worthy to note that a manifold of the state space can be formulated to encompass the
control objectives imposed on a system. Furthermore, the reachability analysis provides
means to investigate how a given control input can satisfy the reachability condition so that
the desired control objectives are met. Thus, by binding the desired dynamical behaviour
with the attainment of a sliding mode, this VSC approach delivers tools to monitor the
closed-loop dynamics and assess the performance of the considered control input.
Additionally, a sliding mode control approach has been used in Chapter 5 to formulate
a dynamical condition for the containment of HIV infection by the HIV-specific CD8+ T
cell response. The result in Chapter 5 shows that the dynamical condition for immunity
provided by the reachability analysis appropriately monitors the progression of the infection.
As compared to the reproductive ratio, the VSC approach provides additional insights on
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HIV infection dynamics. These findings provides a strong motivation to conduct this case
study.
The chapter is organized as follows: Firstly, the HIV model and the reproductive ratio
are outlined. In Section 6.3 a dynamical condition for the containment of HIV infection by
antiretroviral therapy is formulated using the reachability paradigm from variable structure
control. The clinical data sets used for the study and the method used to estimate the
parameters of the model are described and evaluated in Section 6.4. Section 6.5 presents
the results of the simulation experiments conducted to show that the proposed dynamical
condition for immunity is a reliable tool for early diagnosis of the outcome of antiretroviral
therapy on HIV infection.
6.2 System model
The dynamical equations of HIV infection for patients being treated with antiretroviral
therapy can be written as:
dT
dt
= λ− δTT − β0TV + u1(t)
dP
dt
= β0TV − µ1P − u1(t)
dV
dt
= k0P − µ2V − u2(t) (6.1)
with δT < µ1 [59, 60, 96]. The state variables are the number in cell/mm
3 of uninfected
target CD4+ T cells (T ), the number in cell/mm3 of HIV-infected CD4+ T cells producing
new virions (P ) and the concentration in RNA copies/ml of HIV-1 free virions (V ). Fig. 6.1
is provided to improve the understanding of the dynamical system (6.1).
.
Uninfected CD4+ T cells are produced by the thymus at a rate λ (in cell/day) and die
at a rate δT (in day
−1). HIV infects healthy CD4+ T cells at a rate β0 (in µlvirion/day
x10−3). HIV-infected CD4+ T cells produce new virions at a rate k0 (in virion/day) and
die at a rate µ1 (in day
−1). HIV free virions are cleared at a rate µ2 (in day
−1) in the
peripheral blood. As in [59, 60, 148], these six biological rates are non-negative and assumed
to be constant for a given patient. The functions u1(t) and u2(t) represent the action of
reverse-transcriptase (RT) and protease inhibitor (PT) drugs respectively. The effect of
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Figure 6.1: Model (6.1) of HIV infection dynamics following antiretroviral therapy (ART)
antiretroviral drugs on HIV infection dynamics can be modelled as follows:
u1 = η1β0TV (6.2)
u2 = η2k0P (6.3)
where 0 ≤ η1 < 1 and 0 ≤ η2 < 1 are constants related to the efficiency of the deployed
RT and PT drugs, assuming that 100 percent drug efficacy cannot be achieved [60, 157].
The action of antiretroviral therapy will be considered from the perspective of control
engineering and regarded as a control action which seeks to enforce the containment of the
HIV infection. In practice, antiretroviral therapy is declared efficient when it reduces and
maintains the HIV viral load in the peripheral blood stream below the threshold of 50 HIV
RNA copies/ml [157]. The available output measurements of (6.1) are assumed to be
y1(t) = T (t) + P (t); y2(t) = V (t) (6.4)
where y1(t) is the total number in cell/mm
3 of CD4+ T cells in blood samples collected
from patients [150, 152, 154]. This choice is motivated by the information available in the
clinical data sets used for later validation of the proposed methodology.
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The clinical trial data available relates to the period following the initiation of antiretroviral
therapy and thus it is not possible to estimate the values of β0 and k0 [148, 150, 154]. Thus
β0(1− η1) and k0(1− η2) i.e the resultant effects in vivo of the uptake of RT and PT drugs
respectively will be considered and in the model (6.1), the following substitutions are made
β = (1− η1)β0 (6.5)
k = (1− η2)k0 (6.6)
to yield the closed-loop representation
dT
dt
= λ− δTT − βTV
dP
dt
= βTV − µ1P
dV
dt
= kP − µ2V (6.7)
This parametrization of the effects of antiretroviral drugs is as used in previous studies
[59, 148, 157]. The model (6.7) has two equilibrium points. There is a trivial equilibrium




; Ps0 = Vs0 = 0 (6.8)


















2 + a1s+ a0) = 0 (6.10)
where the coefficients of the polynomial are given by:
a2 = δT
a1 = δTµ1 + δTµ2
a0 = −λβk + δTµ1µ2 (6.11)
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Using Descartes’ rule of sign as in [40, 145], the stability of the infection-free steady-state is
assessed by counting the number of sign changes in the characteristic polynomial in (6.10).
Since the biological rates of the model (6.7) are all positive, the coefficients a2 > 0 and
a1 > 0. It remains to investigate the sign of the coefficient a0 in (6.11).
As in Chapter 5 section 3, the reproductive ratio can be utilized to assess the stability of









The first factor is Ts0, the population size of uninfected CD4+ T cells T at the infection-
free steady-state, see (6.8). The second factor is the lifetime of a virus-producing cell.
The third factor is the number of virus particles produced per infected cell and the final
parameter represents the infection rate for a single virus particle. Whether the value of R0
is above or below unity influences the sign of a0 and thus determines the stability of the
infection free steady-state. When R0 < 1, a0 > 0 and the quadratic polynomial has no sign
change. Using Descartes’ rule of signs [145], this implies that the roots of the quadratic
polynomial are negative. As a result, the HIV model (6.7) linearised at the infection-free
steady-state (6.8) has negative poles. Thus, the infection free-steady state is stable when
R0 < 1. In contrast, R0 > 1 implies a0 < 0. Consequently, there exists a sign change
in the second order polynomial in (6.10) which indicates a positive pole. As a result, the
infection-free steady state (6.8) is unstable when R0 > 1. Mathematical investigations in
[116] have proved that if R0 ≤ 1, the infection free steady-state is globally asymptotically
stable (GAS).
















From the results in [35, 116], the non-trivial equilibrium (6.13) is stable when R0 > 1.
This non-trivial equilibrium can represent either an undesirable steady-state corresponding
to chronic infection or a desirable steady-state depending on the parameter values [30,
35, 60, 152]. Since the surrogate markers of the progression of HIV infection in clinical
diagnosis are the measurements of the total number of CD4+ T cells (T + P ) and HIV
load in the peripheral blood stream, a chronic infection steady-state is characterized by a
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low number of CD4+ T cells and a large HIV viral load in the peripheral blood samples.
A corresponding steady-state of asymptomatic infection which can be enforced as a result
of efficient antiretroviral treatment is usually associated with a high number of CD4+ T
cells and HIV load below the limit of detection of 50HIV RNA copies/ml [150, 152]. The
state space of the HIV model (6.7) can be partitioned into two regions. In one region,
HIV is harmful for the infected individual and the corresponding immunological dynamics
and steady-states in this region are undesirable. In the other region, HIV infection is
asymptomatic and the related immunological dynamics and steady-state in this region are
desirable from a clinical perspective. It is thus of interest to develop mathematical tools to
define the boundaries of these regions as well as to predict the location of the steady-state
enforced by antiretroviral therapy to inform clinical diagnosis.
6.2.1 The reproductive ratio, a steady-state condition for the success of
antiretroviral therapy
Using the framework of the reproductive ratio, antiretroviral therapy must force and main-
tain R0 below unity following initiation of treatment to prevent the spread of HIV infection
[30, 116, 155, 158]. The effectiveness of antiretroviral therapy is encompassed in the prod-
uct kβ because the HIV model (6.7) does not allow decoupling of the effects of RT and PT
drugs [155]. Thus, the condition for antiretroviral drugs to eradicate HIV infection derived













. This inequality is a steady-state condition for the infection-free steady-
state to have negative poles and hence to exhibit stable behaviour. The inequality (6.14)
implies that antiretroviral drugs achieve eradication of HIV infection when the effective
control action exceeds a critical threshold value determined by the biological rates.
As discussed in Chapter 5, the framework of the reproductive ratio has some limitations,
When (6.14) is not satisfied, the generated value of R0 alone cannot be used to predict
whether the non-trivial equilibrium (6.13) is located in a state space region associated with
a chronic infection state or an asymptomatic state. In effect, the value of R0 alone does not
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provide information on the magnitude of the CD4+ T cell population and HIV viral load
at the nontrivial equilibrium. As will be demonstrated later in this chapter, there are also
cases where the prediction from R0 alone is seen to contradict the clinical outcome [155].
The reproductive ratio paradigm is thus seen to have limitations as a means to monitor
and predict the containment of HIV infection following drug treatment.
6.3 A reachability condition to monitor the containment of
HIV infection
In the context of HIV infection dynamics in vivo, the work in Chapter 5 has demonstrated
that these dynamics form a closed-loop system in which the specific immune response of
CD8+ T cells against HIV is an intrinsic VSC feedback applied by the immune system to
contain the infection. Furthermore, it has been shown that the reachability paradigm intro-
duced in Chapter 2 can be used to formulate a dynamical condition for the containment of
HIV infection in vivo. Importantly, this approach provides a nonlinear means to determine
and monitor the progression of the infection.
In this section, the approach used in Chapter 5, is considered to investigate dynamical
requirements for the containment of HIV infection in vivo following the initiation of an-
tiretroviral therapy.
It will be seen that the variable structure control paradigm will be particularly useful in
explaining dynamic behaviour which occurs within a boundary layer of the infection free
steady-state. Currently measured data and analytical analysis has produced conflicting
conclusions in such cases [30].
The formulation of a reachability condition to monitor the containment of HIV infection
involves defining an appropriate switching function to describe the desired clinical outcome
of the treatment. A candidate switching manifold is chosen to be compliant with the
objective of antiretroviral therapy to reduce and maintain the HIV viral load below the
limit of detection. The hypothesis is that in the ideal case, the uptake of antiretroviral
drugs, as a control mechanism, has to force the HIV infection dynamics to attain and
remain on the infection-free steady-state (6.8).
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A valid candidate switching function is
sE(t) = P (t) (6.15)
because the manifold sE(t) = P (t) = 0 in which the population dynamic of productively
infected CD4+ T cells vanishes has been observed to be a naturally occurring attractive
manifold in the state-space of (6.7) when the trajectories exhibit a stable motion towards
the infection free steady-state (6.8). The reachability condition for exhibiting a sliding





sE (βTV − µ1P ) < 0 (6.17)
(βTV − µ1P ) < 0
This inequality is fundamentally a dynamical condition for the manifold sE(t) = 0 to be
attractive. In the present context, enforcing a sliding motion on sE(t) = 0 is synonymous
with achieving the containment of HIV infection. In order to ensure (6.16) attains and
remains at a negative value, the therapeutic control u1 associated with the effects of an-
tiretroviral drug therapy must have a sufficiently large magnitude to overcome the positive
feedback β0TV associated with the HIV pathogenesis. The reachability condition (6.16)
thus represents a dynamical condition for antiretroviral drugs to force the dynamics to
lie within a neighbourhood of the manifold sE(t) = 0. The inequality (6.16) represents
a dynamical condition for antiretroviral drug therapy to contain HIV infection. It should
be noted that assessing the sign of dsE
dt
is sufficient to determine whether the reachability
condition is satisfied due to the fact that sE(t) = P (t) ≥ 0 because it represents the number
of infected CD4+ T cells producing new virions. The reachability condition (6.16) can be
written as:
βTV − µ1P < 0 (6.18)
It is interesting to note that the expression (6.17) can be written in terms of the output
dynamics and their derivatives to allow direct monitoring of the condition for immunity
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(y˙2 + µ2y2) < 0 (6.19)
This expression for the reachability condition, which is a function of both η1 and η2 demon-
strates that RT and PT drugs work synergistically to achieve the containment of HIV
infection.
6.4 Parameter identification
It is clear that whether seeking to monitor the clinical outcome of antiretroviral drug
therapy in the treatment of HIV using the reproductive ratio or the proposed reachability
condition, it is first necessary to determine patient dependent parameter estimates based
upon available clinical measurements.
6.4.1 The clinical data sets
Two clinical trials have been considered to evaluate the use of the reachability condition
(6.18) as a tool to monitor the containment of HIV infection following antiretroviral therapy.
From the theoretical point of view, it is desirable to have a large number of data points
at equally spaced intervals. However, practical constraints related to the collection and
analysis of blood samples from HIV infected individuals influence the timings and number of
the measured data [138, 148, 159]. The selected data sets are chosen to test the practicality
of the approach.
The first data set relates to the EDV05 clinical trial conducted at the Centre Hospitalier
Universitaire (CHU) de Nantes, France [148, 152, 157]. In this study, measurements of
the total number of CD4+ T cells and HIV viral load in the peripheral blood stream were
collected following the initiation of Highly Active Antiretroviral Therapy (HAART). The
facilities used in that study allowed HIV viral load to be measured up to the limit of
1.6log10(RNAcopies/ml) i.e 50(RNAcopies/ml). As in [148, 152], the data collected in
the first 21 days are used to compute estimates of the biological rates. This information is
then used to predict the outcome of the full treatment regime. The data measured following
the initial period of 21 days are used to validate the resulting theoretical predictions of the
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efficacy of the treatment. The EDV05 trial has been considered because model parameters
have been estimated by other studies for this patient data [148, 152, 155, 160]. This is
useful to compare the results of the parameter estimation approach adopted in this work
as well as to test the formulated dynamical condition for immunity (6.18). In this chapter,
the syntax pti is used to refer to the patients involved in the EDV05 trial where i denotes
a specific patient number. Note that the results of pt10 are discarded because there is no
clinical data available from the final follow-up visit in the clinical trial. Thus, the efficiency
of the treatment cannot be validated.
The longitudinal data recorded by the AIDS Clinical Trials Group (ACTG 315) [150, 159]
are also chosen to verify the performance of the proposed reachability condition for cases of
success and failure of HAART. Here, the syntax pai is used to refer to the patients involved
in this study. For this trial, data points in the interval [0, 30] days are used to compute the
estimates of the biological rates. The limit of detection of HIV free virion in this trial is
2log10(RNAcopies/ml) i.e 100(RNAcopies/ml). Data below this limit were tabulated as
1.699log10(RNAcopies/ml). As in [161], data below the limit of detection are not used to
estimate the biological rates. As discussed in [138], the selection of a patient data along
with segmentation of the data period into data used for parameter estimation and data
used for the validation of prediction is driven by the availability of sufficient data points
to perform the parameter estimation. The rate at which patient data is sampled differs
from study to study and is not constant across a given study. This realistic scenario of
data availability will be seen not to affect the predictions. Patient data which do not have
data points covering a six month period (≥ 160 days) are discarded due to the fact that
no information is available to confirm the predictions and to assess the long term efficacy
of the antiretroviral therapy.
6.4.2 Parameter identification procedure
Previous mathematical analysis [59, 137, 152] has proved the algebraic and practical iden-
tifiability of the parameter set λ, δT , β, µ1, k, µ2 of the model (6.7) using the output mea-
surements (6.4).
In [59], it was shown that the multi-point identification method provides some advantage
over the higher order identification method used in [137, 141, 162] because it allows the
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computation of the estimates using a finite set of output data points instead of computing
the higher order derivatives of the output measurements.
Here, the multi-point identification method described in [59] is applied to identify the six
biological parameters λ, δT , β, µ1, k, µ2 of the model (6.7) using measurements taken at
irregular intervals within a set period following initiation of antiretroviral treatment for
patients across the two data sets. A pseudo code is provided in the appendix A.
For each patient, shape-preserving piecewise cubic interpolation is used to generate a con-
tinuous stream of data points within the range of the discrete set of measured clinical data
considered for the computation of the estimates of the biological rates. Next, the least-
squares polynomial that are the best fit for y1(t) and y2(t) are computed to evaluate the
time derivatives of the measurements at different time points as in [154]. The degree of
the least-squares polynomial for each patient is selected to improve the quality of the fit.
Subsequently, the following multi-point identification process is carried out. Consider y2





y−12 y˙2 − δT − βy2
)
(y¨2 + (µ1 + µ2)y˙2 + µ1µ2y2)
+λkβy2 − µ1µ2y˙2 − (µ1 + µ2)y¨2 (6.20)
The identification coefficient θ1 is defined as:
θ1 = (β, δ, ρ, ν, η) (6.21)
where
β = β; δ = µ1; ρ = δT ; ν = µ1µ2;µ = µ1 + µ2; η = λkβ (6.22)
This implies that four of the six parameters of the model (6.7) can be identified using
measurement of y2 and corresponding derivatives. The values of the parameters λ and k
are indistinguishable and only their product λk can be estimated. Consider the right hand
side of (6.20):




y−12 y˙2 − δT − βy2
)
[y¨2 + µy˙2 + vy2]
+ηy2 − νy˙2 − µy¨2 (6.23)
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Assume that the quantities (y2, y˙2, y¨2, y
(3)
2 ) are either available from direct measurement or
can be constructed from measurements at five different time points. Denote the values of
(y2, y˙2, y¨2, y
(3)

























then by the implicit function theorem, the system of equations (6.24) has a unique solution
for θ1. This solution provides an estimate of the biological rates δT , β, µ1 and µ2. However,
λ and k cannot be identified using measurement of y2 alone.
To recover the remaining parameters, the first derivative of y1 is written in terms of the
output dynamics as follows:
y˙1 = λ− δT y1 − δPP (6.26)
where µ1 = δT + δP . Using the expression for y˙2, the state variable P can be written in




(y˙2 + µ2y2) (6.27)
Substitute (6.27) into (6.26) to obtain
y˙1 = λ− δT y1 −
δP
k
(y˙2 + µ2y2) (6.28)
Define the identification coefficient θ2 as:
θ2 = (λ, δT , ξ, σ)
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where ξ = δP
k
and σ = µ2δP
k
. Let the identification function be
g(t, y1, y˙2, y2) = λ− δT y1 − ξy˙2 − σy2 (6.29)
The multi-point identification process [59] is performed to estimate θ2. Here, the values
of (y˙1, y1, y˙2, y2)) are needed at four different time points to construct a system of four
equations and four unknowns to estimate θ2. Consequently, the identification equation is
given by
ϕ2 = (y˙1(j)− gj) = 0 (6.30)
where y˙1(j) and gj denote the values of y˙1 and g(t, y1, y˙2, y2) at four time points for j =
1, ..., 4. Proceeding as before, estimates of the biological rates λ,δT and µ2 can be computed.
Nevertheless, µ1 and k cannot be identified using (6.30) only.
It is worth to mention that the computation of the derivatives of the output measurements
y1 and y2 is delicate process because it plays a major role in the parameter estimation
procedure. This difficulty is partially due to the fact that the clinical data are sparse.
Different methods have been proposed to estimation of the time derivatives of the clinical
data such as in [59, 137, 152, 154] or to avoid this step using alternative methods such as in
[156, 161]. Here, the time derivatives of the output measurements are obtained using the
least-squares polynomial method, see appendix A for more details.
Combining θ1 and θ2 from (6.24) and (6.30) respectively, it is possible to construct estimates
of the six biological rates in the model (6.7). In the presented results, λ, δT and µ2 are








The estimation process is conducted for each patient and resulting numerical solutions of
the model (6.7) are obtained using the Runge-Kutta method [154]. To estimate the quality
of the fits, error vectors are constructed where the error at each data point is given by
ey1(ti) = y1(ti)− yˆ1(ti) (6.31)
ey2(ti) = y2(ti)− yˆ2(ti) (6.32)
for i = 1, ..., n where i is the time point of the corresponding measurement and n is the
number of measurements collected within a set period. yˆ1(ti) and yˆ2(ti) are the estimated
values of the total number of CD4+ T cells and HIV viral load produced from the numerical
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model which uses the estimated parameters. The relative accuracy of the output dynamics













for i = 1, ..., n.
6.4.3 Parameter estimation results
In the results presented, a set of patients from each clinical trial has been randomly picked.
Note that the values of the estimated biological rates presented in the following tables are
rounded. The values of the parameters with the accuracy required to reproduce all of the
results can be found in the appendix B. The tabulated biological rates may not identically
reproduce the results presented for the reproductive ratio as the values of the estimates
produced by the identification algorithm are used to compute R0, ay1, ay2. As will be
seen in the results presented, the dynamics exhibit good robustness to such changes in the
parameter values.
Previous work in the literature has estimated parameter values for the dynamics of HIV
infection in the course of antiretroviral drug treatment [59, 152]. Here biological rates
estimated using the Monte Carlo approach from [148, 152] are used to benchmark the
results presented in this chapter. For both estimation approaches, the initial conditions are
selected such that T (0) + P (0) = y1(0) and V (0) = y2(0) where the values of y1(0) and
y2(0), see (6.4), are taken from the clinical data set relating to the EDV05 trial as published
in [152]. It is important to note that for both approaches all the parameter estimates are
generated only using data obtained during the initial 30 days of the period of the trial.
Motivation for this study is to be able to obtain patient specific data that can be used to
predict the likely outcome of the current drug treatment. If the eventual outcome is likely
to be unsuccessful, modification of the antiretroviral drug treatment can take place based
on the patient specific parameter estimates. In this work, the measured data obtained
across the remainder of the trial will be used to validate the parameter estimates as will
the known clinical outcome.
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Table 6.1: Estimates of the biological rates taken from [148, 152]. Common
parameters:δT = 0.01day
−1, µ1 = 0.05day
−1 and µ2 = 0.28day
−1
Results T (0) + P (0) V (0) λ β k R0 ay1 ay2
pt1 200+176 10
6 8.13 1.94e-07 0.04 4.50e-04 4.28 9.25
pt2 138+92 10
5.4 9.53 3.27e-07 0.21 0.0047 14.76 8.81
pt3 110+75 10
4.54 1.77 8.24e-07 0.41 0.0043 13.36 2.44
pt4 120+85 10
5.3 5.45 7.10e-08 293.00 0.809 7.06 22.90
pt5 200+183 10
4.82 6.76 3.94e-07 0.004 7.6098e-05 2.75 5.51
pt6 205+200 10
4.972 6.94 1.21e-07 46.80 0.2807 7.40 21.76
pt7 5+4 10
5.07 3.01 2.43e-06 0.008 4.17e-04 147.01 85.19
pt8 80+42 10
5.3 6.41 8.15e-07 0.002 7.46e-05 5.31 5.92
pt9 68+50 10
5.21 5.36 7.23e-07 0.003 8.30e-05 11.13 3.95
pt11 10+13 10
6.02 2.08 1.79e-07 0.012 3.19e-05 11.90 12.31
pt12 200+105 10
5.7 7.66 2.56e-07 0.002 2.80e-05 4.71 12.56
Table 6.1 reports the results of the Monte Carlo approach from [148, 152]. Table 6.2 shows
the results obtained for the procedure described in this chapter. A major difference between
the two estimation methods is that the algorithm chosen in [148, 152] uses the same values
of the decay parameter δT , µ1 and µ2 for all patients. Nevertheless, as argued in [154],
it is preferable to estimate all parameters to improve personalized treatment and clinical
decisions. For example, when comparing the values of the reproductive ratio R0 presented
in Table 6.1 with the corresponding values in Table 6.2 it is clear that the parameter values
generated from the methodology presented in this chapter generate more realistic values.
Biological rates estimated using the procedure presented in this chapter and patient data
from the ACTG 315 trial are shown in Table 6.3.
Table 6.2: Estimates of the biological rates produced by the identification method pre-
sented in this chapter. Initial conditions are identical to those in Table 6.1
Results λ δT β µ1 k µ2 R0 ay1 ay2
pt1 427.15 0.98 4.09e-04 1.002 1.65 0.39 0.73 3.10 13.74
pt2 525.63 1.13 1.14e-05 3.07 530.50 0.94 0.95 6.44 25.51
pt3 137.97 0.70 0.0028 0.90 0.75 0.49 0.92 20.56 7.56
pt4 91.34 0.21 8.44e-05 0.37 3.50 0.46 0.72 7.97 38.6
pt5 511.21 1.16 0.0014 1.23 0.106 0.48 0.107 0.78 6.25
pt6 447.26 0.87 3.83e-04 1.08 0.98 0.20 0.87 3.25 22.72
pt7 48.54 0.88 1.05e-04 1.09 237.41 1.98 0.63 21.23 84.15
pt8 77.45 0.30 2.39e0-5 0.67 72.35 0.66 1.002 0.91 0.10
pt9 255.40 0.83 2.45e-04 1.48 4.66 0.50 0.46 9.50 0.08
pt11 20.23 0.24 2.11e-05 1.59 717.20 0.76 1.008 5.67 0.1
pt12 216.15 0.47 5.53e-04 0.53 0.57 0.87 0.30 0.54 0.01
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Table 6.3: Estimates of the biological rates produced by the identification method pre-
sented in this chapter.
Results λ δT β µ1 k µ2 R0 ay1 ay2
pa3 19.44 0.05 1.83e-04 0.39 24.61 0.33 11.50 1.50 1.16
pa8 72.46 0.18 7.39e-04 1.05 2.49 0.38 4.95 2.10 0.07
pa10 117.28 0.15 4.15e-05 0.53 16.93 0.35 2.85 21.24 0.21
pa13 46.06 0.19 3.82e-04 0.65 0.03 0.27 0.01 1.92 2.17
pa24 118.39 0.34 4.84e-05 0.45 9.10 0.37 0.89 0.75 0.38
pa34 169.72 0.44 1.30e-04 0.46 4.67 0.49 1.01 3.90 3.44
pa38 137.66 0.49 1.76e-04 0.58 3.54 0.28 1.03 5.64 23.12
pt43 234.49 0.64 2.93e-04 0.73 0.45 0.19 0.33 0.86 10.98
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The estimated parameter values obtained by the proposed method and presented in Tables
6.2 and 6.3 of the six biological rates of the basic HIV model (6.7) using patient data from
the first period of both clinical trials are reasonable and close to the ones published in other
studies [59, 154, 155, 161].
Fig. 6.2-6.5 are displayed as examples to show that the output dynamics produced by the
estimated biological rates are realistic. In all figures, the parameter estimates have been
obtained from clinical measurements obtained in the early phase of the trial and later
measurements are presented to validate the output response predicted from the model.
Fig. 6.2-6.3 illustrate cases in which the uptake of antiretroviral drugs enforces the contain-
ment of HIV load to a small level along with the recovery to a desirable CD4+ T cell count.
Fig. 6.4 relates to cases of immunological failure characterized by a desirable low steady-
state HIV load and poor recovery of CD4+ T cell count. Fig. 6.5 depicts a case in which an-
tiretroviral therapy fails. The figures reinforce that the estimation method used in this work
produces responses similar to the ones generated by other studies [30, 148, 153, 154, 161]
and the responses align well with subsequent measurements obtained later in the drug trial
and not used within the parameter estimation procedure.
Figure 6.2: Comparison of the time evolution of measured CD4+ T cell count and HIV
load versus its estimates for pt1 using the HIV model (6.7).
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Figure 6.3: Comparison of the time evolution of measured CD4+ T cell count and HIV
load versus its estimates for pt8 using the HIV model (6.7).
Figure 6.4: Comparison of the time evolution of measured CD4+ T cell count and HIV
load versus its estimates for pt11 using the HIV model (6.7).
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Figure 6.5: Comparison of the time evolution of measured CD4+ T cell count and HIV
load versus its estimates for pa3 using the HIV model (6.7).
The data used to estimate the parameters can be expected to incorporate measurement error
and it is important to consider the likely effect of such errors on the computed parameter
estimates. A comprehensive review of the practical issues relating to the estimation of the
parameters of the dynamics of HIV can be found in [138]. Results from both structural
and statistical analysis have shown that it is sensible to estimate the parameters using
measurements in the early weeks following the initiation of antiretroviral therapy because
the transient phase after the initiation of treatment contains more dynamic information
[137, 138, 163]. This supports selecting measurements in the first month following initiation
of treatment as adopted in this study. A statistical noise model for HIV standard clinical
data has recently been determined in [161]. The local polynomial regression technique
used in [154] was used to smooth the longitudinal data and to estimate the measurement
noise. After conducting normality tests with the Chi-square and Lilliefors tests, the authors
concluded that a multiplicative zero mean Gaussian noise affects both measurements of
CD4+ T cell count and HIV load. Further, similar noise parameters i.e sample mean and
standard deviation have been found for two patient data. Interestingly, an earlier study on
noise characteristics based on visual observations of the noise on the viral load data also
suggested that the noise might follow a Gaussian distribution [163]. Simulation studies
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in a number of publications have incorporated a zero mean Gaussian noise with different
levels of standard deviation to the numerical solutions of the basic HIV model to test
the practical identifiability of the biological rates [59, 154, 156, 164]. Collectively, these
simulation results provide evidence that reasonable parameter estimates can be obtained
in the presence of noise in the measured data. Furthermore, the estimated biological rates
from patient datasets has been shown to produce viral load dynamics which closely match
the trajectory of observed data [148, 154, 161, 163].
To determine the robustness of the biological rates determined in this study to measure-
ment noise, the established noise model from [161] was added to the patient data and a
second set of parameter estimates was computed. The responses of the HIV model with
parameter estimates generated in the presence of additional noise are compared with the
results obtained with parameter estimates obtained without additional noise for pt1 and pa3
in Fig. 6.6 and Fig. 6.7. respectively. This reinforces that the output dynamics generated
by the estimated biological rates are not dramatically affected by noise and the traces are
visually indistinguishable. Hence, the infection dynamics following antiretroviral treatment
are shown to exhibit some robustness with respect to measurement noise.
Figure 6.6: Comparison of the time evolution of measured CD4+ T cell count and HIV
load for pt1. Original data and the responses generated with parameters estimated in the
presence of additional noise and without additional noise are presented. HIV model (6.7).
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Figure 6.7: Comparison of the time evolution of measured CD4+ T cell count and HIV
load for pa3. Original data and the responses generated with parameters estimated in the
presence of additional noise and without additional noise are presented. HIV model (6.7).
6.5 Prediction of the outcome of antiretroviral treatment
For each patient listed in Table 6.2 and 6.3, the proposed reachability analysis for the
containment of HIV infection is evaluated to predict the outcome of HAART. Note that
these predictions are based only on measured data obtained in the first 30 days following
treatment. The predictions are then compared with clinical outcomes determined from
examining the CD4+ T cell count and HIV viral load at the conclusion of the clinical trial.
The findings show that the time evolution of the reachability condition (6.18) and the
switching function (6.15) exhibit a particular dynamical behaviour characterizing desirable
and undesirable outcomes. This underpins the discrimination of outcomes.
The predictions from the reachability analysis and indeed the reproductive ratio are con-
gruent with clinical outcomes for all patients except pt7 and pa24. For patient pt7 and pa24,
the reachability analysis suggests that HIV infection will be contained. This prediction fails
for pa24 because, despite the fact that HIV load fell below 100(RNAcopies/ml) within 56
days following the initiation of treatment, a significant viral rebound i.e y2(175) = 670.03
was measured at the final visit of the trial, see Fig. 6.8. Similarly, the data for pt7 in [152]
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shows a large viral rebound i.e y2(29) = 2.53 to y2(149) = 5.41log10(RNA copies/ml) and
the HIV viral load at the final clinic visit is y2(212) = 2.58log10(RNA copies/ml). These
results may correspond to cases where model predictions fail due to the appearance of drug
resistance or viral rebound [153]. The results are now explored in situations corresponding
to effective treatment, marginal cases and cases where treatment fails.
Figure 6.8: Comparison of the time evolution of measured CD4+ T cell count and HIV
load versus its estimates for pa24 using the HIV model (6.7).
6.5.1 Effective treatment
The following results are associated with patients where antiretroviral drugs reduce and
then maintain HIV load in the peripheral blood below the limit of 100(RNA copies/ml) i.e
2log10(RNA copies/ml) within six months. These cases relate to patients pt1, pt2, pt3, pt4,
pt5, pt6, pt9, pt12, pa13, pa38, and pa43. For these patients, the reproductive ratio is below
unity, see Table 6.2 and 6.3 and the existing methods successfully predict that antiretroviral
treatment will be able to eradicate the infection. The time evolution of the reachability
condition, see Fig. 6.9-6.10 for pt1 and pa13 respectively, are representative of the dynamical
behaviour of the reachability condition in the other patients in this category. Antiretroviral
drugs in these patients are able to render and maintain the reachability condition negative
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some 5 days after the initiation of treatment. As a result, the magnitude of the switching
function (6.15) is driven to zero and the dynamics of the system (6.7) are forced to move
and remain at the infection-free steady-state (6.8) such as in Fig. 6.2 for pt1. Thus, the
reachability analysis predicts that antiretroviral drugs are successful in eradicating the
virus in these patients. Importantly, it should be noted that there is no oscillation in the
magnitude of the reachability condition in the first weeks and the term βTV keeps on
decreasing before and after the reachability condition is satisfied.
Figure 6.9: Time evolution of the dynamical condition for immunity (6.18) using simu-
lation results for pt1
6.5.2 New insight into marginal cases
Using the values of the biological rates estimated in [148, 152], patients pt1, pt2, pt3, pt4,
pt5, pt6, pt8, pt9, pt11 and pt12 have a reproductive ratio below unity, see Table 6.1. The
reachability analysis indicates that HIV dynamics engendered by these estimates reach and
remain at the infection free steady-state for all these patients. Nevertheless, the multi-
point estimation method used here combined with the reachability analysis reveals insight
into marginal cases in which the HIV viral load is not completely eradicated by HAART
and remains at an undetectable level in the steady-state. From a clinical point of view,
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Figure 6.10: Time evolution of the dynamical condition for immunity (6.18) using sim-
ulation results for pa13
treatment of patient pt8 is efficient because the antiretroviral drugs reduce and maintain
the HIV viral load below the limit of detection of 50RNA copies/ml i.e 1.699log10(RNA
copies/ml) within six months. Nevertheless, the value of the reproductive ratio is above
unity in this case, see Table 6.2. Although antiretroviral drugs are classified as efficient,
the value of the reproductive ratio infers that the infection may not be eradicated. The
existing prediction methodology using R0 appears to contradict the clinical outcome. In
contrast, this prediction is not supported by the reachability analysis because though the
time evolution of the reachability condition in Fig. 6.11 shows that antiretroviral drugs are
able to maintain the reachability condition negative i.e βTV −µ1 < 0, the switching function
sE(t) does not reach the manifold of interest. Nevertheless, it should be noted that sE(t)
reaches a steady-state value which is close to the desired sliding manifold sE(t) = 0. Similar
results are obtained for patient pa34 where it is seen from Fig. 6.12 that the reachability
analysis predicts the patient will have an asymptomatic status despite the fact that the
detection limit of HIV load was 100RNA copies/ml.
Unlike the measured HIV load data of pt8, measurements of HIV load for pt11 remain
above the limit 2log10(RNA copies/ml). However, the last measurement 2.02log10(RNA
copies/ml) is very close to this threshold, see data in [152]. Here again, although the R0 > 1
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for pt11, clinicians found this patient asymptomatic because the HIV load is relatively low.
The reachability analysis conducted using the biological rates estimated here indicates that
sE(t) for pt11 attains a steady-state value close to the desired sliding manifold sE(t) = 0,
see Fig. 6.13. Further, the estimated steady-state of the HIV viral load is located in a
region where i.e Vs1 < 2log10(RNA copies/ml). Further insight can be gained from
Figure 6.11: Time evolution of the switching function (6.15) and dynamical condition
for immunity (6.18) for pt8
the phase portrait of the sliding surface. Fig. 6.14-6.15 reveal that the trajectories move
towards an equilibrium point close to the origin. This suggests that the infection dynamics
move and remain at a clinically desirable steady-state located close to the infection free
steady-state for both pt8 and pt11. It can be thus deduced that the limit of detection of the
HIV viral load in the peripheral blood can be associated with a boundary layer in which
the steady-state of HIV viral load is desirable.
In the field of control systems, the concept of boundary layer control is well established
[10, 15, 21, 22] and it is acceptable to have a control action which forces the sliding surface
to remain within a region close to zero. It is well known that the assumed dynamics of
the switching behaviour in the control strategy directly impact on the characteristics of the
boundary layer. In Chapter 2, it has been demonstrated that a smooth switch control law
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Figure 6.12: Time evolution of the switching function (6.15) and dynamical condition
for immunity (6.18) for pa34
Figure 6.13: Time evolution of the switching function (6.15) and dynamical condition
for immunity (6.18) for pt11
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can be used to generate a boundary layer control action which achieves desirable perfor-
mance despite the fact that ideal sliding motion is not exhibited. Further, the investigations
on the HIV-specific CD8+ T cell response in Chapter 5, have shown that although a potent
killing efficacy is not able to enforce ideal sliding motion, an asymptomatic steady-state can
be exhibited. Consequently, the concept of boundary layer control explains the difference
between the clinical observation and the outcome inferred from the reproductive ratio for
these patients. The origin is not attained but the outcome is sufficiently close to the desired
outcome and within the limits of accuracy of the measurement approach to be clinically
satisfactory.
Figure 6.14: Phase portrait of the sliding surface (6.15) for pt8
Figure 6.15: Phase portrait of the sliding surface (6.15) for pt11
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6.5.3 Failure cases
The following results relate to patients pa3, pa8 and pa10 for whom antiretroviral drugs are
unable to reduce and maintain the HIV viral load below 100RNA copies/ml i.e 2log10(RNA
copies/ml) within six months. In all cases of failure of antiretroviral treatment, the esti-
mated biological rates predict a steady-state viral load Vs1, see (6.13), which exceeds that
limit significantly. Furthermore, the reproductive ratio (6.12) is above unity in all failure
cases, see table 6.3. Therefore, the value of the reproductive ratio suggests that antiretro-
viral drugs are not able to render the infection-free steady-state (6.8) attractive and to
eradicate the virus. To investigate the performance of antiretroviral drugs in these pa-
tients, the reachability analysis is performed. From Fig. 6.16, it can be deduced that the
effects of antiretroviral drugs for pa3 are not sufficient to zero the switching function (6.15).
In fact, sE(t) does not vanish because the magnitude of the reachability condition (6.18)
becomes negative for only a very short period of time and then becomes positive. Impor-
tantly, this dynamical behaviour of the reachability condition in Fig. 6.17 for pa3 is the
same in all cases where antiretroviral drugs are inefficient, see Fig. 6.18. The oscillatory
Figure 6.16: Time evolution of the switching function (6.15) along with the dynamical
condition for immunity (6.18) for pa3
behaviour observed in the reachability condition reflects the fact that antiretroviral drugs in
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Figure 6.17: Time evolution of the dynamical condition for immunity (6.18) using sim-
ulation results for pa3
Figure 6.18: Time evolution of the dynamical condition for immunity (6.18) using sim-
ulation results for pa8 and pa10
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these patients are not able to maintain the reachability condition at the required negative
level following the initiation of treatment. Fig. 6.17 shows that the effects of antiretro-
viral drugs cannot satisfy βTV < µ1P for a prolonged period following the initiation of
treatment. As a result, the time evolution of the reachability condition predicts that the
antiretroviral drugs in these patients are unable to enforce the infection-free steady-state
i.e to eradicate the virus. Moreover, the phase portrait of the sliding surface, see Fig. 6.19,
for these failure cases demonstrates that the HIV infection dynamics do not reach the infec-
tion free steady-state located at the origin but attain a chronic HIV infection steady-state.
For instance, the phase portrait of pa3 shows dynamics moving away from the origin to
reach a chronic infection steady-state whilst the dynamics of pa10 move towards the origin
but stop at a chronic infection steady-state. Importantly, the comparative analysis of the
phase portrait of the sliding surface for different patients reinforces the fact that the tran-
sient dynamics induced by the antiretroviral treatment are diverse in failure cases. This
motivates the design of personalized antiretroviral treatment regimes to improve efficacy
and demonstrates that the reachability analysis presented in this chapter may be helpful
in developing appropriate treatments.
Figure 6.19: Phase portrait of the sliding surface (6.15) for pa3, pa8 and pa10
6.6 Conclusion
In this chapter, the dynamics of HIV infection following initiation of antiretroviral therapy
has been considered as a case study to demonstrate that the framework of the VSC paradigm
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finds applications in immunology. Here, tools from sliding mode control paradigm have been
utilized to assess the performance of antiretroviral drugs for HIV infection. From the results
in Chapter 5, HIV infection dynamics can be regarded as a closed-loop system with the
HIV-specific immune response as an inherent VSC feedback.
Motivated by these findings, the effects of antiretroviral drugs have been treated as an
outer-loop control input to contain the infection in vivo. The basic model of HIV infection
dynamics from [30, 60] has been chosen for this case study because its parameters have
been estimated using measurement of CD4 T cell count and HIV load collected during
clinical trials. Following the approach developed in Chapter 5, a manifold associated with
the infection-free steady-state has been identified. The reachability analysis introduced in
Chapter 2, has been used to formulate a dynamical condition for antiretroviral drugs to
render this manifold attractive in order to enforce the containment of the infection in vivo.
Using two HIV clinical data sets, predictions of the outcome of treatment for a set of pa-
tients have been made using the established reproductive ratio and the proposed dynamical
condition. The results show that the reachability paradigm is superior to the reproductive
ratio because the reachability condition highlights specific dynamical characteristics corre-
sponding to healthy, unhealthy and marginal outcomes.
Hence, the case study conducted in this chapter demonstrates that the framework of VSC
delivers additional insights on immunological dynamics. Consequently, this chapter moti-
vates the use of the VSC paradigm to study the dynamics of the immune system in health
and disease. The main conclusions and future work are articulated in the next chapter.
Chapter 7
Conclusions and Future work
7.1 Conclusions
In this thesis, the dynamics of the immune system have been analysed using the variable
structure control paradigm. The novelty of the approach resides in the fact that the dy-
namics of the immune system in health and disease are examined as a closed-loop system in
which the dynamic response of T cells operates as a control. Collectively, the findings pro-
vide clear evidence to support the argument that the dynamic response of T cells operates
as a variable structure control to achieve immunity and self-tolerance. This means that
the immune system switches between different feedback regimes to establish and maintain
a robust, healthy state. Importantly, this thesis contributes to knowledge in mathematical
immunology because it demonstrates that the framework of VSC is adequate to deliver
insights on the robustness of immunological dynamics. It has been proven that the reach-
ability paradigm from sliding mode control is a novel and efficient means to assess the
performance of the specific T cell response and candidate therapies.
The specific contribution is summarized as follows:
• Synergies between the dynamics of VSCS and the population dynamics of the antigen-
specific T cell response are demonstrated using a phase portrait analysis. This analysis
indicates that the immune response program which describes the dynamic response
of T cells following infection is, in essence, a variable structure control strategy to
prescribe the required changes in T cells population size to achieve the clearance of
the pathogen and the maintenance of a healthy state. From a VSC point of view,
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the dynamical behaviour of the population of the specific CD8+ T cell response
observed after acute or chronic infection is an output of a sophisticated switch be-
tween immunological feedback which promotes or inhibits the immune response. This
switching mechanism seems to be based on the dynamical effects of the interaction
of different molecular and cellular activities following antigen stimulation. Thus, the
immune response program is a switched control feedback strategy which highlights
the changes in the feedback regimes underpinning the specific T cell response.
• A reachability analysis has been conducted using a manifold associated with a healthy
steady-state to highlight switching conditions to enforce robust expansion and con-
traction dynamics. This has been shown to be useful to assess the impact of uncer-
tainty and perturbations on the T cell response dynamics. These conditions have been
used to explain the robustness of the T cell response dynamics during acute infection,
as well as why the T cell response dynamics are impaired during chronic infection.
The analysis of the specific immune response of T cells using a VSC approach opens
a new framework to evaluate immunological dynamics, and might assist the design of
treatment regimes to yield robust immune response dynamics.
• Candidate immune response functions have been analysed as candidate immunological
feedback regime for self-tolerance. A threshold immune response function based on
the concentration of self-antigen has been constructed to model a threshold based
activation/proliferation of self-reacting effector T cells. Besides, an adaptive sliding
mode control has been designed to model the suppression of self-reacting T cells by the
immune system. The control analysis conducted shows that the nature and shape of
candidate immune response function determines the dynamic response of the immune
system and the stability of the tolerance steady-state. Additionally, a reachability
analysis was conducted using a manifold associated with the tolerance steady-state.
This reachability analysis shows how the dynamic response of the immune system can
enforce a robust state of tolerance.
• The reachability paradigm has been utilized to analyse the control attributes of the
cytolytic killing mechanism of HIV-specific CD8+ T cell response on the containment
of HIV infection dynamics in vivo. Using a manifold associated with the infection-free
steady-state, the reachability analysis delivers a dynamical condition for immunity
which is used to monitor the control performance of the HIV-specific CD8+ T cell
response during the course of the infection. The results indicate that the cytolytic
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killing mechanism modelled with a double saturation function operates a continuous
variable structure control law which yields a boundary layer control of the infection
dynamics in vivo. The dynamical condition for immunity also supports the emerging
notion that the immunological requirements for the containment of HIV infection
changes during the course of the infection.
• The VSC approach has been demonstrated to be a novel means for the evaluation
of the impact of antiretroviral therapy on HIV infection dynamics in vivo. A VSC
approach has been used to deliver a dynamical condition for the containment of HIV
infection in vivo by antiretroviral therapy. The basic model of HIV infection dynamics
from [59] has been selected and clinical data from HIV-infected patients has been
used to parameterize this model. Unlike the condition from the reproductive ratio,
the reachability condition delivers a time varying condition for the infection dynamics
to reach and remain at the HIV infection-free steady-state. The findings show that
methodology captures the dynamical characteristics of eventual successful, failed and
marginal outcomes. Hence, the reachability paradigm from VSC theory is a suitable
framework to monitor and predict the progression of the Human Immunodeficiency
Virus (HIV) infection after initiation of antiretroviral therapy.
Together, the findings of the different chapters demonstrate that variable structure control
theory finds application in modelling and simulation in immunology. Importantly, the
approach developed in the thesis makes use of the reachability paradigm to deliver sensible
insights on the robustness of immunological dynamics. This doctoral research encourages
the use of techniques from variable structure control theory to investigate the dynamics of
biological systems with uncertainty.
The work on this thesis was limited by several factors. The approach relies on the fact
that a sensible mathematical model of the given phenomenon is available for analysis.
Furthermore, the availability of clinical data and reliable parameter estimates affect the
scope of the mathematical analysis. Thus, it is recommended to have a good understanding
of the biology represented by the mathematical model. A close collaboration between
experimental and mathematical studies is highly desirable.
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7.2 Future work
The findings of this thesis motivate the use of the variable structure control paradigm to
improve understanding of the dynamics of the immune system as well as to design efficient
therapeutic strategies.
Future work suggestions from headline finds are as follows:
• In [2, 74, 94], it was shown that the expansion, contraction and memory phase of
the specific CD8+ T cell response exhibits different magnitude and kinetics following
re-infection with the same antigen. In this thesis, the dynamics of the antigen-specific
CD8+ T cell response to acute infection has been considered to show that the immune
response program is, in essence, a VSC law governing the population dynamics of the
response. Motivated by the work of this thesis, it will be interesting to use these
experimental data to construct a mathematical model and to apply a VSC approach
to investigate what are the advantages and disadvantages related to changes in the
kinetics of CD8+ T cell expansion, contraction and memory following re-infections
with respect to the establishment of protective immunity. Since the immune response
program is treated as an inherent VSC control, the basic idea is to understand the im-
pact of consecutive infection on the parameters, switching behaviour and performance
of this immunological control mechanism. The findings from this research yield the
potential to inform the design and scheduling of vaccines to achieve better outcomes.
• The variable structure control paradigm supports results on the design of successful
vaccines for chronic infections. To confirm this point, consider the experimental
studies in [2] in which the dynamic response of memory CD8+ T cells specific to
LCMV is impaired following infection with a high viral load. The experiments in
[2] have revealed that activated LCMV-specific memory CD8+ T cells experience a
block in sustaining cell proliferation during this chronic infection. Further, it was
found that an immunological mechanism defined as CD4+ T cell help is a candidate
means of therapeutic intervention. Interestingly, in this context, using an appropriate
model of the specific CD8+ T cell response along with the variable structure control
paradigm, a reachability condition can be formulated to define a dynamical condition
required to maintain the expansion of activated LCMV-specific memory CD8+ T cells
following chronic infection. Moreover, this reachability condition together with the
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expression for the equivalent control can be used to quantify the level of CD4+ T cell
help required to sustain the proliferation dynamic of memory CD8+ T cells in order
to enforce immunity.
• Immunological failure is characterized by a level of CD4+ T cells below 200/mm3
during six months of efficient antiretroviral treatment. The biological mechanisms
inducing immunological failure are not fully understood. Different mathematical
functions supporting different biological assumptions have been investigated in the
literature [152, 155, 160]. Using measurements of the total number of CD4+ T cells
and HIV viral load collected from patients in the first month initiation of an efficient
antiretroviral therapy, the authors in [152, 155, 160] have identified candidate time
invariant parameters to predict immunological failure. To build on this work, it is
assumed that immunological failure is caused by an unknown input i.e unknown bio-
logical dynamics affecting the population dynamics of CD4+ T cells. Using standard
HIV clinical data along with the basic model of HIV dynamics in [152], a sliding mode
observer can be constructed. The idea is to use the equivalent control to reconstruct
the dynamic associated with immunological failure. The objective is to elucidate the
characteristics of immunological failure. The findings could be combined with the
results from this thesis to improve early diagnosis and monitoring of antiretroviral
therapy.
• In [58, 75], it has been pointed that the non-cytolytic mechanism of the HIV-specific
CD8+ T cell response is also an adequate means to contain HIV infection in vivo.
Of note, the parameter representing the non-cytolytic mechanism is present in the
expression of the dynamical condition for immunity and represents a candidate control
action to satisfy the dynamical condition for immunity and contain the infection in
vivo. Using the approach developed in this thesis and the data from [75], it could
be possible to assess the time evolution of the dynamical condition for immunity for
different killing mechanism of the HIV-specific CD8+ T cell response. The impact
of the non-cytolytic and the cytolytic mechanism as two inherent control feedback
of the HIV-specific CD8+ T cell response can be analysed using the framework of
sliding mode control. The dynamic advantages of each mechanism alone and the
complementarity of these mechanisms will be investigated to elucidate ways in which
CD8+ T cells contain HIV infection in vivo. The findings could be useful to inform
robust control mechanisms in the domain of engineering.
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• The paper [36] has investigated the control of HIV infection mainly using bifurcation
techniques. It was shown that the cytolytic killing rate of the HIV-specific CD8+ T
cell response and the size of the latent cell reservoir influence the progression of the
infection after cessation of antiretroviral therapy. This thesis has demonstrated that
the HIV-specific CD8+ T cell response and the effects of antiretroviral drugs in vivo
can be analysed as control inputs which aim to enforce a stable and asymptomatic
steady-state. Motivated by the findings of this thesis, it will be interesting to write
the analytical expression of a manifold associated with the post-treatment control of
HIV infection. The objective is to use this manifold to conduct a reachability analysis.
In essence, this will yield a dynamical condition for the killing efficacy of HIV-specific
CD8+ T cells and antiretroviral drugs to control HIV infection in vivo. It is of
great importance to understand how early uptake of antiretroviral drugs can help the
HIV-specific CD8+ T cell response to establish an asymptomatic state and maintain
this state even after the interruption of antiretroviral therapy [30, 36]. Hence, the
VSC approach used in this thesis has great potential to improve understanding of
functional cure of HIV.
Appendix A
Pseudo-code of the Multi-Point
Identification Method
Pseudo-code
-Get experimental data -Get time data sp3=[0 4 8 9 11 14 17 30 47 60 91 ];
-Get Cd4+ count Tvl= [ 122 133 177 172 208 174 231 201 251 262 276 ];
get virus load Vvl=[5.38 4.57 3.93 3.76 3.64 3.31 3.12 2.78 2.74 2.42 1.6 ]; -Convert virus
log from the log scale to the decimal scale
V lg = 10.(V vl);
- get initial condition x01=[80;42;Vlg(1)];
- safe copy of measurements Tvla=Tvl; Vlga=Vlg;
- Apply a scaling factor
mxV=max(Vlg(1:6));
mxT=max(Tvl(1:6));
- Get data points of the first 21 days Vlg=Vlg(1:6)./mxV;
Tvl=Tvl(1:6)./mxT;





-Compute polynomial polynomial -get some value for py (order of the polynomial) n2=0;




-choose a set of 5 distinct time points within 0 21 - lpb lower bound, upb uppper bound
spd=linspace(lpb,upb,5); -
- get the values to compute the identification system
y2patientest=[polyval(polypatienty2,spd)]’; y2dotdata=[polyval(dp2,spd)]’; y2dbdotdata=[polyval(d2p2,sp
y2tdotdata=[polyval(d3p2,spd)]’;
- compute identification equation
syms B R V M E real ;
fom = ((y2patientest.( − 1)). ∗ y2dotdata−R−B. ∗ y2patientest). ∗ ( y2dbdotdata+M. ∗
y2dotdata+ V. ∗ y2patientest) + E. ∗ y2patientest− V. ∗ y2dotdata−M. ∗ y2dbdotdata;
-solve identification matrix for virus load
rest3=vpasolve(eqest2);
Check for unique solution rb=rest3.B; if ( length((rb)) ==1) - - Check the sign of biological
rates
if((rest3.B(1)) > 0ANDAND(rest3.R(1)) > 0ANDAND(rest3.E(1)) > 0ANDAND(rest3.V (1))
0ANDAND(rest3.M(1)) > 0 )
pdest=(rest3.R(1));
mu1t = −(0.5. ∗ (−rest3.V (1)− ((rest3.V (1).2) + 4. ∗ rest3.M(1)).(0.5) ) );
-Computation of estimates from virus load and CD4+ measurements
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- Get polynomial -px polynomial order polypatienty1=polyfit(t,Tm,+px); polypatienty2=polyfit(t,Vm,p
-differentiate the polynomials
dp1=polyder(polypatienty1); dp2=polyder(polypatienty2); d2p2=polyd
- get time points
spds=linspace(lpbs,upbs,4); - - Get vakues
y1patientest=[polyval(polypatienty1,spds)]’; y1dotdata=[polyval(dp1,spds)]’;
y2patientest=[polyval(polypatienty2,spds)]’; y2dotdata=[polyval(dp2,spds)]’;
- Compute identification equation [m,n]=size(sp3(1:4)); omega=[ones(n,1) y1patientest
y2dotdata y2patientest];
- rom1=rank(omega) syms TH1 TH2 TH3 TH4 om =[TH1; TH2 ;TH3 ;TH4];
eqest=omega*om;
dom1=[diff(eqest(1),TH1) diff(eqest(1),TH2) diff(eqest(1),TH3) diff(eqest(1),TH4);diff(eqest(2),TH1)
diff(eqest(2),TH2) diff(eqest(2),TH3) diff(eqest(2),TH4);diff(eqest(3),TH1) diff(eqest(3),TH2)
diff(eqest(3),TH3) diff(eqest(3),TH4);diff(eqest(4),TH1) diff(eqest(4),TH2) diff(eqest(4),TH3)
diff(eqest(4),TH4)];
detom1=det(dom1);
if (detom1 = 0)
eqests=y1dotdata -omega*om;
- Solve identification equation (25) rest=vpasolve(eqests);
Check for unpique solution if ( length((rest.TH1)) ==1)







mu1 = −(0.5. ∗ (−rest3.V (1)− ((rest3.V (1).2) + 4. ∗ rest3.M(1)).(0.5) ) ); mu2g = (0.5. ∗




- -get virus steady-state level
ssVn= (pses*K)/(mu1*pmu2es) - (pdes/Besg);
-Filter for realistic parameter values
- check the sign of the biological rates
if(rest.TH1(1) > 0ANDANDrest.TH2(1) < 0ANDANDrest.TH3(1) < 0ANDANDrest.TH4(1)
0)
if ( mu1t ¿ pdes )
if ( ssVn ¡= ( 100/mxV) ) - -
if (mxT*(pses/pdes) ¿=200)
if (mu1t¡=3.5) if (pmu2es¡=6) if (pdes¡2)
- pses=double(pses);
pdesg=double(pdesg);
mu2g=double(mu2g); Besg=double(Besg); K=double(K); mu1=double(mu1); pmu2es=double(pmu2es);
pdes=double(pdes);
- Validation check of the output dynamics
- estimation time window tspana=[0 21];




-Check for positivity of the state variables




for idp=2:dpl y1s(idp)=y1sim(sum(t5¡=sp3(idp))); end y1s(1)=y1sim(1);
y2s=zeros(1,dpl)
for idp=2:dpl y2s(idp)=y2sim(sum(t5¡=sp3(idp))); end y2s(1)=y2sim(1);
-Compute the error ey1= mxT.*[Tvla(1:dpl)-y1s]’;
ey2= mxV.*[Vlga(1:dpl)-y2s]’;
Check the fit
dey1h = 100 ∗ (sum(ey1.2)/sum((mxT. ∗ Tvla(1 : dpl)′).2))
dey2h = 100 ∗ (sum(ey2.2)/sum((mxV. ∗ V lga(1 : dpl)′).2))
-Filter for better fitting
if ( ( (dey2h+dey1h)¡= (dey2i + dey1i) ) )
dey2i=dey2h




















Reproductiveration = double((pses ∗Besg ∗K)/(pdes ∗mu1 ∗ pmu2es))
- - ssVn=ssVn
ssVm= (pses*mxT*K*mxV/mxT)/(mu1*pmu2es) - (pdes/(Besg/mxV)); ssVm=double(ssVm)
ET=mxT*(pses/pdes)
-End ifs -End loops
-End
Appendix B
Estimates of HIV Dynamics
Parameters following
Antiretroviral Therapy
Pseudo code of the multi-point method
Parameter estimation results
The following are the results of the parameter estimation procedure described
in Chapter 5. The computational process has produced these estimates with a
high precision. It is shown in the next section that such high precision is not
compulsory and biologically relevant.
Patient pt1
λ = 427.1534026447107000 δT = 0.9876391196788116 β = 0.0004093987658605 µ1 =
1.0026999999999999 k = 1.6594605365105060 µ2 = 0.3979593353698864
Patient pt2
λ = 525.6326523532495700 δT = 1.1393025728584869 β = 0.0000114292728371 µ1 =
3.0764000000000000 k = 530.5060041665457200 µ2 = 0.9490449503506817
Patient pt3
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λ = 137.9741119638239900 δT = 0.7038155848335397 β = 0.0002826190338890 µ1 =
0.9031000000000000 k = 7.5114253152300359 µ2 = 0.4962904358494573
Patient pt4
λ = 61.1615973565333850 δT = 0.2155640611980289 β = 0.0000844969285702 µ1 = 0.3746000000000000
k = 5.2335290818264886 µ2 = 0.4525321093719749
Patient pt5
λ = 511.2167264389443600 δT = 1.1618006804012180 β = 0.0013574984809959 µ1 =
1.2355000000000000 k = 0.1063031494385558 µ2 = 0.4802282398429222
Patient pt6 λ = 447.2664063299146200 δT = 0.8700912309267833 β = 0.0003833533433395
µ1 = 1.0826000000000000 k = 0.9867397078338738 µ2 = 0.2044200509728017
Patient pt7 λ = 48.5473106245905160 δT = 0.8822498032971305 β = 0.0001059037437115
µ1 = 1.0950000000000000 k = 237.4106883197578400 µ2 = 1.9837037442920844
Patient pt8 λ = 32.0253577139126050 δT = 0.1226941299773771 β = 0.0000224738651096
µ1 = 0.6715000000000000 k = 163.5680183774189200 µ2 = 1.4160782657508266
Patient pt9 λ = 255.4070488046519600 δT = 0.8378135735937042 β = 0.0002456884900764
µ1 = 1.4867999999999999 k = 4.6674823943125769 µ2 = 0.5083553798664283
Patient pt11 λ = 20.2317632084434820 δT = 0.2487626750256210 β = 0.0000211458811785
µ1 = 1.5947000000000000 k = 717.2060327118180100 µ2 = 0.7670342435229737
Patient pt12 λ = 216.1561150733994300 δT = 0.4764870265142694 β = 0.0005537155404234
µ1 = 0.5379000000000000 k = 0.5742665980752227 µ2 = 0.8759987609017709
Patient pa3 λ = 19.4408623647801560 δT = 0.0568538325062474 β = 0.0001830425581339
µ1 = 0.3996000000000000 k = 24.6106645104727730 µ2 = 0.3349133769729255
Patient pa8 λ = 72.4635991045300470 δT = 0.1841155797175370 β = 0.0007394551099452
µ1 = 1.0537000000000001 k = 6.9008108987446164 µ2 = 0.3845808819584701
Patient pa10 λ = 117.2810831471476300 δT = 0.1525813697842263 β = 0.0000415717722124
µ1 = 0.5315000000000000 k = 16.9338333596265510 µ2 = 0.3564434330432689
Patient pa13 λ = 43.2603737796453630 δT = 0.1980028036690134 β = 0.0014961695065872
µ1 = 0.6526000000000000 k = 0.0087237030026186 µ2 = 0.2784742989866295
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Patient pa24 λ = 118.3944765066074500 δT = 0.3494973739820475 β = 0.0000484570236368
µ1 = 0.4511000000000000 k = 9.1057495433492903 µ2 = 0.3718590222853928
Patient pa34 λ = 169.7212477179362800 δT = 0.4489658853123205 β = 0.0001301732247592
µ1 = 0.4607000000000000 k = 4.6706068433784020 µ2 = 0.4924810339778832
Patient pa38 λ = 137.6607843710946200 δT = 0.4911172096189913 β = 0.0001765832669711
µ1 = 0.5892000000000000 k = 3.5485606943201660 µ2 = 0.2886473516225888
Patient pa43 λ = 234.4995186440960100 δT = 0.6425517170861793 β = 0.0002931044629164
µ1 = 0.7370000000000000 k = 0.4583934984202140 µ2 = 0.1987462564206444
Robustness to precision
The 16 digit precision for the estimates was obtained because the identification procedure
computed in Matlab used a 16 digit precision. The estimated biological rates are float
numbers because the unique solutions of the system of equations (6.19) and (6.25) used to
compute the estimates are produced with a 16 digit precision. As mentioned in the paper,
these estimates with full accuracy are used for the simulations.
The output dynamics of the basic HIV model exhibits some robustness to the precision of
the estimates. The results for patient pt1, pt8 and pa3 are shown to provide some evidence.
The Matlab vpa () command which is a variable-precision floating-point arithmetic function









Patient pt8 λ = 32
δT = 0.12
β = 0.000022










Fig. B.1, Fig. B.2 and Fig. B.3 show a comparative analysis of the output dynamics pro-
duced by the estimates with full precision and the ones with 2 significant digits. These
graphs confirm that the output dynamics of the model exhibit some robustness to the
precision chosen for the estimates because the trajectories are relatively close to each other.
Figure B.1: Comparison of the time evolution of the estimated dynamics of CD4+ T cell
count and HIV load with different precision. Results for pt1. l (6.7).
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Figure B.2: Comparison of the time evolution of the estimated dynamics of CD4+ T cell
count and HIV load with different precision. Results for pt8. l (6.7).
Figure B.3: Comparison of the time evolution of the estimated dynamics of CD4+ T cell
count and HIV load with different precision. Results for pa3. l (6.7).
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stability and performance depends on the immune response mechanism. This paper
presents an analysis of the immune system from the viewpoint of variable structure
control. The immune response function is regarded as a switch. The influence of
candidate personal immune response functions inspired by both experimental and
mathematical work from immunology on capturing this crucial dynamics is reviewed.
Motivated by this analysis and knowledge of variable structure control, a discon-
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inhibition of undesirable responses to self-tissues is a key property of the naturally
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occurring robust feedback mechanism seen within a healthy immune system. In this
paper, Variable Structure Control (VSC) theory is used to design an adaptive sliding
mode control to model the observed self-tolerance exhibited by a healthy immune
system. A suitable sliding manifold and corresponding reachability condition are for-
mulated based on knowledge of the healthy tolerance steady-state. Unlike existing
candidate immune response functions, the proposed control function exhibits robust
performance commensurate with the self-tolerance mechanisms of the immune system
which have been observed experimentally.
